1 |
Prieto-fernández L, Montoro-jiménez I, de Luxan-delgado B, Otero-rosales M, Rodrigo JP, Calvo F, García-pedrero JM, Álvarez-teijeiro S. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment. Biomedicine & Pharmacotherapy 2023;161:114502. [DOI: 10.1016/j.biopha.2023.114502] [Reference Citation Analysis]
|
2 |
Lee YM, Chen YH, Ou DL, Hsu CL, Liu JH, Ko JY, Hu MC, Tan CT. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma. J Pathol 2023;259:428-40. [PMID: 36641765 DOI: 10.1002/path.6055] [Reference Citation Analysis]
|
3 |
Guo C, Liu Z, Zhang H. DNA 6mA demethylase ALKBH1 regulates DDX18 expression to promote proliferation of human head and neck squamous cell carcinoma. Cell Oncol (Dordr) 2023. [PMID: 36976498 DOI: 10.1007/s13402-023-00800-1] [Reference Citation Analysis]
|
4 |
Peng Q, Jiang X, Tan S, Xu X, Xia L, Wu N, Lin J, Oyang L, Tang Y, Peng M, Su M, Luo X, Han Y, Liao Q, Zhou Y. Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma. Aging (Albany NY) 2023;15. [PMID: 36947706 DOI: 10.18632/aging.204579] [Reference Citation Analysis]
|
5 |
Wang Q, Zhao Y, Chen Y, Chen Y, Song X, Zhang L, He Q, Ye B, Wu L, Huang X, Wang D. High PD-L1 expression associates with low T-cadherin expression and poor prognosis in human papillomavirus-negative head and neck squamous cell carcinoma. Head Neck 2023. [PMID: 36939297 DOI: 10.1002/hed.27329] [Reference Citation Analysis]
|
6 |
Li H, Ye M, Hu Z, Lu H, Zheng D, Wu M, Ge T, Xu S, Ge Z, Zhang S, Xu G, Chen H. IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis. Medicine (Baltimore) 2023;102:e33124. [PMID: 36930079 DOI: 10.1097/MD.0000000000033124] [Reference Citation Analysis]
|
7 |
Gómez-armayones S, Tous S, Chimenos-küstner E, Arranz C, Marquez S, Penín R, Quirós B, Taberna M, Alemany L, Servitje O, Mena M. Risk Factors for Malignant Transformation of Oral Lichen Planus.. [DOI: 10.21203/rs.3.rs-2663588/v1] [Reference Citation Analysis]
|
8 |
Park HY, Lee JS, Wee JH, Kang JW, Kim ES, Koo T, Hwang HS, Kim HJ, Kang HS, Lim H, Kim NY, Nam ES, Cho SJ, Kwon MJ. Assessment of the Mutation Profile of Tonsillar Squamous Cell Carcinomas Using Targeted Next-Generation Sequencing. Biomedicines 2023;11:851. [DOI: 10.3390/biomedicines11030851] [Reference Citation Analysis]
|
9 |
Chi H, Yang J, Peng G, Zhang J, Song G, Xie X, Xia Z, Liu J, Tian G. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1091218] [Reference Citation Analysis]
|
10 |
Li Y, Huang Y, Li B, Yang K. Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma. BMC Med Genomics 2023;16:38. [PMID: 36855110 DOI: 10.1186/s12920-023-01470-6] [Reference Citation Analysis]
|
11 |
Sofiani VH, Veisi P, Rukerd MRZ, Ghazi R, Nakhaie M. The complexity of human papilloma virus in cancers: a narrative review. Infect Agent Cancer 2023;18:13. [PMID: 36843070 DOI: 10.1186/s13027-023-00488-w] [Reference Citation Analysis]
|
12 |
Bueno-Urquiza LJ, Martínez-Barajas MG, Villegas-Mercado CE, García-Bernal JR, Pereira-Suárez AL, Aguilar-Medina M, Bermúdez M. The Two Faces of Immune-Related lncRNAs in Head and Neck Squamous Cell Carcinoma. Cells 2023;12. [PMID: 36899863 DOI: 10.3390/cells12050727] [Reference Citation Analysis]
|
13 |
Garley M. Unobvious Neutrophil Extracellular Traps Signification in the Course of Oral Squamous Cell Carcinoma: Current Understanding and Future Perspectives. Cancer Control 2023;30:10732748231159313. [PMID: 36814071 DOI: 10.1177/10732748231159313] [Reference Citation Analysis]
|
14 |
Duan Y, Yue K, Ye B, Chen P, Zhang J, He Q, Wu Y, Lai Q, Li H, Wu Y, Jing C, Wang X. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2. Cell Death Dis 2023;14:149. [PMID: 36813772 DOI: 10.1038/s41419-023-05667-6] [Reference Citation Analysis]
|
15 |
Elmakaty I, Elsayed B, Elmarasi M, Kujan O, Malki MI. Clinicopathological and prognostic value of chemokine receptor CCR7 expression in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Expert Rev Anticancer Ther 2023. [PMID: 36744447 DOI: 10.1080/14737140.2023.2177156] [Reference Citation Analysis]
|
16 |
P H, Rangarajan M, Pandya HJ. Breath VOC analysis and machine learning approaches for disease screening: a review. J Breath Res 2023;17. [PMID: 36634360 DOI: 10.1088/1752-7163/acb283] [Reference Citation Analysis]
|
17 |
Liu Q, Li S, Qiu Y, Zhang J, Rios FJ, Zou Z, Touyz RM. Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7. Front Cardiovasc Med 2023;10:1002438. [PMID: 36818331 DOI: 10.3389/fcvm.2023.1002438] [Reference Citation Analysis]
|
18 |
Palumbo C, Benvenuto M, Focaccetti C, Albonici L, Cifaldi L, Rufini A, Nardozi D, Angiolini V, Bei A, Masuelli L, Bei R. Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma. Front Med (Lausanne) 2023;10:1066021. [PMID: 36817764 DOI: 10.3389/fmed.2023.1066021] [Reference Citation Analysis]
|
19 |
Wang J, Man QW, Fu QY, Zhong NN, Wang HQ, Li SR, Gao X, Lin H, Su FC, Bu LL, Chen G, Liu B. Preliminary Extracellular Vesicle Profiling in Drainage Fluid After Neck Dissection in OSCC. J Dent Res 2023;102:178-86. [PMID: 36331313 DOI: 10.1177/00220345221130013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
20 |
Pomella S, Cassandri M, Melaiu O, Marampon F, Gargari M, Campanella V, Rota R, Barillari G. DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma. Int J Mol Sci 2023;24. [PMID: 36768994 DOI: 10.3390/ijms24032673] [Reference Citation Analysis]
|
21 |
Khadela A, Shah Y, Mistry P, Bodiwala K, Cb A. Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technol Cancer Res Treat 2023;22:15330338221150559. [PMID: 36683526 DOI: 10.1177/15330338221150559] [Reference Citation Analysis]
|
22 |
Starke S, Zwanenburg A, Leger K, Zöphel K, Kotzerke J, Krause M, Baumann M, Troost EGC, Löck S. Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction. Cancers (Basel) 2023;15. [PMID: 36765628 DOI: 10.3390/cancers15030673] [Reference Citation Analysis]
|
23 |
Glathar AR, Oyelakin A, Nayak KB, Sosa J, Romano RA, Sinha S. A Systemic and Integrated Analysis of p63-Driven Regulatory Networks in Mouse Oral Squamous Cell Carcinoma. Cancers (Basel) 2023;15. [PMID: 36672394 DOI: 10.3390/cancers15020446] [Reference Citation Analysis]
|
24 |
Yang F, Zhou L, Chen J, Luo Y, Wang Y. Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis. Front Genet 2022;13:1035910. [PMID: 36685969 DOI: 10.3389/fgene.2022.1035910] [Reference Citation Analysis]
|
25 |
Liu D, Zhou LQ, Cheng Q, Wang J, Kong WJ, Zhang SL. Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma. Front Genet 2022;13:988606. [PMID: 36685979 DOI: 10.3389/fgene.2022.988606] [Reference Citation Analysis]
|
26 |
Wang J, Li S, Wang K, Zhu L, Yang L, Zhu Y, Zhang Z, Hu L, Yuan Y, Fan Q, Ren J, Yang G, Ding W, Zhou X, Cui J, Zhang C, Yuan Y, Huang R, Tian J, Tao X. A c-MET-Targeted Topical Fluorescent Probe cMBP-ICG Improves Oral Squamous Cell Carcinoma Detection in Humans. Ann Surg Oncol 2023;30:641-51. [PMID: 36184713 DOI: 10.1245/s10434-022-12532-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
27 |
Gu X, Wang L, Coates PJ, Gnanasundram SV, Sgaramella N, Sörlin J, Erdogan B, Magan M, Nylander K. Evidence for etiologic field changes in tongue distant from tumor in patients with squamous cell carcinoma of the oral tongue. J Pathol 2023;259:93-102. [PMID: 36314576 DOI: 10.1002/path.6025] [Reference Citation Analysis]
|
28 |
Wang Q, Liao C, Tan Z, Li X, Guan X, Li H, Tian Z, Liu J, An J. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway. Cancer Gene Ther 2023;30:182-91. [PMID: 36151332 DOI: 10.1038/s41417-022-00530-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
29 |
Jingbo W, Yuan Y, Tao X. ASO Author Reflections: Topically Applied Targeted Near-Infrared Fluorescence Imaging Probe Helps Detect Head and Neck Squamous Cell Carcinoma. Ann Surg Oncol 2023;30:652. [PMID: 36180620 DOI: 10.1245/s10434-022-12592-z] [Reference Citation Analysis]
|
30 |
Feng Y, Zhou YH, Zhao J, Su XL, Chen NX, Zhao YQ, Ye Q, Hu J, Ou-Yang ZY, Zhong MM, Yang YF, Han PJ, Guo Y, Feng YZ. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation. Front Genet 2023;14:1041042. [PMID: 36936420 DOI: 10.3389/fgene.2023.1041042] [Reference Citation Analysis]
|
31 |
Jiang X, Ke J, Jia L, An X, Ma H, Li Z, Yuan W. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. J Cancer Res Clin Oncol 2023;149:203-18. [PMID: 36376617 DOI: 10.1007/s00432-022-04471-7] [Reference Citation Analysis]
|
32 |
Zhou L, Cheng Q, Hu Y, Tan H, Li X, Wu S, Zhou T, Zhou J. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation. Front Oncol 2022;12:1030802. [PMID: 36620545 DOI: 10.3389/fonc.2022.1030802] [Reference Citation Analysis]
|
33 |
Tran BT, Gelin A, Durand S, Texier M, Daste A, Toullec C, Benihoud K, Breuskin I, Gorphe P, Garic F, Brenner C, Le Tourneau C, Fayette J, Niki T, David M, Busson P, Even C. Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors. Oncoimmunology 2023;12:2150472. [PMID: 36545254 DOI: 10.1080/2162402X.2022.2150472] [Reference Citation Analysis]
|
34 |
Zhang DJ, Fu ZM, Guo YY, Guo F, Wan YN, Guan GF. Circ_0000052/miR-382-3p axis induces PD-L1 expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma. J Cell Mol Med 2023;27:113-26. [PMID: 36515567 DOI: 10.1111/jcmm.17643] [Reference Citation Analysis]
|
35 |
Huang J, Xu Z, Yuan Z, Teh BM, Zhou C, Shen Y. Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma. Front Oncol 2022;12:983956. [PMID: 36568234 DOI: 10.3389/fonc.2022.983956] [Reference Citation Analysis]
|
36 |
Yang Y, Ma B, Han L, Xu W, Du X, Wei W, Liao T, Ji Q, Qu N, Wang Y. Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Front Genet 2022;13:1028469. [PMID: 36568368 DOI: 10.3389/fgene.2022.1028469] [Reference Citation Analysis]
|
37 |
Pastorino R, Sassano M, Danilo Tiziano F, Giraldi L, Amore R, Arzani D, Abiusi E, Ahrens W, Vilches LA, Canova C, Healy CM, Holcatova I, Lagiou P, Polesel J, Popovic M, Nygård S, Cadoni G, Znaor A, Boffetta P, Matsuo K, Oze I, Brennan P, Boccia S. Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiol Biomarkers Prev 2022;31:2237-43. [PMID: 36126276 DOI: 10.1158/1055-9965.EPI-22-0376] [Reference Citation Analysis]
|
38 |
Böke S, Schneider F, Hoefert S, Becker S. Lokal fortgeschrittene Kopf-Hals-Tumoren: Therapiekonzepte und neue Ansätze. TumorDiagnostik & Therapie 2022;43:667-670. [DOI: 10.1055/a-1934-0538] [Reference Citation Analysis]
|
39 |
He Y, Yang D, Li Y, Xiang J, Wang L, Wang Y. Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.949713] [Reference Citation Analysis]
|
40 |
Bechstedt N, Pomjanski N, Schramm M, Remmerbach TW. Evaluation of Static DNA Ploidy Analysis Using Conventional Brush Biopsy-Based Cytology Samples as an Adjuvant Diagnostic Tool for the Detection of a Malignant Transformation in Potentially Oral Malignant Diseases: A Prospective Study. Cancers (Basel) 2022;14. [PMID: 36497310 DOI: 10.3390/cancers14235828] [Reference Citation Analysis]
|
41 |
Yang W, Zhang T, Song X, Dong G, Xu L, Jiang F. SNP-Target Genes Interaction Perturbing the Cancer Risk in the Post-GWAS. Cancers (Basel) 2022;14. [PMID: 36428729 DOI: 10.3390/cancers14225636] [Reference Citation Analysis]
|
42 |
Dey Ghosh R, Guha Majumder S. Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. Cancers (Basel) 2022;14. [PMID: 36428681 DOI: 10.3390/cancers14225590] [Reference Citation Analysis]
|
43 |
Ju G, Yao Z, Zhao Y, Zhao X, Liu F. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.. [DOI: 10.21203/rs.3.rs-1956294/v2] [Reference Citation Analysis]
|
44 |
Yao S, Huang Z, Wei C, Wang Y, Xiao H, Chen S, Huang Z. CD79A Work as a Potential Target For The Prognosis of Patients With HNSCC: Analysis of Immune Cell Infiltration In Head and Neck Squamous Cell Carcinoma Based on The CIBERSORTx Deconvolution Algorithm.. [DOI: 10.21203/rs.3.rs-2177047/v1] [Reference Citation Analysis]
|
45 |
Morand GB. Metabolische Tumorbildgebung bei muskosalen Kopf- und Hals-Karzinomen. Praxis 2022;111:878-883. [DOI: 10.1024/1661-8157/a003926] [Reference Citation Analysis]
|
46 |
Salcedo-Bellido I, Requena P, Mateos R, Ortega-Rico C, Olmedo-Requena R, Lozano-Lorca M, Arrebola JP, Barrios-Rodríguez R. Factors associated with the development of second primary tumours in head and neck cancer patients. Eur J Cancer Care (Engl) 2022;31:e13699. [PMID: 36117311 DOI: 10.1111/ecc.13699] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
47 |
Han Y, Shi Y, Chen B, Wang J, Liu Y, Sheng S, Fu Z, Shen C, Wang X, Yin S, Li H. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.961695] [Reference Citation Analysis]
|
48 |
Sharifi S, Dalir Abdolahinia E, Ghavimi MA, Dizaj SM, Aschner M, Saso L, Khan H. Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5. Curr Issues Mol Biol 2022;44:5247-59. [PMID: 36354669 DOI: 10.3390/cimb44110357] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
49 |
Wang J, Man Q, Zhong N, Wang H, Zhang C, Li S, Bu L, Liu B. ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC. IJMS 2022;23:12777. [DOI: 10.3390/ijms232112777] [Reference Citation Analysis]
|
50 |
Chen X, Luo Q, Xiao Y, Zhu J, Zhang Y, Ding J, Li J. LINC00467: an oncogenic long noncoding RNA. Cancer Cell Int 2022;22:303. [PMID: 36203193 DOI: 10.1186/s12935-022-02733-5] [Reference Citation Analysis]
|
51 |
Taziki M, Rajaei S, Firouzei G, Hashemzadeh F, Rajabalian M, Mansoury M, Sedaghat S, Ghahraman F, Ghasemi-Kebria F, Weiderpass E, Roshandel G. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran. Cancer Epidemiol 2022;80:102247. [PMID: 36081275 DOI: 10.1016/j.canep.2022.102247] [Reference Citation Analysis]
|
52 |
Errazquin R, Page A, Suñol A, Segrelles C, Carrasco E, Peral J, Garrido-Aranda A, Del Marro S, Ortiz J, Lorz C, Minguillon J, Surralles J, Belendez C, Alvarez M, Balmaña J, Bravo A, Ramirez A, Garcia-Escudero R. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. Oral Oncol 2022;134:106184. [PMID: 36191479 DOI: 10.1016/j.oraloncology.2022.106184] [Reference Citation Analysis]
|
53 |
Chen B, Luo Y, Kang X, Sun Y, Jiang C, Yi B, Yan X, Chen Y, Shi R. Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes. Front Genet 2022;13:981222. [DOI: 10.3389/fgene.2022.981222] [Reference Citation Analysis]
|
54 |
Prieto-fernández L, Menéndez ST, Otero-rosales M, Montoro-jiménez I, Hermida-prado F, García-pedrero JM, Álvarez-teijeiro S. Pathobiological functions and clinical implications of annexin dysregulation in human cancers. Front Cell Dev Biol 2022;10:1009908. [DOI: 10.3389/fcell.2022.1009908] [Reference Citation Analysis]
|
55 |
Azad A, Kong A. The Therapeutic Potential of Imidazole or Quinone-Based Compounds as Radiosensitisers in Combination with Radiotherapy for the Treatment of Head and Neck Squamous Cell Carcinoma. Cancers 2022;14:4694. [DOI: 10.3390/cancers14194694] [Reference Citation Analysis]
|
56 |
Chen X, Chen DR, Liu H, Yang L, Zhang Y, Bu LL, Sun ZJ, Cai L. Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma. J Control Release 2022;351:381-93. [PMID: 36096364 DOI: 10.1016/j.jconrel.2022.09.010] [Reference Citation Analysis]
|
57 |
Cheng Y, Chen J, Shi Y, Fang X, Tang Z. MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy. Cancers (Basel) 2022;14. [PMID: 36230547 DOI: 10.3390/cancers14194625] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
58 |
Spalthoff S, Nejati-rad N, Rahlf B, Jehn P, Gellrich N, Lentge F, Korn P. Time is crucial in malignant tumor cases: Speeding up the process of patient-specific implant creation. Front Oncol 2022;12:904343. [DOI: 10.3389/fonc.2022.904343] [Reference Citation Analysis]
|
59 |
Koyama S, Ehara H, Donishi R, Morisaki T, Ogura T, Taira K, Fukuhara T, Fujiwara K. Photoimmunotherapy with surgical navigation and computed tomography guidance for recurrent maxillary sinus carcinoma. Auris Nasus Larynx 2022:S0385-8146(22)00204-8. [PMID: 36123249 DOI: 10.1016/j.anl.2022.09.001] [Reference Citation Analysis]
|
60 |
Schinke H, Shi E, Lin Z, Quadt T, Kranz G, Zhou J, Wang H, Hess J, Heuer S, Belka C, Zitzelsberger H, Schumacher U, Genduso S, Riecken K, Gao Y, Wu Z, Reichel CA, Walz C, Canis M, Unger K, Baumeister P, Pan M, Gires O. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer. Mol Cancer 2022;21:178. [PMID: 36076232 DOI: 10.1186/s12943-022-01646-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
61 |
Ahmadi Kamalabadi M, Neshastehriz A, Ghaznavi H, Amini SM. Folate functionalized gold-coated magnetic nanoparticles effect in combined electroporation and radiation treatment of HPV-positive oropharyngeal cancer. Med Oncol 2022;39:196. [PMID: 36071293 DOI: 10.1007/s12032-022-01780-2] [Reference Citation Analysis]
|
62 |
He F, Zhou X, Huang G, Jiang Q, Wan L, Qiu J, Yuchi A. Establishment and Identification of Patient-Derived Xenograft Model for Oral Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/3135470] [Reference Citation Analysis]
|
63 |
Tarek HE, Shalash HN, Morsy RAA, Mostafa B, Hassan M, Abbas RM, Ellithy MM. Salivary and serum expression of TNF-α and Ki-67 in oral potentially malignant lesions. Bull Natl Res Cent 2022;46:241. [DOI: 10.1186/s42269-022-00931-9] [Reference Citation Analysis]
|
64 |
Chen X, Tan B, Xu M, Zhou H, Ou J, Zhang X, Yu Z, Chen T. Apparent Diffusion Coefficient Derived from Diffusion-weighted Imaging to Differentiate between Tumor, Tumor-adjacent and Tumor-distant Tissues in Resectable Rectal Adenocarcinoma. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110506] [Reference Citation Analysis]
|
65 |
Desilets A, Soulières D. PI3K Inhibition for Squamous Cell Head and Neck Carcinoma. Cancer J 2022;28:369-76. [PMID: 36165725 DOI: 10.1097/PPO.0000000000000618] [Reference Citation Analysis]
|
66 |
Chang JW, Seo ST, Im MA, Won HR, Liu L, Oh C, Jin YL, Piao Y, Kim HJ, Kim JT, Jung SN, Koo BS. Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squamous cell carcinoma. Transl Res 2022;247:58-78. [PMID: 35462077 DOI: 10.1016/j.trsl.2022.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
67 |
Xue Y, Song X, Fan S, Deng R. The role of tumor-associated macrophages in oral squamous cell carcinoma. Front Physiol 2022;13:959747. [DOI: 10.3389/fphys.2022.959747] [Reference Citation Analysis]
|
68 |
Wang H, Jiang J, Wu J, Zhang M, Pang X, Dai L, Tang Y, Liang X. Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma. Cancers 2022;14:4151. [DOI: 10.3390/cancers14174151] [Reference Citation Analysis]
|
69 |
Jangholi A, Müller Bark J, Kenny L, Vasani S, Rao S, Dolcetti R, Punyadeera C. Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma. Biochim Biophys Acta Rev Cancer 2022;1877:188784. [PMID: 36028150 DOI: 10.1016/j.bbcan.2022.188784] [Reference Citation Analysis]
|
70 |
Ju G, Yao Z, Zhao Y, Zhao X, Liu F. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.. [DOI: 10.21203/rs.3.rs-1956294/v1] [Reference Citation Analysis]
|
71 |
Zhou X, Wang X. Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma. Biomedicines 2022;10:1990. [DOI: 10.3390/biomedicines10081990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
72 |
Andrei EC, Baniță IM, Munteanu MC, Busuioc CJ, Mateescu GO, Mălin RD, Pisoschi CG. Oral Papillomatosis: Its Relation with Human Papilloma Virus Infection and Local Immunity—An Update. Medicina 2022;58:1103. [DOI: 10.3390/medicina58081103] [Reference Citation Analysis]
|
73 |
Wang J, Su X, Zhang X, Chen W, Li J, Yang Z, Li X, Chen J, Zhang Y, Chen S, Song M. Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection. Sci Rep 2022;12:13696. [PMID: 35953555 DOI: 10.1038/s41598-022-17932-3] [Reference Citation Analysis]
|
74 |
Salnikov M, Gameiro SF, Zeng PYF, Barrett JW, Nichols AC, Mymryk JS. The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis. mSphere 2022;:e0031722. [PMID: 35950764 DOI: 10.1128/msphere.00317-22] [Reference Citation Analysis]
|
75 |
Moya-garcia CR, Okuyama H, Sadeghi N, Li J, Tabrizian M, Li-jessen NYK. In vitro models for head and neck cancer: Current status and future perspective. Front Oncol 2022;12:960340. [DOI: 10.3389/fonc.2022.960340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
76 |
Chattopadhyay T, Biswal P, Lalruatfela A, Mallick B. Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications. Biochim Biophys Acta Rev Cancer 2022;:188772. [PMID: 35931391 DOI: 10.1016/j.bbcan.2022.188772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
77 |
Wu Y, Koyuncu CF, Toro P, Corredor G, Feng Q, Buzzy C, Old M, Teknos T, Connelly ST, Jordan RC, Lang Kuhs KA, Lu C, Lewis JS Jr, Madabhushi A. A machine learning model for separating epithelial and stromal regions in oral cavity squamous cell carcinomas using H&E-stained histology images: A multi-center, retrospective study. Oral Oncol 2022;131:105942. [PMID: 35689952 DOI: 10.1016/j.oraloncology.2022.105942] [Reference Citation Analysis]
|
78 |
Ure A, Mukhedkar D, Arroyo Mühr LS. Using HPV-meta for human papillomavirus RNA quality detection. Sci Rep 2022;12:13058. [PMID: 35906372 DOI: 10.1038/s41598-022-17318-5] [Reference Citation Analysis]
|
79 |
Mandic R, Marquardt A, Terhorst P, Ali U, Nowak-Rossmann A, Cai C, Rodepeter FR, Stiewe T, Wezorke B, Wanzel M, Neff A, Stuck BA, Bette M. The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC. BMC Cancer 2022;22:785. [PMID: 35850701 DOI: 10.1186/s12885-022-09854-0] [Reference Citation Analysis]
|
80 |
Ghosh S, Shah PA, Johnson FM. Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2022;23:7889. [PMID: 35887235 DOI: 10.3390/ijms23147889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
81 |
Xiao F, Wang K, Chen Y, Zhang Y. Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma. Evid Based Complement Alternat Med 2022;2022:1572249. [PMID: 35795287 DOI: 10.1155/2022/1572249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
82 |
Yin X, Wang J, Bian Y, Jia Q, Shen Z, Zhang H. Comprehensive Analysis of LINC01615 in Head and Neck Squamous Cell Carcinoma: A Hub Biomarker Identified by Machine Learning and Experimental Validation. J Oncol 2022;2022:5039962. [PMID: 35794984 DOI: 10.1155/2022/5039962] [Reference Citation Analysis]
|
83 |
Zhang Y, Gu D. Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma. Front Oncol 2022;12:889844. [DOI: 10.3389/fonc.2022.889844] [Reference Citation Analysis]
|
84 |
Ren ZH, Lei JS, Yang ZM, Zhang S, Yu JJ, Wu HJ. Postoperative radiotherapy may not be necessary for locally advanced head and neck squamous cell carcinoma: a case-match multicentre study. BMC Oral Health 2022;22:253. [PMID: 35751079 DOI: 10.1186/s12903-022-02288-x] [Reference Citation Analysis]
|
85 |
Lou C, Shi J, Xu Q. Exosomal miR-626 promotes the malignant behavior of oral cancer cells by targeting NFIB. Mol Biol Rep 2022. [PMID: 35711020 DOI: 10.1007/s11033-022-07336-x] [Reference Citation Analysis]
|
86 |
Cao AC, Sannigrahi MK, Rajagopalan P, Brody RM, Raghav L, Gimotty PA, Basu D. Cancer type-specific prioritization strategy for targetable dependencies developed from the DepMap profile of head and neck cancer.. [DOI: 10.1101/2022.06.12.495566] [Reference Citation Analysis]
|
87 |
Qian H, Wang L, Li Y, Wang B, Li C, Fang L, Tang L. The traditional uses, phytochemistry and pharmacology of Abrus precatorius L.: A comprehensive review. J Ethnopharmacol 2022;296:115463. [PMID: 35714881 DOI: 10.1016/j.jep.2022.115463] [Reference Citation Analysis]
|
88 |
Hou Y, Zhou M, Li Y, Tian T, Sun X, Chen M, Xu W, Lu M. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway. Mol Carcinog 2022. [PMID: 35687049 DOI: 10.1002/mc.23422] [Reference Citation Analysis]
|
89 |
Oyelakin A, Nayak KB, Glathar AR, Gluck C, Wrynn T, Tugores A, Romano RA, Sinha S. EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC. NAR Cancer 2022;4:zcac017. [PMID: 35664541 DOI: 10.1093/narcan/zcac017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
90 |
Lee G, Begley J, Ahluwalia K, Shariff JA, Wadhwa S, O’hea C, Isola G. Parent Attitudes regarding Orthodontists’ Role as Potential Administrators of Human Papilloma Virus (HPV) Vaccines. International Journal of Dentistry 2022;2022:1-7. [DOI: 10.1155/2022/6541532] [Reference Citation Analysis]
|
91 |
Errazquin R, Page A, Suñol A, Segrelles C, Carrasco E, Peral J, Garrido-aranda A, Del Marro S, Ortiz J, Lorz C, Minguillon J, Surralles J, Belendez C, Alvarez M, Balmaña J, Bravo A, Ramirez A, Garcia-escudero R. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.. [DOI: 10.1101/2022.06.05.494848] [Reference Citation Analysis]
|
92 |
Wang J, Li S, Wang K, Zhu L, Yang L, Zhu Y, Zhang Z, Hu L, Yuan Y, Fan Q, Ren J, Yang G, Ding W, Zhou X, Huang R, Cui J, Zhang C, Yuan Y, Tian J, Tao X. Surgical Guidance of Head and Neck Squamous Cell Carcinoma Enabled by a c-MET-Targeting Fluorescent Probe cMBP-ICG.. [DOI: 10.1101/2022.06.02.22272990] [Reference Citation Analysis]
|
93 |
Lan T, Ge Q, Zheng K, Huang L, Yan Y, Zheng L, Lu Y, Zheng D. FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation via Cell Cycle and DNA Repair. Front Oncol 2022;12:870055. [PMID: 35646625 DOI: 10.3389/fonc.2022.870055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
94 |
Donaldson G, Mccadden L, Napier S, Tan TJ. Laryngeal dysplasia: a 10-year review of rates of progression to invasive carcinoma and treatment-specific outcomes in a regional ENT department in Northern Ireland. J Laryngol Otol 2022;136:547-553. [DOI: 10.1017/s0022215122000366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
95 |
Chen S, Zheng J, Zhang B, Tang X, Cun Y, Wu T, Xu Y, Ma T, Cheng J, Yu Z, Wang H. Identification and characterization of virus-encoded circular RNAs in host cells. Microb Genom 2022;8. [PMID: 35731570 DOI: 10.1099/mgen.0.000848] [Reference Citation Analysis]
|
96 |
Patel U, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab. Br J Cancer 2022;126:1439-49. [PMID: 35140342 DOI: 10.1038/s41416-022-01730-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
97 |
Zhang D, Fu Y, Tian G, Li J, Shang D, Zhou S. UCHL1 promotes proliferation and metastasis in head and neck squamous cell carcinoma and could be a potential therapeutic target. Oral Surg Oral Med Oral Pathol Oral Radiol 2022;133:684-97. [PMID: 35165060 DOI: 10.1016/j.oooo.2021.11.004] [Reference Citation Analysis]
|
98 |
Feng H, Wang D, Liu J, Zou L, Xu S, Liang Z, Qin G. Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis. J Clin Lab Anal 2022;:e24496. [PMID: 35595945 DOI: 10.1002/jcla.24496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
99 |
Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study. Tumori 2022;:3008916221078061. [PMID: 35578746 DOI: 10.1177/03008916221078061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
100 |
Lepka P, Zatoński T, Barnaś S, Lepka P, Hałoń A. Correlation between brush cytology results and histopathological examination in diagnostic evaluation of precancerous conditions and laryngeal cancer: A prospective study. Postępy Higieny i Medycyny Doświadczalnej 2022;76:149-56. [DOI: 10.2478/ahem-2022-0015] [Reference Citation Analysis]
|
101 |
Ye H, Zheng Z, Song Y, Huang G, Wu Q, Ai Y, Lv X, Marchetti C. Metabolism-Related Bioinformatics Analysis Reveals That HPRT1 Facilitates the Progression of Oral Squamous Cell Carcinoma In Vitro. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/7453185] [Reference Citation Analysis]
|
102 |
Lu T, Zhang Z, Zhang J, Pan X, Zhu X, Wang X, Li Z, Ruan M, Li H, Chen W, Yan M. CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment. J Extracell Vesicles 2022;11:e12218. [PMID: 35524455 DOI: 10.1002/jev2.12218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
103 |
Huang J, Xu Z, Teh BM, Zhou C, Yuan Z, Shi Y, Shen Y. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma. J Clin Lab Anal 2022;:e24480. [PMID: 35522142 DOI: 10.1002/jcla.24480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
104 |
Zhu M, Zhou L, Hu S, Miao Q, Gong J, Zhang N, Zhang G, Wang M, Wang J, He H, Wang Y. Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody-Drug Conjugate LR-DM1 for Pancreatic Cancer. J Med Chem 2022. [PMID: 35522590 DOI: 10.1021/acs.jmedchem.1c01920] [Reference Citation Analysis]
|
105 |
Wang PW, Su YH, Chou PH, Huang MY, Chen TW. Survival-related genes are diversified across cancers but generally enriched in cancer hallmark pathways. BMC Genomics 2022;22:918. [PMID: 35508961 DOI: 10.1186/s12864-022-08581-x] [Reference Citation Analysis]
|
106 |
Vaysse PM, Demers I, van den Hout MFCM, van de Worp W, Anthony IGM, Baijens LWJ, Tan BI, Lacko M, Vaassen LAA, van Mierlo A, Langen RCJ, Speel EM, Heeren RMA, Porta Siegel T, Kremer B. Evaluation of the Sensitivity of Metabolic Profiling by Rapid Evaporative Ionization Mass Spectrometry: Toward More Radical Oral Cavity Cancer Resections. Anal Chem 2022. [PMID: 35503862 DOI: 10.1021/acs.analchem.1c03583] [Reference Citation Analysis]
|
107 |
Bottner J, Ribbat-Idel J, Klapper L, Jagomast T, Lemster AL, Perner S, Idel C, Kirfel J. Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma. Int J Mol Sci 2022;23:5075. [PMID: 35563463 DOI: 10.3390/ijms23095075] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
108 |
Hekmat S, Neshastehriz A, Kamalabadi MA, Eynali S, Ghaznavi H, Afjeh-dana E. Different Effects of Reversible Electroporation-Mediated Fe3O4@AuNPs Delivery as Radiosensitizing Agents on Cancer Cells versus Normal Cells. NANO 2022;17. [DOI: 10.1142/s1793292022500370] [Reference Citation Analysis]
|
109 |
Michmerhuizen NL, Ludwig ML, Birkeland AC, Nimmagadda S, Zhai J, Wang J, Jewell BM, Genouw D, Remer L, Kim D, Foltin SK, Bhangale A, Kulkarni A, Bradford CR, Swiecicki PL, Carey TE, Jiang H, Brenner JC. Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma. Head Neck 2022;44:1192-205. [PMID: 35224804 DOI: 10.1002/hed.27018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
110 |
Ma L, Little JV, Chen AY, Myers L, Sumer BD, Fei B. Automatic detection of head and neck squamous cell carcinoma on histologic slides using hyperspectral microscopic imaging. J Biomed Opt 2022;27. [PMID: 35484692 DOI: 10.1117/1.JBO.27.4.046501] [Reference Citation Analysis]
|
111 |
Wang X, Li R, Wu L, Chen Y, Liu S, Zhao H, Wang Y, Wang L, Shao Z. Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma. Cell Biosci 2022;12:49. [PMID: 35477537 DOI: 10.1186/s13578-022-00785-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
112 |
Huo RX, Jin YY, Zhuo YX, Ji XT, Cui Y, Wu XJ, Wang YJ, Zhang L, Zhang WH, Cai YM, Zheng CC, Cui RX, Wang QY, Sun Z, Wang FW. Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma. World J Clin Cases 2022; 10(11): 3414-3425 [DOI: 10.12998/wjcc.v10.i11.3414] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
113 |
Chen L, Ling Y, Yang H, Mei J. Comprehensive Analysis of the Potential Prognostic Value of 11 Glycosylation-Related Genes in Head and Neck Squamous Cell Carcinoma and Their Correlation with PD-L1 Expression and Immune Infiltration. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/2786680] [Reference Citation Analysis]
|
114 |
Nguyen KA, Keith MJ, Keysar SB, Hall SC, Bimali A, Jimeno A, Wang XJ, Young CD. Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity. Mol Carcinog 2022. [PMID: 35417043 DOI: 10.1002/mc.23409] [Reference Citation Analysis]
|
115 |
Liu T, Lee C, Chen Y, Chang Y, Huang H, Lee Y, Yen J, Chao D, Chang J. Mutation Analysis of Second Primary Tumors in Oral Cancer in Taiwanese Patients through Next-Generation Sequencing. Diagnostics 2022;12:951. [DOI: 10.3390/diagnostics12040951] [Reference Citation Analysis]
|
116 |
Todorovic V, Groselj B, Cemazar M, Prevc A, Zakelj MN, Strojan P, Sersa G. Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity. Radiol Oncol 2022;56:173-84. [PMID: 35390246 DOI: 10.2478/raon-2022-0014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
117 |
Kondo Y, Suzuki S, Ono S, Goto M, Miyabe S, Ogawa T, Tsuchida H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Ueda R, Nagao T. In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients. Int J Mol Sci 2022;23:4077. [PMID: 35456895 DOI: 10.3390/ijms23084077] [Reference Citation Analysis]
|
118 |
Chai AWY, Yee PS, Cheong SC. Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers. Front Oncol 2022;12:837835. [PMID: 35372020 DOI: 10.3389/fonc.2022.837835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
119 |
Sarnella A, Ferrara Y, Auletta L, Albanese S, Cerchia L, Alterio V, De Simone G, Supuran CT, Zannetti A. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. J Exp Clin Cancer Res 2022;41:122. [PMID: 35365193 DOI: 10.1186/s13046-022-02345-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
120 |
Cao R, Zhang W, Zhang H, Wang L, Chen X, Ren X, Cheng B, Xia J. Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma. Front Oncol 2022;12:798483. [PMID: 35350568 DOI: 10.3389/fonc.2022.798483] [Reference Citation Analysis]
|
121 |
Nair S, Bonner JA, Bredel M. EGFR Mutations in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2022;23:3818. [PMID: 35409179 DOI: 10.3390/ijms23073818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
122 |
Falco M, Tammaro C, Takeuchi T, Cossu AM, Scafuro G, Zappavigna S, Itro A, Addeo R, Scrima M, Lombardi A, Ricciardiello F, Irace C, Caraglia M, Misso G. Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. Cancers (Basel) 2022;14:1716. [PMID: 35406495 DOI: 10.3390/cancers14071716] [Reference Citation Analysis]
|
123 |
Nicolai A, Taurone S, Carradori S, Artico M, Greco A, Costi R, Scarpa S. The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells. Invest New Drugs. [DOI: 10.1007/s10637-022-01238-2] [Reference Citation Analysis]
|
124 |
Prasad M, Zorea J, Jagadeeshan S, Shnerb AB, Mathukkada S, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yegodayev KM, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstein O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Conde-Lopez C, Hess J, Kurth I, Morris LGT, Saintigny P, Elkabets M. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. J Immunother Cancer 2022;10:e003917. [PMID: 35292516 DOI: 10.1136/jitc-2021-003917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
125 |
De Herdt MJ, van der Steen B, Baatenburg de Jong RJ, Looijenga LHJ, Koljenović S, Hardillo JA. The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies. Cancers (Basel) 2022;14:1491. [PMID: 35326642 DOI: 10.3390/cancers14061491] [Reference Citation Analysis]
|
126 |
Luo Y, Xu W, Ma B, Wang Y. Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC. Front Genet 2022;13:822115. [DOI: 10.3389/fgene.2022.822115] [Reference Citation Analysis]
|
127 |
Jiang X, Qin Y, Xia W, Li J, Shi N, Feng Q, Tang A, Yi X. An immune-lncRNA risk model to predict prognosis for patients with head and neck squamous cell carcinoma.. [DOI: 10.1101/2022.03.10.483771] [Reference Citation Analysis]
|
128 |
Teh MT, Ma H, Liang YY, Solomon MC, Chaurasia A, Patil R, Tekade SA, Mishra D, Qadir F, Yeung JS, Liu X, Kriuar S, Zhao R, Waseem A, Hutchison IL. Molecular Signatures of Tumour and Its Microenvironment for Precise Quantitative Diagnosis of Oral Squamous Cell Carcinoma: An International Multi-Cohort Diagnostic Validation Study. Cancers (Basel) 2022;14:1389. [PMID: 35326543 DOI: 10.3390/cancers14061389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
129 |
Jablonska J, Rist M, Spyra I, Tengler L, Domnich M, Kansy B, Giebel B, Thakur BK, Rotter N, Lang S, Ludwig S. Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck Cancer. Cells 2022;11:902. [DOI: 10.3390/cells11050902] [Reference Citation Analysis]
|
130 |
Torres VC, Wang L, Hodge S, Solanki A, Mcmahon NP, Gibbs SL, Tichauer KM, Samkoe KS. Nonlinear unmixing to account for blood absorption in multispectral imaging for improved quantification of intracellular and extracellular EGFR. Visualizing and Quantifying Drug Distribution in Tissue VI 2022. [DOI: 10.1117/12.2609773] [Reference Citation Analysis]
|
131 |
Lee SY, Lee M, Yu DS, Lee YB. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population. Journal of Dermatological Science 2022. [DOI: 10.1016/j.jdermsci.2022.03.007] [Reference Citation Analysis]
|
132 |
Schmid M, Giger R, Nisa L, Mueller SA, Schubert M, Schubert AD. Association of Multiprofessional Preoperative Assessment and Information for Patients With Head and Neck Cancer With Postoperative Outcomes. JAMA Otolaryngol Head Neck Surg 2022;148:259-67. [PMID: 35050322 DOI: 10.1001/jamaoto.2021.4048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
133 |
Bai S, Hou W, Yao Y, Meng J, Wei Y, Hu F, Hu X, Wu J, Zhang N, Xu R, Tian F, Wang B, Liao H, Du Y, Fang H, He W, Liu Y, Shen B, Du J. Exocyst controls exosome biogenesis via Rab11a. Molecular Therapy - Nucleic Acids 2022;27:535-546. [DOI: 10.1016/j.omtn.2021.12.023] [Reference Citation Analysis]
|
134 |
Ramos-garcía P, González-moles MÁ, Warnakulasuriya S. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis. Oral Oncology 2022;126:105734. [DOI: 10.1016/j.oraloncology.2022.105734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
135 |
Vaidya M, Dmello C, Mogre S. Utility of Keratins as Biomarkers for Human Oral Precancer and Cancer. Life 2022;12:343. [DOI: 10.3390/life12030343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
136 |
Zang W, Liu J, Geng F, Liu D, Zhang S, Li Y, Pan Y. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition. PeerJ 2022;10:e12991. [PMID: 35223210 DOI: 10.7717/peerj.12991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
137 |
Zhang Z, Hu X, Qiu D, Sun Y, Lei L, Xu Y. Development and Validation of a Necroptosis-Related Prognostic Model in Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/8402568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
138 |
Löck S, Linge A, Lohaus F, Ebert N, Gudziol V, Nowak A, Tinhofer I, Kalinauskaite G, Guberina M, Stuschke M, Balermpas P, von der Grün J, Grosu AL, Debus J, Ganswindt U, Belka C, Peeken JC, Combs SE, De-Colle C, Zips D, Baretton GB, Krause M, Baumann M; DKTK-ROG. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG. Radiother Oncol 2022:S0167-8140(22)00094-9. [PMID: 35182686 DOI: 10.1016/j.radonc.2022.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
139 |
Liu S, Shi C, Wang X, Ma X, Gao P. Low expression of RalGAPs associates with the poorer overall survival of head and neck squamous cell carcinoma. Transl Cancer Res 2021;10:5085-94. [PMID: 35116360 DOI: 10.21037/tcr-21-1489] [Reference Citation Analysis]
|
140 |
Jia Y, Chen X, Zhao D, Ma S. SNHG1/miR-194-5p/MTFR1 Axis Promotes TGFβ1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells. Mol Biotechnol 2022. [PMID: 35107755 DOI: 10.1007/s12033-021-00445-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
141 |
Karukonda P, Odhiambo D, Mowery YM. Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma. Mol Carcinog 2022;61:225-38. [PMID: 34964992 DOI: 10.1002/mc.23384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
142 |
Morand GB, Diaconescu A, Ibrahim I, Lamarche G, Ruas JS, Dalfen J, Hier MP, Alaoui-Jamali MA, Maschietto M, da Silva SD. Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review. Clin Exp Metastasis 2022. [PMID: 35084607 DOI: 10.1007/s10585-022-10148-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
143 |
Tealdi S, Ferro E, Campa CC, Bosia C. microRNA-Mediated Encoding and Decoding of Time-Dependent Signals in Tumorigenesis. Biomolecules 2022;12:213. [DOI: 10.3390/biom12020213] [Reference Citation Analysis]
|
144 |
Liu B, Hu J, Zhao H, Zhao L, Pan S. MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma. Front Oncol 2021;11:706095. [PMID: 35070952 DOI: 10.3389/fonc.2021.706095] [Reference Citation Analysis]
|
145 |
Wondergem NE, Nijenhuis DNLM, Poell JB, Leemans CR, Brakenhoff RH, van de Ven R. At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma. Front Oral Health 2021;2:647980. [PMID: 35047999 DOI: 10.3389/froh.2021.647980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
146 |
Bos T, Ratti JA, Harada H. Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer. Front Oral Health 2021;2:676643. [PMID: 35048023 DOI: 10.3389/froh.2021.676643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
147 |
Zhou LQ, Shen JX, Zhou JY, Hu Y, Xiao HJ. The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database. Sci Rep 2022;12:579. [PMID: 35022464 DOI: 10.1038/s41598-021-04591-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
148 |
van der Kamp MF, Halmos GB, Guryev V, Horvatovich PL, Schuuring E, van der Laan BFAM, van der Vegt B, Plaat BEC, Verhoeven CJ. Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory? Cell Oncol (Dordr) 2022. [PMID: 35015241 DOI: 10.1007/s13402-021-00655-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
149 |
Wang Y, Wang P, Liu X, Gao Z, Cao X, Zhao X. Prognostic Role of Long Noncoding RNAs in Oral Squamous Cell Carcinoma: A Meta-Analysis. Dis Markers 2021;2021:6407528. [PMID: 34987674 DOI: 10.1155/2021/6407528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
150 |
Manjunathan R, Jayaraman S, S. R, Kumaran RI, Chandrakesan P, Rajagopal P, Sambandam Y. Reactive Oxygen Species in Oral Squamous Cell Carcinoma Progression and Importance of Stem Cells in Cancer Therapeutics. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_218] [Reference Citation Analysis]
|
151 |
Manjunathan R, Jayaraman S, S R, Ileng Kumaran R, Chandrakesan P, Rajagopal P, Sambandam Y. Reactive Oxygen Species in Oral Squamous Cell Carcinoma Progression and Importance of Stem Cells in Cancer Therapeutics. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_218-1] [Reference Citation Analysis]
|
152 |
Sabahi M, Hanaei S, Rezaei N. Interdisciplinary Approach in Head and Neck Cancers. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_67] [Reference Citation Analysis]
|
153 |
Sable MN, Kane SV. Molecular Carcinopathogenesis in Oral Squamous Cell Carcinoma. Microbes and Oral Squamous Cell Carcinoma 2022. [DOI: 10.1007/978-981-19-0592-6_3] [Reference Citation Analysis]
|
154 |
Sun S, Zhao S, Yang H, Wang F. microRNA 21 Promotes the Proliferation and Metastasis of Oral Squamous Cell Carcinoma by Targeting RECK. J Hard Tissue Biology 2022;31:257-262. [DOI: 10.2485/jhtb.31.257] [Reference Citation Analysis]
|
155 |
Shen M, Zhou Z, Li BB, Lv M, Feng C, Chen S, Shi S, Kang M, Zhao T. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis. Technol Cancer Res Treat 2022;21:15330338221081245. [PMID: 35235474 DOI: 10.1177/15330338221081245] [Reference Citation Analysis]
|
156 |
Zheng YM, Zhan JF, Yuan MG, Hou F, Jiang G, Wu ZJ, Dong C. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Eur J Radiol 2022;146:110093. [PMID: 34890937 DOI: 10.1016/j.ejrad.2021.110093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
157 |
Ramakrishnan BP, Thomas P, Lathakumari SC, Pillai RK. Significance of SOX2 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study. World Journal of Dentistry 2022;13:S213-S219. [DOI: 10.5005/jp-journals-10015-2148] [Reference Citation Analysis]
|
158 |
Mirzaei G, Petreaca RC. Distribution of copy number variations and rearrangement endpoints in human cancers with a review of literature. Mutat Res 2022;824:111773. [PMID: 35091282 DOI: 10.1016/j.mrfmmm.2021.111773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
159 |
Xu HG, Reshetnikov V, Wondrak M, Eckhardt L, Kunz-Schughart LA, Janko C, Tietze R, Alexiou C, Borchardt H, Aigner A, Gong W, Schmitt M, Sellner L, Daum S, Özkan HG, Mokhir A. Intracellular Amplifiers of Reactive Oxygen Species Affecting Mitochondria as Radiosensitizers. Cancers (Basel) 2021;14:208. [PMID: 35008371 DOI: 10.3390/cancers14010208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
160 |
Huang GZ, Chen ZQ, Wu J, Shao TR, Zou C, Ai YL, Lv XZ. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target. J Immunol Res 2021;2021:9250207. [PMID: 34950739 DOI: 10.1155/2021/9250207] [Reference Citation Analysis]
|
161 |
Guo Y, Pan WK, Wang ZW, Su WH, Xu K, Jia H, Chen J. Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis. Biomed Res Int 2021;2021:4532438. [PMID: 34917682 DOI: 10.1155/2021/4532438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
162 |
Yang M, Ding J, Luo Q, Chen X, Chen F. Improving the diagnostic efficacy of squamous cell carcinoma antigen for oral squamous cell carcinoma via saponin disruption of serum extracellular vesicles. Clin Chim Acta 2021;525:40-5. [PMID: 34921893 DOI: 10.1016/j.cca.2021.12.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
163 |
Wang F, Tan R, Feng K, Hu J, Zhuang Z, Wang C, Hou J, Liu X. Magnetic Resonance Imaging-Based Radiomics Features Associated with Depth of Invasion Predicted Lymph Node Metastasis and Prognosis in Tongue Cancer. J Magn Reson Imaging 2021. [PMID: 34888985 DOI: 10.1002/jmri.28019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
164 |
Marcozzi A, Jager M, Elferink M, Straver R, van Ginkel JH, Peltenburg B, Chen LT, Renkens I, van Kuik J, Terhaard C, de Bree R, Devriese LA, Willems SM, Kloosterman WP, de Ridder J. Accurate detection of circulating tumor DNA using nanopore consensus sequencing. NPJ Genom Med 2021;6:106. [PMID: 34887408 DOI: 10.1038/s41525-021-00272-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
165 |
Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, Savage PA, Lingen MW, Agrawal N, Izumchenko E. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer 2021. [PMID: 34876674 DOI: 10.1038/s41416-021-01626-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
166 |
Lepka P, Hałoń A, Barnaś S, Zatoński T. The combination of brush cytology with the results of histopathological examination in laryngeal cancer diagnosis. Postępy Higieny i Medycyny Doświadczalnej 2021;75:847-51. [DOI: 10.2478/ahem-2021-0030] [Reference Citation Analysis]
|
167 |
Shen Q, Xiong P, Yang D, Chen L. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma. Arch Oral Biol 2021;134:105336. [PMID: 34891100 DOI: 10.1016/j.archoralbio.2021.105336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
168 |
Hosseinpour-Moghadam R, Mehryab F, Torshabi M, Haeri A. Applications of Novel and Nanostructured Drug Delivery Systems for the Treatment of Oral Cavity Diseases. Clin Ther 2021;43:e377-402. [PMID: 34844769 DOI: 10.1016/j.clinthera.2021.10.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
169 |
Adeola HA, Sabiu S, Aruleba RT, Adekiya TA, Adefuye AO, Adefuye OJ, Oyinloye BE. Phytodentistry in Africa: prospects for head and neck cancers. Clin Phytosci 2021;7:17. [DOI: 10.1186/s40816-021-00254-8] [Reference Citation Analysis]
|
170 |
Arvelo F, Sojo F, Cotte C. Cáncer y Microbiota. Invest Clin 2021;62:407-440. [DOI: 10.22209/ic.v62n4a09] [Reference Citation Analysis]
|
171 |
Sluga M, Battelino S, Vozel D. Prospects of Extracellular Vesicles in Otorhinolaryngology, Head and Neck Surgery. JNT 2021;2:208-23. [DOI: 10.3390/jnt2040013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
172 |
Tanaka N, Minemura C, Asai S, Kikkawa N, Kinoshita T, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N. Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma. Genes (Basel) 2021;12:1910. [PMID: 34946859 DOI: 10.3390/genes12121910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
173 |
Berger J, Zech HB, Hoffer K, von Bargen CM, Nordquist L, Bussmann L, Gatzemeier F, Busch CJ, Möckelmann N, Münscher A, Betz CS, Petersen C, Rothkamm K, Rieckmann T, Köcher S, Kriegs M. Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors. Oral Oncol 2021;123:105603. [PMID: 34798574 DOI: 10.1016/j.oraloncology.2021.105603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
174 |
Shen Y, Sun C, Zhao B, Guo H, Li J, Xia Y, Liu M, Piao S, Saiyin W. miR-34c-5p mediates the cellular malignant behaviors of oral squamous cell carcinoma through targeted binding of TRIM29. Ann Transl Med 2021;9:1537. [PMID: 34790743 DOI: 10.21037/atm-21-4679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
175 |
Fu L, Jin Q, Dong Q, Li Q. AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling. Onco Targets Ther 2021;14:5237-48. [PMID: 34785906 DOI: 10.2147/OTT.S333134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
176 |
Widyaputra S, Pranata N, Setiawan I, Ari Anggraini J. The Presence of HPV in Dental Calculus: It’s Role in Pathogenesis of Oral and Cervical Cancer. Cervical Cancer - A Global Public Health Treatise 2021. [DOI: 10.5772/intechopen.98347] [Reference Citation Analysis]
|
177 |
Camuzi D, Simão TA, Dias F, Ribeiro Pinto LF, Soares-Lima SC. Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis. Cancers (Basel) 2021;13:5630. [PMID: 34830785 DOI: 10.3390/cancers13225630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
178 |
Bley IA, Zwick A, Hans MC, Thieser K, Wagner V, Ludwig N, Khalmurzaev O, Matveev VB, Loertzer P, Pryalukhin A, Hartmann A, Geppert CI, Loertzer H, Wunderlich H, Naumann CM, Kalthoff H, Junker K, Smola S, Lohse S. DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells. Transl Oncol 2021;15:101267. [PMID: 34773828 DOI: 10.1016/j.tranon.2021.101267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
179 |
Shiah SG, Chou ST, Chang JY. MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5604. [PMID: 34830755 DOI: 10.3390/cancers13225604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
180 |
Zheng DW, Deng WW, Song WF, Wu CC, Liu J, Hong S, Zhuang ZN, Cheng H, Sun ZJ, Zhang XZ. Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma. Nat Biomed Eng 2021. [PMID: 34750535 DOI: 10.1038/s41551-021-00807-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
|
181 |
Sezer N, Arı İ, Biçer Y, Koç M. Superparamagnetic nanoarchitectures: Multimodal functionalities and applications. Journal of Magnetism and Magnetic Materials 2021;538:168300. [DOI: 10.1016/j.jmmm.2021.168300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
182 |
Sproll KC, Schorn LK, Reising B, Schumacher S, Lommen J, Kübler NR, Knoefel WT, Beier M, Neves RP, Behrens B, Horny K, Stoecklein NH. Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma. Mol Oncol 2021. [PMID: 34719102 DOI: 10.1002/1878-0261.13113] [Reference Citation Analysis]
|
183 |
Baumeister P, Zhou J, Canis M, Gires O. Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2021;13:5355. [PMID: 34771518 DOI: 10.3390/cancers13215355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
184 |
Martín-Lozano G, Gómez-Díaz R, Iglesías-Martín F, Torres-Lagares D, Gutiérrez-Corrales A, Gutiérrez-Pérez JL. Mutations in p53 Gene Exons in a Sample from the South of Spain in Oral Cancer. J Clin Exp Dent 2021;13:e1001-5. [PMID: 34667495 DOI: 10.4317/jced.58799] [Reference Citation Analysis]
|
185 |
Guigay J, Lee KW, Patel MR, Daste A, Wong DJ, Goel S, Gordon MS, Gutierrez M, Balmanoukian A, Le Tourneau C, Mita A, Vansteene D, Keilholz U, Schöffski P, Grote HJ, Zhou D, Bajars M, Penel N. Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial. J Immunother Cancer 2021;9:e002998. [PMID: 34663640 DOI: 10.1136/jitc-2021-002998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
186 |
Gruijs M, Ganzevles SH, Stigter-van Walsum M, van der Mast R, van Ostaijen-Ten Dam MM, Tuk CW, Schilham MW, Leemans CR, Brakenhoff RH, van Egmond M, van de Ven R, Bakema JE. NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models. Int J Mol Sci 2021;22:11057. [PMID: 34681717 DOI: 10.3390/ijms222011057] [Reference Citation Analysis]
|
187 |
Bai Y, Boath J, White GR, Kariyawasam UGIU, Farah CS, Darido C. The Balance between Differentiation and Terminal Differentiation Maintains Oral Epithelial Homeostasis. Cancers (Basel) 2021;13:5123. [PMID: 34680271 DOI: 10.3390/cancers13205123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
188 |
Wang Y, Cao Z, Liu F, Ou Y. Clinical significance of activated Wnt/β-catenin signaling in apoptosis inhibition of oral cancer. Open Life Sci 2021;16:1045-52. [PMID: 34632073 DOI: 10.1515/biol-2021-0104] [Reference Citation Analysis]
|
189 |
Dongre HN, Haave H, Fromreide S, Erland FA, Moe SEE, Dhayalan SM, Riis RK, Sapkota D, Costea DE, Aarstad HJ, Vintermyr OK. Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters. Front Oncol 2021;11:734134. [PMID: 34631566 DOI: 10.3389/fonc.2021.734134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
190 |
Zheng H, Liu H, Lu Y, Li H. Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma. Front Surg 2021;8:717084. [PMID: 34631779 DOI: 10.3389/fsurg.2021.717084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
191 |
Onozato Y, Sasaki Y, Abe Y, Sato H, Yagi M, Mizumoto N, Kon T, Sakai T, Ito M, Umehara M, Koseki A, Ueno Y. Novel genomic alteration in superficial esophageal squamous cell neoplasms in non-smoker non-drinker females. Sci Rep 2021;11:20150. [PMID: 34635759 DOI: 10.1038/s41598-021-99790-z] [Reference Citation Analysis]
|
192 |
Choi KH, Song JH, Kim YS, Moon SH, Lee J, Oh YT, Oh D, Kim JH, Kim JW. Survey of radiation field and dose in human papillomavirus-positive oropharyngeal cancer: is de-escalation actually applied in clinical practice? Radiat Oncol J 2021;39:174-83. [PMID: 34610656 DOI: 10.3857/roj.2021.00556] [Reference Citation Analysis]
|
193 |
Li Q, Liang Y, Liu Z, Yu C. Associations of GWAS-Identified Risk Loci with Progression, Efficacy and Toxicity of Radiotherapy of Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy. Pharmgenomics Pers Med 2021;14:1205-10. [PMID: 34584443 DOI: 10.2147/PGPM.S325349] [Reference Citation Analysis]
|
194 |
Seppälä M, Jauhiainen L, Tervo S, Al-Samadi A, Rautiainen M, Salo T, Lehti K, Monni O, Hautaniemi S, Tynninen O, Mäkitie A, Mäkinen LK, Paavonen T, Toppila-Salmi S. The expression and prognostic relevance of CDH3 in tongue squamous cell carcinoma. APMIS 2021;129:717-28. [PMID: 34580913 DOI: 10.1111/apm.13176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
195 |
Saliba M, Ghossein R, Xu B. HPV-related head and neck cancers: Pathology and biology. J Surg Oncol 2021;124:923-30. [PMID: 34582040 DOI: 10.1002/jso.26683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
196 |
Baysal H, De Pauw I, Zaryouh H, Peeters M, Vermorken JB, Lardon F, De Waele J, Wouters A. The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies. Front Immunol 2021;12:737311. [PMID: 34557197 DOI: 10.3389/fimmu.2021.737311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
197 |
Ma W, Cao Q, She W. Identification and clinical validation of gene signatures with grade and survival in head and neck carcinomas. Braz J Med Biol Res 2021;54:e11069. [PMID: 34550272 DOI: 10.1590/1414-431X2020e11069] [Reference Citation Analysis]
|
198 |
Miari R, Azzam N, Bar-Shalom R, Fares F. 5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line. PLoS One 2021;16:e0253756. [PMID: 34534222 DOI: 10.1371/journal.pone.0253756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
199 |
Shi C, Liu S, Tian X, Wang X, Gao P. A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma. BMC Cancer 2021;21:1035. [PMID: 34530752 DOI: 10.1186/s12885-021-08765-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
200 |
Dolcetti L, Barber PR, Weitsman G, Thavaraj S, Ng K, Chan JNE, Patten P, Mustapha R, Deng J, Ng T. RUNIMC: An R-based package for imaging mass cytometry data analysis and pipeline validation.. [DOI: 10.1101/2021.09.14.460258] [Reference Citation Analysis]
|
201 |
Georgaki M, Theofilou VI, Pettas E, Stoufi E, Younis RH, Kolokotronis A, Sauk JJ, Nikitakis NG. Understanding the complex pathogenesis of oral cancer: A comprehensive review. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:566-79. [PMID: 34518141 DOI: 10.1016/j.oooo.2021.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
202 |
Wu P, Xie C, Yang L, Liu Y, Zeng J, Li X, Fang X, Fan Y, Zhao S, Kuang N, Xuan T, Xia X, Yi X, Huang Y, Yu Z, Tang Y. The genomic architectures of tumour-adjacent tissues, plasma and saliva reveal evolutionary underpinnings of relapse in head and neck squamous cell carcinoma. Br J Cancer 2021;125:854-64. [PMID: 34230611 DOI: 10.1038/s41416-021-01464-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
203 |
Yeh CH, Chen J, Zheng G, Huang L, Hsu YC. Novel Pyropheophorbide Phosphatydic Acids Photosensitizer Combined EGFR siRNA Gene Therapy for Head and Neck Cancer Treatment. Pharmaceutics 2021;13:1435. [PMID: 34575510 DOI: 10.3390/pharmaceutics13091435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
204 |
Moreira D, Sampath S, Won H, White SV, Su YL, Alcantara M, Wang C, Lee P, Maghami E, Massarelli E, Kortylewski M. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity. J Clin Invest 2021;131:137001. [PMID: 33232304 DOI: 10.1172/JCI137001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
|
205 |
Wang YP, Liu IJ, Chen KC, Wu HC. NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis 2021;10:59. [PMID: 34465724 DOI: 10.1038/s41389-021-00348-5] [Reference Citation Analysis]
|
206 |
Wu JJ, Ma LW, Jiang CH, Chen J, Li N, Chen XQ, Min AJ, Wang WJ, Hu YQ, Gao X. Supraclavicular lymph node recurrence after radical surgery: is epidermal growth factor receptor a predictive marker? Int J Oral Maxillofac Surg 2021:S0901-5027(21)00275-7. [PMID: 34479791 DOI: 10.1016/j.ijom.2021.08.001] [Reference Citation Analysis]
|
207 |
Gül D, Habtemichael N, Dietrich D, Dietrich J, Gößwein D, Khamis A, Deuss E, Künzel J, Schneider G, Strieth S, Stauber RH. Identification of cytokeratin24 as a tumor suppressor for the management of head and neck cancer. Biol Chem 2021. [PMID: 34450690 DOI: 10.1515/hsz-2021-0287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
208 |
Mandal S, Bandyopadhyay S, Tyagi K, Roy A. Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis. Biochim Biophys Acta Rev Cancer 2021;1876:188619. [PMID: 34454048 DOI: 10.1016/j.bbcan.2021.188619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
209 |
Prasad M, Zorea J, Jagadeeshan S, Shnerb A, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yagodayev K, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstei O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Hess J, Morris LG, Saintigny P, Elkabets M. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.. [DOI: 10.1101/2021.08.22.457244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
210 |
Pires RC, Carvalho R, Gama RR, Carvalho AL, Santos CR, Capuzzo RDC. Progressive Increase Trend in HPV-Related Oropharyngeal Squamous Cell Carcinoma in Brazil. Int Arch Otorhinolaryngol 2022;26:e132-6. [DOI: 10.1055/s-0041-1730297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
211 |
Balaji H, Demers I, Wuerdemann N, Schrijnder J, Kremer B, Klussmann JP, Huebbers CU, Speel EM. Causes and Consequences of HPV Integration in Head and Neck Squamous Cell Carcinomas: State of the Art. Cancers (Basel) 2021;13:4089. [PMID: 34439243 DOI: 10.3390/cancers13164089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
212 |
Li CC, Shen Z, Bavarian R, Yang F, Bhattacharya A. Oral Cancer: Genetics and the Role of Precision Medicine. Surg Oncol Clin N Am 2020;29:127-44. [PMID: 31757309 DOI: 10.1016/j.soc.2019.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
213 |
Wang X, Li K, Wan Y, Chen F, Cheng M, Xiong G, Wang G, Chen S, Chen Z, Chen J, Xu X, Wang C, Peng L, Chen D. Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma. Int J Oral Sci 2021;13:26. [PMID: 34381012 DOI: 10.1038/s41368-021-00130-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
214 |
Polatova DS, Madaminov AY. Molecular and clinical aspects of oropharyngeal squamous cell carcinoma associated with human papillomavirus. Opuholi golovy i šei 2021;11:31-40. [DOI: 10.17650/2313-805x-2021-11-2-31-40] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
215 |
Sathasivam HP, Kist R, Sloan P, Thomson P, Nugent M, Alexander J, Haider S, Robinson M. Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology. Br J Cancer 2021;125:413-21. [PMID: 33972745 DOI: 10.1038/s41416-021-01411-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
216 |
Guo E, Mao X, Wang X, Guo L, An C, Zhang C, Song K, Wang G, Duan C, Zhang X, Yang X, Yuan Z, Sun J, Li X, Yang W, Meng H, Miao S. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma. Cell Death Dis 2021;12:764. [PMID: 34344861 DOI: 10.1038/s41419-021-04063-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
217 |
Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci 2021;13:24. [PMID: 34341329 DOI: 10.1038/s41368-021-00131-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 19.5] [Reference Citation Analysis]
|
218 |
Napolitano V, Russo D, Morra F, Merolla F, Varricchio S, Ilardi G, Di Crescenzo RM, Martino F, Mascolo M, Celetti A, Tamagnone L, Staibano S. Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress. Cancers (Basel) 2021;13:3822. [PMID: 34359721 DOI: 10.3390/cancers13153822] [Reference Citation Analysis]
|
219 |
Hayashi T, Yoshikawa K, Suzuki S, Gosho M, Ueda R, Kazaoka Y. Tumor-infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma. Clin Exp Dent Res 2021. [PMID: 34319010 DOI: 10.1002/cre2.477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
220 |
Goudsmit C, da Veiga Leprevost F, Basrur V, Peters L, Nesvizhskii A, Walline H. Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status. Cancers (Basel) 2021;13:3714. [PMID: 34359613 DOI: 10.3390/cancers13153714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
221 |
Bamps M, Dok R, Nuyts S. The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3717. [PMID: 34359617 DOI: 10.3390/cancers13153717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
222 |
Tuomainen K, Hyytiäinen A, Al-Samadi A, Ianevski P, Ianevski A, Potdar S, Turunen L, Saarela J, Kuznetsov S, Wahbi W, Risteli M, Mäkitie A, Monni O, Salo T. High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma. Sci Rep 2021;11:14755. [PMID: 34285300 DOI: 10.1038/s41598-021-94259-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
223 |
Sharaf K, Lechner A, Haider SP, Wiebringhaus R, Walz C, Kranz G, Canis M, Haubner F, Gires O, Baumeister P. Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients. Curr Oncol 2021;28:2763-74. [PMID: 34287293 DOI: 10.3390/curroncol28040241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
224 |
Sidenko EA, Kakurina GV, Cheremisina OV, Spirina LV, Shashova EE, Korshunov DA, Kondakova IV. The mRNA expression levels of calpains and their activity in malignant and dysplastic epithelium of the upper respiratory tract. Bûll sib med 2021;20:88-94. [DOI: 10.20538/1682-0363-2021-2-88-94] [Reference Citation Analysis]
|
225 |
Broner EC, Trujillo JA, Korzinkin M, Subbannayya T, Agrawal N, Ozerov IV, Zhavoronkov A, Rooper L, Kotlov N, Shen L, Pearson AT, Rosenberg AJ, Savage PA, Mishra V, Chatterjee A, Sidransky D, Izumchenko E. Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:677051. [PMID: 34336664 DOI: 10.3389/fonc.2021.677051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
226 |
Li Y, Gong L, Qin N, Wei X, Miao L, Yuan H, Wang C, Ma H. Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma. Oral Oncol 2021;121:105437. [PMID: 34265729 DOI: 10.1016/j.oraloncology.2021.105437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
227 |
Wu T, Zhang ZT, Li L, Liu RY, Bei BT. Correlation between hypoxia-inducible factor-1α C1772T/G1790A polymorphisms and head and neck cancer risk: a meta-analysis. World J Surg Oncol 2021;19:210. [PMID: 34256803 DOI: 10.1186/s12957-021-02324-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
228 |
Kordbacheh F, Farah CS. Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3453. [PMID: 34298667 DOI: 10.3390/cancers13143453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
229 |
Wang M, Zhang L, Ren W, Li S, Zhi K, Zheng J, Gao L. Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis. Front Oncol 2021;11:693284. [PMID: 34307158 DOI: 10.3389/fonc.2021.693284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
230 |
Mühr LSA, Guerendiain D, Cuschieri K, Sundström K. Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures. Viruses 2021;13:1323. [PMID: 34372528 DOI: 10.3390/v13071323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
231 |
Reid P, Staudacher AH, Marcu LG, Olver I, Moghaddasi L, Brown MP, Bezak E. Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head Neck 2021;43:3086-96. [PMID: 34235809 DOI: 10.1002/hed.26802] [Reference Citation Analysis]
|
232 |
Rzhevskiy A, Kapitannikova A, Malinina P, Volovetsky A, Aboulkheyr Es H, Kulasinghe A, Thiery JP, Maslennikova A, Zvyagin AV, Ebrahimi Warkiani M. Emerging role of circulating tumor cells in immunotherapy. Theranostics 2021;11:8057-75. [PMID: 34335980 DOI: 10.7150/thno.59677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
233 |
Merolla F, Ilardi G, Di Spigna G, Russo D, Martino F, Varricchio S, Dell'Aversana GO, Mascolo M, Covelli B, Caltabiano R, Broggi G, Audino G, Celetti A, Postiglione L, Staibano S. Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors. Oral Oncol 2021;120:105367. [PMID: 34237585 DOI: 10.1016/j.oraloncology.2021.105367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
234 |
Cavaliere M, Bisogno A, Scarpa A, D'Urso A, Marra P, Colacurcio V, De Luca P, Ralli M, Cassandro E, Cassandro C. Biomarkers of laryngeal squamous cell carcinoma: a review. Ann Diagn Pathol 2021;54:151787. [PMID: 34242969 DOI: 10.1016/j.anndiagpath.2021.151787] [Reference Citation Analysis]
|
235 |
Ferrari E, Pezzi ME, Cassi D, Pertinhez TA, Spisni A, Meleti M. Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review. Int J Mol Sci 2021;22:6795. [PMID: 34202728 DOI: 10.3390/ijms22136795] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
|
236 |
Park HG, Kim JH, Dancer AN, Kothapalli KS, Brenna JT. The aromatase inhibitor letrozole restores FADS2 function in ER+ MCF7 human breast cancer cells. Prostaglandins Leukot Essent Fatty Acids 2021;171:102312. [PMID: 34303883 DOI: 10.1016/j.plefa.2021.102312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
237 |
Soares-Lima SC, Mehanna H, Camuzi D, de Souza-Santos PT, Simão TA, Nicolau-Neto P, Almeida Lopes MS, Cuenin C, Talukdar FR, Batis N, Costa I, Dias F, Degli Esposti D, Boroni M, Herceg Z, Ribeiro Pinto LF. Upper Aerodigestive Tract Squamous Cell Carcinomas Show Distinct Overall DNA Methylation Profiles and Different Molecular Mechanisms behind WNT Signaling Disruption. Cancers (Basel) 2021;13:3014. [PMID: 34208581 DOI: 10.3390/cancers13123014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
238 |
Prime SS, Cirillo N, Cheong SC, Prime MS, Parkinson EK. Targeting the genetic landscape of oral potentially malignant disorders has the potential as a preventative strategy in oral cancer. Cancer Lett 2021;518:102-14. [PMID: 34139286 DOI: 10.1016/j.canlet.2021.05.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
239 |
Ju Y, Wu X, Wang H, Li B, Long Q, Zhang D, Chen H, Xiao N, Li F, Zhang S, Yang S. Genomic Landscape of Head and Neck Squamous Cell Carcinoma Across Different Anatomic Sites in Chinese Population. Front Genet 2021;12:680699. [PMID: 34194478 DOI: 10.3389/fgene.2021.680699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
240 |
Kozłowska J, Kolenda T, Poter P, Sobocińska J, Guglas K, Stasiak M, Bliźniak R, Teresiak A, Lamperska K. Long Intergenic Non-Coding RNAs in HNSCC: From "Junk DNA" to Important Prognostic Factor. Cancers (Basel) 2021;13:2949. [PMID: 34204634 DOI: 10.3390/cancers13122949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
241 |
He F, Chen Z, Deng W, Zhan T, Huang X, Zheng Y, Yang H. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. Int Immunopharmacol 2021;98:107789. [PMID: 34130150 DOI: 10.1016/j.intimp.2021.107789] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
|
242 |
Nicolai A, Madia VN, Messore A, De Vita D, De Leo A, Ialongo D, Tudino V, Tortorella E, Scipione L, Taurone S, Pergolizzi T, Artico M, Di Santo R, Costi R, Scarpa S. Anti-Tumoral Effects of a (1H-Pyrrol-1-yl)Methyl-1H-Benzoimidazole Carbamate Ester Derivative on Head and Neck Squamous Carcinoma Cell Lines. Pharmaceuticals (Basel) 2021;14:564. [PMID: 34204738 DOI: 10.3390/ph14060564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
243 |
Sorroche BP, Talukdar FR, Lima SCS, Melendez ME, de Carvalho AC, de Almeida GC, De Marchi P, Lopes M, Ribeiro Pinto LF, Carvalho AL, Herceg Z, Arantes LMRB. DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma. Cancers (Basel) 2021;13:2915. [PMID: 34207933 DOI: 10.3390/cancers13122915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
244 |
Rodrigues MFSD, Xavier FCA, Esteves CD, Nascimento RB, Nobile JS, Severino P, de Cicco R, Toporcov TN, Tajara EH, Nunes FD. Homeobox gene amplification and methylation in oral squamous cell carcinoma. Arch Oral Biol 2021;129:105195. [PMID: 34126417 DOI: 10.1016/j.archoralbio.2021.105195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
245 |
Oshima S, Asai S, Seki N, Minemura C, Kinoshita T, Goto Y, Kikkawa N, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K. Identification of Tumor Suppressive Genes Regulated by miR-31-5p and miR-31-3p in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2021;22:6199. [PMID: 34201353 DOI: 10.3390/ijms22126199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
246 |
Kabzinski J, Maczynska M, Majsterek I. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. Biomolecules 2021;11:844. [PMID: 34198889 DOI: 10.3390/biom11060844] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
247 |
van Harten AM, Brakenhoff RH. Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications. Cancers (Basel) 2021;13:2774. [PMID: 34204886 DOI: 10.3390/cancers13112774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
248 |
Nathansen J, Lukiyanchuk V, Hein L, Stolte MI, Borgmann K, Löck S, Kurth I, Baumann M, Krause M, Linge A, Dubrovska A. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L. Oncogene 2021;40:4214-28. [PMID: 34079088 DOI: 10.1038/s41388-021-01842-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
249 |
Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra GL, Franchin G, Fanetti G, Miccichè F, Giacomarra V, Lupato V, Favero A, Concina I, Srinivasan S, Avanzo M, Castiglioni I, Barzan L, Sulfaro S, Petrone G, Viale A, Draetta GF, Vecchione A, Belletti B, Baldassarre G. miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC. EMBO Mol Med 2021;13:e12872. [PMID: 34062049 DOI: 10.15252/emmm.202012872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
250 |
Vahabi M, Blandino G, Di Agostino S. MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies. Transl Cancer Res 2021;10:3090-110. [PMID: 35116619 DOI: 10.21037/tcr-20-2530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
251 |
Karlik E, Gurbuz O, Yildiz Y, Gozukirmizi N. Endogenous retrovirus HERV-K6 and HERV-K11 polymorphisms’ analyses in head and neck squamous cell carcinoma patients. Meta Gene 2021;28:100876. [DOI: 10.1016/j.mgene.2021.100876] [Reference Citation Analysis]
|
252 |
Jing FY, Zhou LM, Ning YJ, Wang XJ, Zhu YM. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review. Front Cell Dev Biol 2021;9:683254. [PMID: 34136491 DOI: 10.3389/fcell.2021.683254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
253 |
Ventura TMO, Ribeiro NR, Taira EA, de Lima Leite A, Dionizio A, Rubira CMF, da Silva Santos PS, Buzalaf MAR. Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment. Clin Oral Investig 2021. [PMID: 34052889 DOI: 10.1007/s00784-021-03995-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
254 |
Pierik AS, Leemans CR, Brakenhoff RH. Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization. Cancers (Basel) 2021;13:2635. [PMID: 34071997 DOI: 10.3390/cancers13112635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
255 |
Melis M, Zhang T, Scognamiglio T, Gudas LJ. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma. Carcinogenesis 2020;41:1553-64. [PMID: 32115621 DOI: 10.1093/carcin/bgaa019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
256 |
He J, Fang X, Han M. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma. Front Genet 2021;12:654657. [PMID: 34108990 DOI: 10.3389/fgene.2021.654657] [Reference Citation Analysis]
|
257 |
Arroyo Mühr LS, Hultin E, Dillner J. Transcription of human papillomaviruses in nonmelanoma skin cancers of the immunosuppressed. Int J Cancer 2021;149:1341-7. [PMID: 33990956 DOI: 10.1002/ijc.33683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
258 |
Hu Y, Ai LS, Zhou LQ. Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis. PLoS One 2021;16:e0251202. [PMID: 33989301 DOI: 10.1371/journal.pone.0251202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
259 |
Thotambailu A, Cheriamane D, Santhepete M, Kumar Bhandary S, Avanippully J, Bhadravathi P. Role of Pomegranate in the Management of Cancer. Pomegranate [Working Title] 2021. [DOI: 10.5772/intechopen.97188] [Reference Citation Analysis]
|
260 |
Tokuzen N, Nakashiro KI, Tojo S, Goda H, Kuribayashi N, Uchida D. Human papillomavirus-16 infection and p16 expression in oral squamous cell carcinoma. Oncol Lett 2021;22:528. [PMID: 34055093 DOI: 10.3892/ol.2021.12789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
261 |
Biagioni A, Tavakol S, Ahmadirad N, Zahmatkeshan M, Magnelli L, Mandegary A, Samareh Fekri H, Asadi MH, Mohammadinejad R, Ahn KS. Small nucleolar RNA host genes promoting epithelial-mesenchymal transition lead cancer progression and metastasis. IUBMB Life 2021;73:825-42. [PMID: 33938625 DOI: 10.1002/iub.2501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
262 |
Verduci L, Tarcitano E, Strano S, Yarden Y, Blandino G. CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis 2021;12:468. [PMID: 33976116 DOI: 10.1038/s41419-021-03743-3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 86] [Article Influence: 37.5] [Reference Citation Analysis]
|
263 |
Wu-Chou YH, Hsieh CH, Liao CT, Lin YT, Fan WL, Yang CH. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma. Pathol Res Pract 2021;223:153474. [PMID: 33993060 DOI: 10.1016/j.prp.2021.153474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
264 |
Bußmann L, Hoffer K, von Bargen CM, Droste C, Lange T, Kemmling J, Schröder-Schwarz J, Vu AT, Akingunsade L, Nollau P, Rangarajan S, de Wijn R, Oetting A, Müller C, Böckelmann LC, Zech HB, Berger JC, Möckelmann N, Busch CJ, Böttcher A, Gatzemeier F, Klinghammer K, Simnica D, Binder M, Struve N, Rieckmann T, Schumacher U, Clauditz TS, Betz CS, Petersen C, Rothkamm K, Münscher A, Kriegs M. Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets. Int J Cancer 2021;149:1166-80. [PMID: 33890294 DOI: 10.1002/ijc.33606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
265 |
Sidenko EA, Mikhalev DE, Kakurina GV, Cheremisina OV, Baidik OD, Choynzonov EL, Kondakova IV. THE ACTIVITY OF CIRCULATING PROTEASOMES IN TUMOR AND PRECANCEROUS DISEASES OF THE HEAD AND NECK ORGANS. Sib onkol ž 2021;20:46-52. [DOI: 10.21294/1814-4861-2021-20-2-46-52] [Reference Citation Analysis]
|
266 |
Farah CS. Molecular landscape of head and neck cancer and implications for therapy. Ann Transl Med 2021;9:915. [PMID: 34164549 DOI: 10.21037/atm-20-6264] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
267 |
Koucký V, Bouček J, Plzák J, Fialová A. Importance of immune cell infiltration in tumor microenvironment of head and neck cancer. Onkologie 2021;15:67-72. [DOI: 10.36290/xon.2021.013] [Reference Citation Analysis]
|
268 |
Wang X, Cao K, Guo E, Mao X, Guo L, Zhang C, Guo J, Wang G, Yang X, Sun J, Miao S. Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma. Front Immunol 2021;12:658631. [PMID: 33995377 DOI: 10.3389/fimmu.2021.658631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
269 |
Nisar S, Yousuf P, Masoodi T, Wani NA, Hashem S, Singh M, Sageena G, Mishra D, Kumar R, Haris M, Bhat AA, Macha MA. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int J Mol Sci 2021;22:4584. [PMID: 33925575 DOI: 10.3390/ijms22094584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
270 |
Lin B, Wang S, Yao Y, Shen Y, Yang H. Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer. Oncol Lett 2021;22:498. [PMID: 33981360 DOI: 10.3892/ol.2021.12759] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
271 |
Cao CH, Liu R, Lin XR, Luo JQ, Cao LJ, Zhang QJ, Lin SR, Geng L, Sun ZY, Ye SK, Yu ZY, Shi Y, Xia X. LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma. Int J Biol Sci 2021;17:1744-56. [PMID: 33994859 DOI: 10.7150/ijbs.56970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
272 |
Zhou LQ, Hu Y, Xiao HJ. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis. BMC Cancer 2021;21:424. [PMID: 33863308 DOI: 10.1186/s12885-021-08170-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
273 |
Fang R, Iqbal M, Chen L, Liao J, Luo J, Wei F, Wen W, Sun W. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Aging (Albany NY) 2021;13:11507-27. [PMID: 33867351 DOI: 10.18632/aging.202842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
274 |
Wang X, Guo Y, Wang C, Wang Q, Yan G. Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients. Onco Targets Ther 2021;14:2699-710. [PMID: 33888994 DOI: 10.2147/OTT.S297209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
275 |
Wang S, Chen X, Qiao T. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis. Oncol Rep 2021;45:99. [PMID: 33846802 DOI: 10.3892/or.2021.8050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
276 |
Merckx G, Lo Monaco M, Lambrichts I, Himmelreich U, Bronckaers A, Wolfs E. Safety and Homing of Human Dental Pulp Stromal Cells in Head and Neck Cancer. Stem Cell Rev Rep 2021. [PMID: 33822326 DOI: 10.1007/s12015-021-10159-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
277 |
Wu HT, Chen WT, Chen WJ, Li CL, Liu J. Bioinformatics analysis reveals that ANXA1 and SPINK5 are novel tumor suppressor genes in patients with oral squamous cell carcinoma. Transl Cancer Res 2021;10:1761-72. [PMID: 35116500 DOI: 10.21037/tcr-20-3382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
278 |
Vadovics M, Igaz N, Alföldi R, Rakk D, Veres É, Szücs B, Horváth M, Tóth R, Szücs A, Horváth P, Tiszlavicz L, Vágvölgyi C, Nosanchuk J, Szekeres A, Kiricsi M, Puskás L, Gácser A. Candida albicans enhances the progression of oral squamous cell cancrinoma in vitro and in vivo.. [DOI: 10.1101/2021.03.31.437836] [Reference Citation Analysis]
|
279 |
Rasmussen JH, Olin AB, Lelkaitis G, Hansen AE, Andersen FL, Johannesen HH, Kjaer A, Fischer BM, Specht L, Bentzen SM, von Buchwald C, Wessel I, Vogelius IR. Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma. Eur J Radiol 2021;139:109668. [PMID: 33848777 DOI: 10.1016/j.ejrad.2021.109668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
280 |
Kim HR, Moon JH, Lee JH, Lim YC. Inhibitor of DNA Binding 2 (ID2): A Novel Marker for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 33783641 DOI: 10.1245/s10434-021-09832-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
281 |
Xin W, Zhao C, Jiang L, Pei D, Zhao L, Zhang C. Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC. Pathol Oncol Res 2021;27:585192. [PMID: 34257533 DOI: 10.3389/pore.2021.585192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
282 |
Wang H, Wang F, Ouyang W, Jiang X, Wang Y. BCAT1 overexpression regulates proliferation and c‑Myc/GLUT1 signaling in head and neck squamous cell carcinoma. Oncol Rep 2021;45:52. [PMID: 33760210 DOI: 10.3892/or.2021.8003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
283 |
Zafar E, Maqbool MF, Iqbal A, Maryam A, Shakir HA, Irfan M, Khan M, Li Y, Ma T. A comprehensive review on anticancer mechanism of bazedoxifene. Biotechnol Appl Biochem 2021. [PMID: 33759222 DOI: 10.1002/bab.2150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
284 |
Mutlu M, Mutlu P, Azarkan S, Bayır Ö, Öcal B, Saylam G, Korkmaz MH. Evaluation of Methylation Profiles of An Epidermal Growth Factor Receptor Gene in a Head and Neck Squamous Cell Carcinoma Patient Group. Balkan J Med Genet 2020;23:65-72. [PMID: 33816074 DOI: 10.2478/bjmg-2020-0025] [Reference Citation Analysis]
|
285 |
Marijić B, Braut T, Babarović E, Krstulja M, Maržić D, Avirović M, Kujundžić M, Hadžisejdić I. Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma. Appl Immunohistochem Mol Morphol 2021;29:576-84. [PMID: 33758141 DOI: 10.1097/PAI.0000000000000932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
286 |
Duncan L, Shay C, Teng Y. Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer. Adv Exp Med Biol 2021;1286:107-14. [PMID: 33725348 DOI: 10.1007/978-3-030-55035-6_7] [Reference Citation Analysis]
|
287 |
Wu K, Mao YY, Han NN, Wu H, Zhang S. PLAU1 Facilitated Proliferation, Invasion, and Metastasis via Interaction With MMP1 in Head and Neck Squamous Carcinoma. Front Oncol 2021;11:574260. [PMID: 33816223 DOI: 10.3389/fonc.2021.574260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
288 |
Liu G, Yuan C, Ma J, Pan Y, Xu H. Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:604784. [PMID: 33816236 DOI: 10.3389/fonc.2021.604784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
289 |
Wang G, Zhang M, Cheng M, Wang X, Li K, Chen J, Chen Z, Chen S, Chen J, Xiong G, Xu X, Wang C, Chen D. Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms. Cancer Lett 2021;507:55-69. [PMID: 33741424 DOI: 10.1016/j.canlet.2021.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
290 |
González-Moles MÁ, Ramos-García P, Esteban F. Significance of the Overexpression of Substance P and Its Receptor NK-1R in Head and Neck Carcinogenesis: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:1349. [PMID: 33802704 DOI: 10.3390/cancers13061349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
291 |
Liang B, Tao Y, Wang T. Profiles of immune cell infiltration in head and neck squamous carcinoma. Biosci Rep 2020;40:BSR20192724. [PMID: 32095823 DOI: 10.1042/BSR20192724] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
292 |
Pritzker KPH, Darling MR, Hwang JT, Mock D. Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade? Expert Rev Mol Diagn 2021;21:289-98. [PMID: 33682567 DOI: 10.1080/14737159.2021.1898949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
293 |
Dlamini Z, Alaouna M, Mbatha S, Bhayat A, Mabongo M, Chatziioannou A, Hull R. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets. Genes (Basel) 2021;12:422. [PMID: 33804181 DOI: 10.3390/genes12030422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
294 |
Altuntaş OM, Süslü N, Güler Tezel YG, Tatlı Doğan H, Yılmaz T. Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer. Braz J Otorhinolaryngol 2021:S1808-8694(21)00054-9. [PMID: 33757755 DOI: 10.1016/j.bjorl.2021.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
295 |
Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, Chikamatsu K. AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:1233. [PMID: 33799788 DOI: 10.3390/cancers13061233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
296 |
Locatello LG, Bruno C, Gallo O. Early glottic cancer recurrence: A critical review on its current management. Crit Rev Oncol Hematol 2021;160:103298. [PMID: 33716199 DOI: 10.1016/j.critrevonc.2021.103298] [Reference Citation Analysis]
|
297 |
Feng B, Hess J. Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer. Cancers (Basel) 2021;13:1162. [PMID: 33800421 DOI: 10.3390/cancers13051162] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
298 |
Schoonbeek RC, Zwertbroek J, Plaat BEC, Takes RP, Ridge JA, Strojan P, Ferlito A, van Dijk BAC, Halmos GB. Determinants of delay and association with outcome in head and neck cancer: A systematic review. Eur J Surg Oncol 2021;47:1816-27. [PMID: 33715909 DOI: 10.1016/j.ejso.2021.02.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
299 |
Veigas F, Mahmoud YD, Merlo J, Rinflerch A, Rabinovich GA, Girotti MR. Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:1018. [PMID: 33804419 DOI: 10.3390/cancers13051018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
300 |
Freihat O, Tóth Z, Pintér T, Kedves A, Sipos D, Cselik Z, Lippai N, Repa I, Kovács Á. Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC). Oral Oncol 2021;116:105239. [PMID: 33640578 DOI: 10.1016/j.oraloncology.2021.105239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
301 |
Huang GZ, Wu QQ, Zheng ZN, Shao TR, Li F, Lu XY, Ye HY, Chen GX, Song YX, Zeng WS, Ai YL, Lv XZ. Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC). Onco Targets Ther 2021;14:1275-89. [PMID: 33658795 DOI: 10.2147/OTT.S293148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
302 |
Vadovics M, Ho J, Igaz N, Alföldi R, Rakk D, Veres É, Szücs B, Horváth M, Tóth R, Szücs A, Csibi A, Horváth P, Tiszlavicz L, Vágvölgyi C, Nosanchuk JD, Szekeres A, Kiricsi M, Henley-Smith R, Moyes DL, Thavaraj S, Brown R, Puskás LG, Naglik JR, Gácser A. Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma In Vitro and In Vivo. mBio 2021;13:e0314421. [PMID: 35089096 DOI: 10.1128/mBio.03144-21] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
303 |
Barem Rabenhorst SH, Lima Verde Osterne R, Weege Nonaka CF, Montezuma Sales Rodrigues A, Luiz Maia Nogueira R, Mário Rodriguez Burbano R, Barroso Cavalcante R. Detection of deletions in 1q25, 1p36 and 1pTEL and chromosome 17 aneuploidy in oral epithelial dysplasia and oral squamous cell carcinoma by fluorescence in situ hybridization (FISH). Oral Oncol 2021;116:105221. [PMID: 33610067 DOI: 10.1016/j.oraloncology.2021.105221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
304 |
Wang R. Overexpression of ELOVL6 has been associated with poor prognosis in patients with head and neck squamous cell carcinoma.. [DOI: 10.1101/2021.02.13.431065] [Reference Citation Analysis]
|
305 |
Odell EW. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Dis 2021. [PMID: 33577101 DOI: 10.1111/odi.13797] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
306 |
Lin B, Li H, Zhang T, Ye X, Yang H, Shen Y. Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer. Aging (Albany NY) 2021;13:5718-47. [PMID: 33592580 DOI: 10.18632/aging.202499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
307 |
Gallo O, Locatello LG. All that glitters is not gold: Clinical implications from the genetic analysis of head and neck cancer recurrences. Oral Oncol 2021;117:105187. [PMID: 33582000 DOI: 10.1016/j.oraloncology.2021.105187] [Reference Citation Analysis]
|
308 |
Akbari Dilmaghani N, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Bashash D. The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies. IUBMB Life 2021;73:618-42. [PMID: 33476088 DOI: 10.1002/iub.2446] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
309 |
Zhang C, Wang H, Deng M, He L, Ping F, He Y, Fan Z, Cheng B, Xia J. Upregulated miR‑411‑5p levels promote lymph node metastasis by targeting RYBP in head and neck squamous cell carcinoma. Int J Mol Med 2021;47:36. [PMID: 33537835 DOI: 10.3892/ijmm.2021.4869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
310 |
Xie G, Zhu A, Gu X. Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma. Head Neck 2021;43:1721-9. [PMID: 33533173 DOI: 10.1002/hed.26633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
311 |
Riva G, Albano C, Gugliesi F, Pasquero S, Pacheco SFC, Pecorari G, Landolfo S, Biolatti M, Dell'Oste V. HPV Meets APOBEC: New Players in Head and Neck Cancer. Int J Mol Sci 2021;22:1402. [PMID: 33573337 DOI: 10.3390/ijms22031402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
312 |
Rong C, Zhou R, Wan S, Su D, Wang SL, Hess J. Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer. Front Oncol 2020;10:592501. [PMID: 33585209 DOI: 10.3389/fonc.2020.592501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
313 |
Lorenzo-Pouso AI, Gallas-Torreira M, Pérez-Sayáns M, Chamorro-Petronacci CM, Alvarez-Calderon O, Takkouche B, Supuran CT, García-García A. Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis. J Enzyme Inhib Med Chem 2020;35:1258-66. [PMID: 32466707 DOI: 10.1080/14756366.2020.1772250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
314 |
Gadsden NJ, Fulcher CD, Li D, Shrivastava N, Thomas C, Segall JE, Prystowsky MB, Schlecht NF, Gavathiotis E, Ow TJ. Palbociclib Renders Human Papilloma Virus-Negative Head and Neck Squamous Cell Carcinoma Vulnerable to the Senolytic Agent Navitoclax. Mol Cancer Res 2021;19:862-73. [PMID: 33495400 DOI: 10.1158/1541-7786.MCR-20-0915] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
315 |
Mulder FJ, Klufah F, Janssen FME, Farshadpour F, Willems SM, de Bree R, Zur Hausen A, van den Hout MFCM, Kremer B, Speel EM. Presence of Human Papillomavirus and Epstein-Barr Virus, but Absence of Merkel Cell Polyomavirus, in Head and Neck Cancer of Non-Smokers and Non-Drinkers. Front Oncol 2020;10:560434. [PMID: 33552950 DOI: 10.3389/fonc.2020.560434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
316 |
Zhu Z, Liu Y, Wu D, Wang H. Association Between Mitochondrial DNA Copy Number and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Dose-Response Meta-Analysis. Med Sci Monit 2021;27:e928327. [PMID: 33468984 DOI: 10.12659/MSM.928327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
317 |
Muzaffar J, Bari S, Kirtane K, Chung CH. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:338. [PMID: 33477635 DOI: 10.3390/cancers13020338] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
|
318 |
Korsten LHA, Jansen F, Lissenberg-Witte BI, Vergeer M, Brakenhoff RH, Leemans CR, Verdonck-de Leeuw IM. The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter? Support Care Cancer 2021;29:4473-83. [PMID: 33454834 DOI: 10.1007/s00520-020-05932-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
319 |
Bhat AA, Yousuf P, Wani NA, Rizwan A, Chauhan SS, Siddiqi MA, Bedognetti D, El-Rifai W, Frenneaux MP, Batra SK, Haris M, Macha MA. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduct Target Ther 2021;6:12. [PMID: 33436555 DOI: 10.1038/s41392-020-00419-w] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
|
320 |
Eccher A, Fontanini G, Fusco N, Girolami I, Graziano P, Rocco EG, Martini M, Morbini P, Pantanowitz L, Parwani A, Pisano AM, Troncone G, Vigliar E. Digital Slides as an Effective Tool for Programmed Death Ligand 1 Combined Positive Score Assessment and Training: Lessons Learned from the "Programmed Death Ligand 1 Key Learning Program in Head-and-Neck Squamous Cell Carcinoma". J Pathol Inform 2021;12:1. [PMID: 34012705 DOI: 10.4103/jpi.jpi_63_20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
321 |
Sathasivam HP, Nayar D, Sloan P, Thomson PJ, Odell EW, Robinson M. Dysplasia and DNA ploidy to prognosticate clinical outcome in oral potentially malignant disorders. J Oral Pathol Med 2021;50:200-9. [PMID: 33151583 DOI: 10.1111/jop.13121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
322 |
Shen Q, Zhu H, Lei Q, Chen L, Yang D, Sui W. MicroRNA‑149‑3p inhibits cell proliferation by targeting AKT2 in oral squamous cell carcinoma. Mol Med Rep 2021;23:172. [PMID: 33398370 DOI: 10.3892/mmr.2020.11811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
323 |
Jia H, Wang X, Sun Z. Screening and validation of plasma long non-coding RNAs as biomarkers for the early diagnosis and staging of oral squamous cell carcinoma. Oncol Lett 2021;21:172. [PMID: 33552289 DOI: 10.3892/ol.2021.12433] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
324 |
Nwachuku K, Johnson DE, Grandis JR. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma: Opportunities for Detection and Monitoring Via Analysis of Circulating Tumor DNA. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69852-2_5] [Reference Citation Analysis]
|
325 |
Spitler R. Overview of Early Detection, Diagnosis, and Treatment of Head and Neck Cancers. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69859-1_1] [Reference Citation Analysis]
|
326 |
De Pauw I, Boeckx C, Wouters A. Mechanisms of Cetuximab Resistance and How to Overcome It. Critical Issues in Head and Neck Oncology 2021. [DOI: 10.1007/978-3-030-63234-2_3] [Reference Citation Analysis]
|
327 |
Das T, Zhong R, Spiotto MT. Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis. Adv Exp Med Biol 2021;1287:105-22. [PMID: 33034029 DOI: 10.1007/978-3-030-55031-8_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
328 |
Nonaka T, Wong DTW. Circulating Biomarkers in Head and Neck Cancer. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69852-2_6] [Reference Citation Analysis]
|
329 |
Sahu SN, Sahoo T, Mishra B, Pattanayak SK, Sahu R. Interaction of Ru-4′-(2-pyridyl)- 2,2′:6′,2″-Terpyridine with Diseased HER2 Protein. Lecture Notes in Mechanical Engineering 2021. [DOI: 10.1007/978-981-15-7779-6_35] [Reference Citation Analysis]
|
330 |
Qiu S, Li D, Shen Z, Li Q, Shen Y, Deng H, Wu Y, Zhou C. Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma. J Cancer 2021;12:693-702. [PMID: 33403027 DOI: 10.7150/jca.47978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
331 |
Bianciardi L, Corallo C, Criscuoli M, Fortunato D, Zarovni N, Zocco D. Emerging Technologies in Markets for the Early Detection of Head and Neck Cancer. Early Detection and Treatment of Head & Neck Cancers 2021. [DOI: 10.1007/978-3-030-69859-1_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
332 |
Odell E, Gale N, Thavaraj S, Nadal A, Zidar N, Gnepp DR. Precursor Lesions for Squamous Carcinoma in the Upper Aerodigestive Tract. Gnepp's Diagnostic Surgical Pathology of the Head and Neck 2021. [DOI: 10.1016/b978-0-323-53114-6.00001-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
333 |
Wu ZH, Tang Y, Zhou Y. A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma. Mediators Inflamm 2020;2020:6716908. [PMID: 33456371 DOI: 10.1155/2020/6716908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
334 |
Schinke H, Heider T, Herkommer T, Simon F, Blancke Soares A, Kranz G, Samaga D, Dajka L, Feuchtinger A, Walch A, Valeanu L, Walz C, Kirchner T, Canis M, Baumeister P, Belka C, Maihöfer C, Marschner S, Pflugradt U, Ganswindt U, Hess J, Zitzelsberger H, Gires O. Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas. Mol Oncol 2021;15:1040-53. [PMID: 33340247 DOI: 10.1002/1878-0261.12886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
335 |
Bockhorst C, Dietrich J, Vogt TJ, Stauber RH, Strieth S, Bootz F, Dietrich D, Vos L. The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head and neck squamous cell carcinoma. Epigenomics 2021;13:113-27. [PMID: 33351665 DOI: 10.2217/epi-2020-0208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
336 |
Wang L, Wang Y, Han N, Wang X, Ruan M. HPRT promotes proliferation and metastasis in head and neck squamous cell carcinoma through direct interaction with STAT3. Exp Cell Res 2021;399:112424. [PMID: 33340493 DOI: 10.1016/j.yexcr.2020.112424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
337 |
Lee JC, Wu ATH, Chen JH, Huang WY, Lawal B, Mokgautsi N, Huang HS, Ho CL. HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses. Cancers (Basel) 2020;12:E3759. [PMID: 33327484 DOI: 10.3390/cancers12123759] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
338 |
Dasgupta A, Fatima K, DiCenzo D, Bhardwaj D, Quiaoit K, Saifuddin M, Karam I, Poon I, Husain Z, Tran WT, Sannachi L, Czarnota GJ. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy. Cancer Med 2021;10:2579-89. [PMID: 33314716 DOI: 10.1002/cam4.3634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
339 |
Fukuda N, Yunokawa M, Fujiwara Y, Wang X, Ohmoto A, Hayashi N, Urasaki T, Sato Y, Nakano K, Ono M, Tomomatsu J, Mitani H, Takahashi S. Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients. Cancer Rep (Hoboken) 2021;4:e1322. [PMID: 33295110 DOI: 10.1002/cnr2.1322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
340 |
Liu C, Billet S, Choudhury D, Cheng R, Haldar S, Fernandez A, Biondi S, Liu Z, Zhou H, Bhowmick NA. Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance. Neoplasia 2021;23:118-28. [PMID: 33310208 DOI: 10.1016/j.neo.2020.11.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
341 |
Fukusumi T, Guo TW, Ren S, Haft S, Liu C, Sakai A, Ando M, Saito Y, Sadat S, Califano JA. Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma. Int J Oncol 2021;58:226-37. [PMID: 33491747 DOI: 10.3892/ijo.2020.5156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
342 |
Peña-Oyarzún D, Reyes M, Hernández-Cáceres MP, Kretschmar C, Morselli E, Ramirez-Sarmiento CA, Lavandero S, Torres VA, Criollo A. Role of Autophagy in the Microenvironment of Oral Squamous Cell Carcinoma. Front Oncol 2020;10:602661. [PMID: 33363032 DOI: 10.3389/fonc.2020.602661] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
343 |
Ferrisse TM, Rocha AFL, Lança MLA, Silveira HA, Almeida LY, Bufalino A, León JE. Post-radiotherapy recurrence of conventional oral squamous cell carcinoma showing sarcomatoid components: an immunohistochemical study. Autops Case Rep 2021;11:e2020219. [PMID: 34277487 DOI: 10.4322/acr.2020.219] [Reference Citation Analysis]
|
344 |
Zanetti-Domingues LC, Bonner SE, Iyer RS, Martin-Fernandez ML, Huber V. Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer. Cells 2020;9:E2639. [PMID: 33302515 DOI: 10.3390/cells9122639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
345 |
Starzyńska A, Adamska P, Sejda A, Sakowicz-Burkiewicz M, Adamski ŁJ, Marvaso G, Wychowański P, Jereczek-Fossa BA. Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma? Life (Basel) 2020;10:E325. [PMID: 33287350 DOI: 10.3390/life10120325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
346 |
Gupta A, Yadav S, Pt A, Mishra J, Samaiya A, Panday RK, Shukla S. The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer. Lab Invest 2020;100:1589-601. [PMID: 32669614 DOI: 10.1038/s41374-020-0466-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
347 |
Schiavetto CM, de Abreu PM, von Zeidler SV, de Jesus LM, Carvalho RS, Cirino MT, Carloni AC, Oliveira C, Scapulatempo-Neto C, de Almeida GC, de Menezes NS, Carvalho AL, Reis RM, de Carvalho AC. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients. Mol Diagn Ther 2021;25:59-70. [PMID: 33245553 DOI: 10.1007/s40291-020-00502-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
|
348 |
Krishnamurthy K, Lindsey AM, Estrada CA, Martinez CC, Cusnir M, Schwartz M, Sriganeshan V, Poppiti R. Title- Genomic landscape of squamous cell carcinoma- Different genetic pathways culminating in a common phenotype. Cancer Treat Res Commun 2020;25:100238. [PMID: 33260028 DOI: 10.1016/j.ctarc.2020.100238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
349 |
Al Qaraghuli MM. Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer: Current Approaches and Future Considerations of Photothermal Therapies. Front Oncol 2020;10:559596. [PMID: 33324546 DOI: 10.3389/fonc.2020.559596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
350 |
Ganci F, Allegretti M, Manciocco V, Fiorentino F, Sanguineti G, Giacomini P, Pellini R, Spinella F, Blandino G. Two distinct TP53 mutations in HNSCC primary tumor: Only one circulates in the blood. Oral Oncol 2021;115:105096. [PMID: 33234482 DOI: 10.1016/j.oraloncology.2020.105096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
351 |
Laban S, Brand M, Ezić J, Doescher J, Völkel G, Kestler HA, Brunner C, Hoffmann TK. [Tumor biology of oropharyngeal carcinoma]. HNO 2021;69:249-55. [PMID: 33215226 DOI: 10.1007/s00106-020-00964-4] [Reference Citation Analysis]
|
352 |
Dittberner A, Friedl B, Wittig A, Buentzel J, Kaftan H, Boeger D, Mueller AH, Schultze-Mosgau S, Schlattmann P, Ernst T, Guntinas-Lichius O. Gender Disparities in Epidemiology, Treatment, and Outcome for Head and Neck Cancer in Germany: A Population-Based Long-Term Analysis from 1996 to 2016 of the Thuringian Cancer Registry. Cancers (Basel) 2020;12:E3418. [PMID: 33218009 DOI: 10.3390/cancers12113418] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
|
353 |
Kostalanova YV, Ganina KA, Makhonin AA, Gabrielyan AG. Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck. Opuholi golovy i šei 2020;10:41-47. [DOI: 10.17650/2222-1468-2020-10-3-41-47] [Reference Citation Analysis]
|
354 |
Ludwig S, Sharma P, Wise P, Sposto R, Hollingshead D, Lamb J, Lang S, Fabbri M, Whiteside TL. mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer. Int J Mol Sci 2020;21:E8570. [PMID: 33202950 DOI: 10.3390/ijms21228570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
355 |
Sequeira I, Rashid M, Tomás IM, Williams MJ, Graham TA, Adams DJ, Vigilante A, Watt FM. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology. Nat Commun 2020;11:5671. [PMID: 33168804 DOI: 10.1038/s41467-020-19401-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
356 |
Swartz JE, Wegner I, Noorlag R, van Kempen PMW, van Es RJJ, de Bree R, Willems SMW. HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas. Head Neck 2021;43:745-56. [PMID: 33155375 DOI: 10.1002/hed.26530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
357 |
Li W, Lu H, Wang H, Ning X, Liu Q, Zhang H, Liu Z, Wang J, Zhao W, Gu Y, Li H, Sun X, Hu L, Wang D. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107. Cancer Lett 2021;499:301-13. [PMID: 33160003 DOI: 10.1016/j.canlet.2020.11.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
358 |
Wang Z, Yuan S, Cao X, Huang C, Zhang A, Lu C, Liu L. MiR‐335‐5p inhibits the progression of head and neck squamous cell carcinoma by targeting MAP3K2. FEBS Open Bio 2020;10:2282-93. [DOI: 10.1002/2211-5463.12955] [Reference Citation Analysis]
|
359 |
Vieira V, Campos LH, Jesus LH, Klabunde C, Gamba TD, Flores IL, Oliveira MG, Rados PV. Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer. Med Oral Patol Oral Cir Bucal 2020;25:e752-61. [PMID: 32701933 DOI: 10.4317/medoral.23777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
360 |
Tian Y, Wang J, Qin C, Zhu G, Chen X, Chen Z, Qin Y, Wei M, Li Z, Zhang X, Lv Y, Cai G. Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning. Front Genet 2020;11:566159. [PMID: 33329703 DOI: 10.3389/fgene.2020.566159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
361 |
Feng L, Zhang J, Sun M, Qiu F, Chen W, Qiu W. Tumor Suppressor LINC02487 Inhibits Oral Squamous Cell Carcinoma Cell Migration and Invasion Through the USP17-SNAI1 Axis. Front Oncol 2020;10:559808. [PMID: 33194625 DOI: 10.3389/fonc.2020.559808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
362 |
Wang Y, Jiang Y, Chen L. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data. J Cell Mol Med 2020;24:13824-36. [PMID: 33107676 DOI: 10.1111/jcmm.15972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
363 |
Wang Y, Xu Y, Hua Q, Jiang Y, Liu P, Zhang W, Xiang R. Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma. Biomed Res Int 2020;2020:4725314. [PMID: 33134377 DOI: 10.1155/2020/4725314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
364 |
Cilona M, Locatello LG, Novelli L, Gallo O. The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review. Cancers (Basel) 2020;12:E3006. [PMID: 33081243 DOI: 10.3390/cancers12103006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
365 |
Kar M, Sultania M, Roy S, Padhi S, Banerjee B. 𝛽-Catenin-a Possible Prognostic Molecular Marker for Recurrence in Histopathologically Negative Surgical Margin of Oral Cancer. Indian J Surg Oncol 2021;12:128-33. [PMID: 33994738 DOI: 10.1007/s13193-020-01217-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
366 |
Liu Z, Hurst DR, Qu X, Lu LG, Wu CZ, Li YY, Li Y. Re-expression of DIRAS3 and p53 induces apoptosis and impaired autophagy in head and neck squamous cell carcinoma. Mil Med Res 2020;7:48. [PMID: 33038921 DOI: 10.1186/s40779-020-00275-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
367 |
Radzhabova ZA, Kotov MД, Mitrofanov AS, Bekyasheva ZS, Levchenko EV. Immunotherapy for regional, recurrent and metastatic head and neck cancer: recent advances and future directions. Medicinskij alfavit 2020. [DOI: 10.33667/2078-5631-2020-20-60-69] [Reference Citation Analysis]
|
368 |
Yamamoto T, Niibe Y, Matsumoto Y, Aoki M, Oh RJ, Ozaki M, Kobayashi M, Manabe Y, Shintani T, Dekura Y, Onishi H, Yamashita H, Jingu K. Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases. Cancer Med 2020;9:8902-11. [PMID: 33022899 DOI: 10.1002/cam4.3508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
369 |
Vucur C, Wirtz DA, Weinhold L, Zipfel M, Schmid M, Schmidt-Wolf IG, Jaehde U. Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles. J Oncol Pharm Pract 2021;27:1439-46. [PMID: 33019873 DOI: 10.1177/1078155220962178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
370 |
Kim SI, Kang JW, Noh JK, Jung HR, Lee YC, Lee JW, Kong M, Eun YG. Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma. Radiat Oncol J 2020;38:99-108. [PMID: 33012153 DOI: 10.3857/roj.2020.00136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
371 |
Fernández-Mateos J, Pérez-García J, Seijas-Tamayo R, Mesía R, Rubió-Casadevall J, García-Girón C, Iglesias L, Carral Maseda A, Adansa Klain JC, Taberna M, Vazquez S, Gómez MA, Del Barco E, Ocana A, González-Sarmiento R, Cruz-Hernández JJ. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial. Sci Rep 2020;10:16634. [PMID: 33024167 DOI: 10.1038/s41598-020-72927-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
372 |
Huang Y, Liu Z, Zhong L, Wen Y, Ye Q, Cao D, Li P, Liu Y. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. BMC Genomics 2020;21:691. [PMID: 33023466 DOI: 10.1186/s12864-020-07104-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
373 |
Wang Z, Yuan H, Huang J, Hu D, Qin X, Sun C, Chen G, Wang B. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma. Head Neck 2021;43:182-97. [PMID: 33009692 DOI: 10.1002/hed.26474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
374 |
Pranata N, Maskoen AM, Sahiratmadja E, Widyaputra S. Dental Calculus as a Potential Biosource for Human Papillomavirus Detection in Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev 2020;21:3093-7. [PMID: 33112572 DOI: 10.31557/APJCP.2020.21.10.3093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
375 |
Xu L, Jin Y, Qin X. Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma. International Immunopharmacology 2020;87:106844. [DOI: 10.1016/j.intimp.2020.106844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
376 |
Sengupta A, Barui G. A STUDY ON EXPRESSION OF P16 AS A SURROGATE MARKER OF HIGH RISK HPV INFECTION IN OROPHARYNGEAL, HEAD & NECK SQUAMOUS CELL CARCINOMA & ITS CORRELATION WITH DIFFERENT HISTOMORPHOLOGICAL FEATURES. ijsr 2020. [DOI: 10.36106/ijsr/7321510] [Reference Citation Analysis]
|
377 |
Li P, Zhang S, Mo Y, Zhang L, Wang Y, Xiong F, Zhang S, Liu J, Xu Y, Zeng Z, Xiong W, Li Y, Gong Z. Long non-coding RNA expression profiles and related regulatory networks in areca nut chewing-induced tongue squamous cell carcinoma. Oncol Lett 2020;20:302. [PMID: 33093911 DOI: 10.3892/ol.2020.12165] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
378 |
Garley M, Jabłońska E, Dziemiańczyk-Pakieła D, Miltyk W, Ratajczak-Wrona W, Borys J, Moniuszko M, Grubczak K. LDGs versus NDGs in patients with oral squamous cell carcinoma (OSCC). Cytokine 2021;137:155311. [PMID: 33002741 DOI: 10.1016/j.cyto.2020.155311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
379 |
Kopczyńska M, Kolenda T, Guglas K, Sobocińska J, Teresiak A, Bliźniak R, Mackiewicz A, Mackiewicz J, Lamperska K. PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas. Diagnostics (Basel) 2020;10:E762. [PMID: 32998396 DOI: 10.3390/diagnostics10100762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
380 |
Starke S, Leger S, Zwanenburg A, Leger K, Lohaus F, Linge A, Schreiber A, Kalinauskaite G, Tinhofer I, Guberina N, Guberina M, Balermpas P, von der Grün J, Ganswindt U, Belka C, Peeken JC, Combs SE, Boeke S, Zips D, Richter C, Troost EGC, Krause M, Baumann M, Löck S. 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma. Sci Rep 2020;10:15625. [PMID: 32973220 DOI: 10.1038/s41598-020-70542-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
381 |
Liu Y, Yin S. A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas. J Oncol 2020;2020:7353874. [PMID: 33029143 DOI: 10.1155/2020/7353874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
382 |
Sacconi A, Donzelli S, Pulito C, Ferrero S, Spinella F, Morrone A, Rigoni M, Pimpinelli F, Ensoli F, Sanguineti G, Pellini R, Agrawal N, Izumchenko E, Ciliberto G, Giannì A, Muti P, Strano S, Blandino G. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients. J Exp Clin Cancer Res 2020;39:200. [PMID: 32967703 DOI: 10.1186/s13046-020-01708-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
383 |
Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. J Natl Cancer Inst 2020;112:266-77. [PMID: 31124563 DOI: 10.1093/jnci/djz097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
384 |
Qiao XW, Jiang J, Pang X, Huang MC, Tang YJ, Liang XH, Tang YL. The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer. Front Immunol 2020;11:1721. [PMID: 33072064 DOI: 10.3389/fimmu.2020.01721] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 14.7] [Reference Citation Analysis]
|
385 |
Patel U, Pandey M, Kannan S, Samant TA, Gera P, Mittal N, Rane S, Patil A, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab. Br J Cancer 2020;123:1757-66. [PMID: 32939054 DOI: 10.1038/s41416-020-01064-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
386 |
Lan XY, Chung TT, Huang CL, Lee YJ, Li WC. Traditional Herbal Medicine Mediated Regulations during Head and Neck Carcinogenesis. Biomolecules 2020;10:E1321. [PMID: 32942674 DOI: 10.3390/biom10091321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
387 |
Liu J, Yang Q, Xiao KC, Dobleman T, Hu S, Xiao GG. Obg-like ATPase 1 inhibited oral carcinoma cell metastasis through TGFβ/SMAD2 axis in vitro. BMC Mol Cell Biol 2020;21:65. [PMID: 32928102 DOI: 10.1186/s12860-020-00311-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
388 |
Zuo J, Huo M, Wang L, Li J, Chen Y, Xiong P. Photonic hyperthermal and sonodynamic nanotherapy targeting oral squamous cell carcinoma. J Mater Chem B 2020. [PMID: 32926057 DOI: 10.1039/d0tb01089h] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
389 |
Khanna S, Palackdharry S, Roof L, Wicker CA, Mark J, Zhu Z, Jandorav R, Molinolo A, Takiar V, Wise-Draper TM. Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer. Cancers Head Neck 2020;5:11. [PMID: 32944296 DOI: 10.1186/s41199-020-00058-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
390 |
Figueroa-González G, Carrillo-Hernández JF, Perez-Rodriguez I, Cantú de León D, Campos-Parra AD, Martínez-Gutiérrez AD, Coronel-Hernández J, García-Castillo V, López-Camarillo C, Peralta-Zaragoza O, Jacobo-Herrera NJ, Guardado-Estrada M, Pérez-Plasencia C. Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer. Genes (Basel) 2020;11:E1058. [PMID: 32911741 DOI: 10.3390/genes11091058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
391 |
Dobler C, Jost T, Hecht M, Fietkau R, Distel L. Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells. Cells 2020;9:E2012. [PMID: 32883016 DOI: 10.3390/cells9092012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
392 |
Goto RN, Sobral LM, Stringhetta-padovani K, Garcia CB, da Silva G, Vitek MP, Leopoldino AM. Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma. European Journal of Pharmacology 2020;882:173268. [DOI: 10.1016/j.ejphar.2020.173268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
393 |
González-Moles MÁ, Ayén Á, González-Ruiz I, de Porras-Carrique T, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel) 2020;12:E2393. [PMID: 32847023 DOI: 10.3390/cancers12092393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
394 |
Zhang H, Wang Y, Qi J, Abbaszadeh S. Penalized maximum-likelihood reconstruction for improving limited-angle artifacts in a dedicated head and neck PET system. Phys Med Biol 2020;65:165016. [PMID: 32325441 DOI: 10.1088/1361-6560/ab8c92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
395 |
Ji Y, Xue Y. Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma. Onco Targets Ther 2020;13:8395-411. [PMID: 32904613 DOI: 10.2147/OTT.S257200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
396 |
Patel A, Mohammad Abedi S, Lekkala M, Baumgart M. Genomic-based treatment of patients with head and neck cancer. Expert Review of Precision Medicine and Drug Development 2020;5:401-8. [DOI: 10.1080/23808993.2020.1799710] [Reference Citation Analysis]
|
397 |
Jin T, Guo Y, Huang Z, Zhang Q, Huang Z, Zhang Y, Huang Z. Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway. J Cancer 2020;11:5971-81. [PMID: 32922538 DOI: 10.7150/jca.45389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
398 |
Wan SC, Wu H, Li H, Deng WW, Xiao Y, Wu CC, Yang LL, Zhang WF, Sun ZJ. Overexpression of PREX1 in oral squamous cell carcinoma indicates poor prognosis. J Mol Histol 2020;51:531-40. [PMID: 32785873 DOI: 10.1007/s10735-020-09901-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
399 |
Wei H, Yu K, Liu Y, Li L, Wang G. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma. BMC Cancer 2020;20:756. [PMID: 32787801 DOI: 10.1186/s12885-020-07243-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
400 |
Ghosh S, Maulik S, Chatterjee S, Mallick I, Chakravorty N, Mukherjee J. Prediction of survival outcome based on clinical features and pretreatment 18FDG-PET/CT for HNSCC patients. Comput Methods Programs Biomed 2020;195:105669. [PMID: 32763771 DOI: 10.1016/j.cmpb.2020.105669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
401 |
Wang JH. Why the Outcome of Anti-Tumor Immune Responses is Heterogeneous: A Novel Idea in the Context of Immunological Heterogeneity in Cancers. Bioessays 2020;42:e2000024. [PMID: 32767371 DOI: 10.1002/bies.202000024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
402 |
Chi J, Preeshagul IR, Sheikh-Fayyaz S, Teckie S, Kohn N, Ziemba Y, Laser A, Frank D, Ghaly M, Kamdar D, Kraus D, Paul D, Seetharamu N. Evaluating of HPV-DNA ISH as an adjunct to p16 testing in oropharyngeal cancer. Future Sci OA 2020;6:FSO606. [PMID: 33235805 DOI: 10.2144/fsoa-2020-0052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
403 |
Chinnery T, Arifin A, Tay KY, Leung A, Nichols AC, Palma DA, Mattonen SA, Lang P. Utilizing Artificial Intelligence for Head and Neck Cancer Outcomes Prediction From Imaging. Can Assoc Radiol J 2021;72:73-85. [PMID: 32735452 DOI: 10.1177/0846537120942134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
404 |
Chantree P, Surarak T, Sangpairoj K, Aguilar P, Hitakomate E. Antitumor Effects of Fucoidan Via Apoptotic and Autophagic Induction on HSC-3 Oral Squamous CellCarcinoma. Asian Pac J Cancer Prev 2020;21:2469-77. [PMID: 32856880 DOI: 10.31557/APJCP.2020.21.8.2469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
405 |
Chen X, Luo Q, Ding J, Yang M, Zhang R, Chen F. Zymosan promotes proliferation, Candida albicans adhesion and IL-1β production of oral squamous cell carcinoma in vitro. Infect Agent Cancer 2020;15:51. [PMID: 32760436 DOI: 10.1186/s13027-020-00315-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
406 |
Lin D, Lin B, Bhanot H, Riou R, Abt NB, Rajagopal J, Saladi SV. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers. Oral Oncol 2020;111:104930. [PMID: 32745900 DOI: 10.1016/j.oraloncology.2020.104930] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
407 |
Lyanova AA, Vladimirova LY, Ulianova EP, Storozhakova AE, Abramova NA, Popova IL, Teplyakova MA, Tikhanovskaya NM, Myagkova VS, Novoselova KA, Ryadinskaya LA, Strakhova LK, Kalabanova EA. Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2020-9-182-189] [Reference Citation Analysis]
|
408 |
Wang YC, Huang JL, Lee KW, Lu HH, Lin YJ, Chen LF, Wang CS, Cheng YC, Zeng ZT, Chu PY, Lin CS. Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53's DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption. Cancers (Basel) 2020;12:E2053. [PMID: 32722430 DOI: 10.3390/cancers12082053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
409 |
Huang G, Pan ST. ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer. Oxid Med Cell Longev 2020;2020:5047987. [PMID: 32774675 DOI: 10.1155/2020/5047987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
|
410 |
Okoturo E, Osasuyi A, Opaleye T. Genetic Polymorphism of Head and Neck Cancers in African Populations: A Systematic Review. OTO Open 2020;4:2473974X20942202. [PMID: 32743234 DOI: 10.1177/2473974X20942202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
411 |
Hilke FJ, Muyas F, Admard J, Kootz B, Nann D, Welz S, Rieß O, Zips D, Ossowski S, Schroeder C, Clasen K. Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy. Radiother Oncol 2020;151:182-9. [PMID: 32687856 DOI: 10.1016/j.radonc.2020.07.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
412 |
Costa EFD, Lima TRP, Lopes-Aguiar L, Nogueira GAS, Visacri MB, Quintanilha JCF, Pincinato EC, Calonga L, Mariano FV, Altemani AMAM, Altemani JMC, Moriel P, Chone CT, Ramos CD, Lima CSP. FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients. Tumour Biol 2020;42:1010428320938494. [PMID: 32628088 DOI: 10.1177/1010428320938494] [Reference Citation Analysis]
|
413 |
Marcozzi A, Jager M, Elferink M, Straver R, van Ginkel JH, Peltenburg B, Chen L, Renkens I, van Kuik J, Terhaard C, de Bree R, Devriese LA, Willems SM, Kloosterman WP, de Ridder J. Accurate detection of circulating tumor DNA using nanopore consensus sequencing.. [DOI: 10.1101/2020.07.14.202010] [Reference Citation Analysis]
|
414 |
Zito Marino F, Ronchi A, Stilo M, Cozzolino I, La Mantia E, Colacurci N, Colella G, Franco R. Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV. Infect Agent Cancer 2020;15:46. [PMID: 32684947 DOI: 10.1186/s13027-020-00310-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
415 |
Hsieh JC, Wang HM, Wu MH, Chang KP, Chang PH, Liao CT, Liau CT. Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy. Head Neck 2019;41 Suppl 1:19-45. [PMID: 31573749 DOI: 10.1002/hed.25932] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
|
416 |
Zhou C, Parsons JL. The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma. Expert Rev Mol Med 2020;22:e3. [PMID: 32611474 DOI: 10.1017/erm.2020.4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
417 |
Reyes M, Flores T, Betancur D, Peña-Oyarzún D, Torres VA. Wnt/β-Catenin Signaling in Oral Carcinogenesis. Int J Mol Sci 2020;21:E4682. [PMID: 32630122 DOI: 10.3390/ijms21134682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
418 |
Yin Y, Tan Y, Yao Y, Lu N, Zhang F. SNHG12/miR-326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma. Oral Dis 2020;26:1631-9. [PMID: 32506729 DOI: 10.1111/odi.13458] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
419 |
Archanjo AB, Assis ALEM, Oliveira MM, Mendes SO, Borçoi AR, Maia LL, Souza RP, Cicco R, Saito KC, Kimura ET, Carvalho MB, Nunes FD, Tajara EH, Santos MD, Nogueira BV, Trivilin LO, Pinheiro CJG, Álvares-da-Silva AM. Elemental characterization of oral cavity squamous cell carcinoma and its relationship with smoking, prognosis and survival. Sci Rep 2020;10:10382. [PMID: 32587307 DOI: 10.1038/s41598-020-67270-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
420 |
Madhura MG, Rao RS, Patil S, Fageeh HN, Alhazmi A, Awan KH. Advanced diagnostic aids for oral cancer. Dis Mon 2020;66:101034. [PMID: 32594996 DOI: 10.1016/j.disamonth.2020.101034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
421 |
Jakob M, Sharaf K, Schirmer M, Leu M, Küffer S, Bertlich M, Ihler F, Haubner F, Canis M, Kitz J. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC. Strahlenther Onkol 2021;197:231-45. [PMID: 32588101 DOI: 10.1007/s00066-020-01653-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
|
422 |
Enver N, Şahin A, Sönmez S, Demokan S. Most Cited Articles in Head and Neck Oncology. Ear Nose Throat J 2020;:145561320934920. [PMID: 32579405 DOI: 10.1177/0145561320934920] [Reference Citation Analysis]
|
423 |
Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, Chen J, Cheng M, Huang Z, Ren H, Chen J, Peng L, Gao F, Chen D, Wang A. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma. Mol Ther 2020;28:2177-90. [PMID: 32621798 DOI: 10.1016/j.ymthe.2020.06.024] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 17.7] [Reference Citation Analysis]
|
424 |
Pulito C, Strano S, Blandino G. Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers. Ann Transl Med 2020;8:612. [PMID: 32566549 DOI: 10.21037/atm.2020.03.104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
425 |
Mes SW, Brink A, Sistermans EA, Straver R, Oudejans CBM, Poell JB, Leemans CR, Brakenhoff RH. Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients. Oral Oncol 2020;109:104852. [PMID: 32590298 DOI: 10.1016/j.oraloncology.2020.104852] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
426 |
Liu M, An H, Zhang Y, Sun W, Cheng S, Wang R, Wang X, Feng L. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes. EBioMedicine 2020;57:102831. [PMID: 32580137 DOI: 10.1016/j.ebiom.2020.102831] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
427 |
Coppock JD, Mills AM, Stelow EB. Galectin-3 Expression in High-Risk HPV-Positive and Negative Head & Neck Squamous Cell Carcinomas and Regional Lymph Node Metastases. Head Neck Pathol 2021;15:163-8. [PMID: 32564273 DOI: 10.1007/s12105-020-01195-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
428 |
de Carvalho AC, Perdomo S, Dos Santos W, Fernandes GC, de Jesus LM, Carvalho RS, Scapulatempo-Neto C, de Almeida GC, Sorroche BP, Arantes LMRB, Melendez ME, De Marchi P, Hayes N, Reis RM, Carvalho AL. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Sci Rep 2020;10:9970. [PMID: 32561788 DOI: 10.1038/s41598-020-66741-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
429 |
Ludwig N, Gillespie DG, Reichert TE, Jackson EK, Whiteside TL. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2020;12:E1602. [PMID: 32560461 DOI: 10.3390/cancers12061602] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
430 |
Sacconi A, Donzelli S, Pulito C, Ferrero S, Morrone A, Rigoni M, Pimpinelli F, Ensoli F, Sanguineti G, Pellini R, Agrawal N, Izumchenko E, Ciliberto G, Giannì A, Muti P, Strano S, Blandino G. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.. [DOI: 10.1101/2020.06.16.154211] [Reference Citation Analysis]
|
431 |
Baysal H, De Pauw I, Zaryouh H, De Waele J, Peeters M, Pauwels P, Vermorken JB, Smits E, Lardon F, Jacobs J, Wouters A. Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status. Br J Cancer 2020;123:752-61. [PMID: 32541873 DOI: 10.1038/s41416-020-0934-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
432 |
Dickinson A, Saraswat M, Syrjänen S, Tohmola T, Silén R, Randén-Brady R, Carpén T, Hagström J, Haglund C, Mattila P, Mäkitie A, Joenväärä S, Silén S. Comparing serum protein levels can aid in differentiating HPV-negative and -positive oropharyngeal squamous cell carcinoma patients. PLoS One 2020;15:e0233974. [PMID: 32542012 DOI: 10.1371/journal.pone.0233974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
433 |
Wurlitzer M, Möckelmann N, Kriegs M, Vens M, Omidi M, Hoffer K, Bargen CV, Möller-Koop C, Witt M, Droste C, Oetting A, Petersen H, Busch CJ, Münscher A, Schlüter H, Clauditz TS, Rieckmann T. Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer. Cancers (Basel) 2020;12:E1531. [PMID: 32545200 DOI: 10.3390/cancers12061531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
434 |
Rahimi S. HPV-related squamous cell carcinoma of oropharynx: a review. J Clin Pathol 2020;73:624-9. [PMID: 32499224 DOI: 10.1136/jclinpath-2020-206686] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
435 |
Yang J, Xie K, Li C. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma. Life Sci 2020;256:117906. [PMID: 32504750 DOI: 10.1016/j.lfs.2020.117906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
436 |
Nimbalkar VK, Manna S, Maru GB, Mahimkar MB. Head and Neck Cancer Prevention by Phytochemicals: Current Status and Challenges. Curr Pharmacol Rep 2020;6:85-102. [DOI: 10.1007/s40495-020-00213-w] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
437 |
Li J, Huang S, Zeng L, Li K, Yang L, Gao S, Guan C, Zhang S, Lao X, Liao G, Liang Y. Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model. Cell Death Dis 2020;11:391. [PMID: 32444644 DOI: 10.1038/s41419-020-2538-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
438 |
Chuang YH, Lee CH, Lin CY, Liu CL, Huang SH, Lee JY, Chiu YY, Lee JC, Yang JM. An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer. Cancers (Basel) 2020;12:E1324. [PMID: 32455963 DOI: 10.3390/cancers12051324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
439 |
Lin CX, Tu CW, Ma YK, Ye PC, Shao X, Yang ZA, Fang YM. Nobiletin inhibits cell growth through restraining aerobic glycolysis via PKA-CREB pathway in oral squamous cell carcinoma. Food Sci Nutr 2020;8:3515-24. [PMID: 32724614 DOI: 10.1002/fsn3.1634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
440 |
Ma HF, Lv GX, Zhang DH. miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2. Onco Targets Ther 2020;13:4485-93. [PMID: 32547079 DOI: 10.2147/OTT.S246289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
441 |
Demir Duman F, Sebek M, Thanh NTK, Loizidou M, Shakib K, MacRobert AJ. Enhanced photodynamic therapy and fluorescence imaging using gold nanorods for porphyrin delivery in a novel in vitro squamous cell carcinoma 3D model. J Mater Chem B 2020;8:5131-42. [PMID: 32420578 DOI: 10.1039/d0tb00810a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
442 |
Zhou K, Li Y, Liao W, Zhang M, Bai L, Li Q. Pembrolizumab alone or with chemotherapy for squamous cell carcinoma of the head and neck: A cost-effectiveness analysis from Chinese perspective. Oral Oncol 2020;107:104754. [PMID: 32428689 DOI: 10.1016/j.oraloncology.2020.104754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
443 |
Dai F, Dai L, Zheng X, Guo Y, Zhang Y, Niu M, Lu Y, Li H, Hou R, Zhang Y, Wen S, Hu W, An C, Wu Y, Gao W. Non-coding RNAs in drug resistance of head and neck cancers: A review. Biomed Pharmacother 2020;127:110231. [PMID: 32428836 DOI: 10.1016/j.biopha.2020.110231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
444 |
Pan J, Deng H, Hu S, Xia C, Chen Y, Wang J, Wang Y. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC. World J Surg Oncol 2020;18:96. [PMID: 32414418 DOI: 10.1186/s12957-020-01874-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
445 |
Ghosh RD, Pattatheyil A, Roychoudhury S. Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications. Front Oncol 2020;10:619. [PMID: 32547936 DOI: 10.3389/fonc.2020.00619] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
446 |
Bzhalava Z, Arroyo Mühr LS, Dillner J. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas. Vaccine 2020;38:4066-70. [PMID: 32362526 DOI: 10.1016/j.vaccine.2020.04.049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
447 |
Ambele MA, van Zyl A, Pepper MS, van Heerden MB, van Heerden WFP. Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33 Are Possible Common Genetic Alterations in Oral Cancer Patients. Front Oncol 2020;10:683. [PMID: 32426287 DOI: 10.3389/fonc.2020.00683] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
448 |
Matsuda S, Mafune A, Kohda N, Hama T, Urashima M. Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma. PLoS One 2020;15:e0231932. [PMID: 32324779 DOI: 10.1371/journal.pone.0231932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
449 |
Wang P, Jiang S, Li Y, Luo Q, Lin J, Hu L, Fan L. Downshifting nanoprobes with follicle stimulating hormone peptide fabrication for highly efficient NIR II fluorescent bioimaging guided ovarian tumor surgery. Nanomedicine 2020;28:102198. [PMID: 32334101 DOI: 10.1016/j.nano.2020.102198] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
450 |
Wu S, Xiong F, Zhang X, Qiu T, Tang M, Ye X, Chen Z, Zhou G. Preparation and Evaluation of Dual Targeting Nanoparticles for Oral Cancer. J Wuhan Univ Technol -Mat Sci Edit 2019;34:1495-504. [DOI: 10.1007/s11595-019-2218-4] [Reference Citation Analysis]
|
451 |
Hu WC, Teo WH, Huang TF, Lee TC, Lo JF. Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells. Front Oncol 2020;10:463. [PMID: 32351887 DOI: 10.3389/fonc.2020.00463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
452 |
Ghantous Y, Nashef A, Abu-Elnaaj I. Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients. J Clin Med 2020;9:E1035. [PMID: 32272578 DOI: 10.3390/jcm9041035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
453 |
Schmidt S, Linge A, Grosser M, Lohaus F, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Schäfer H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Baumann M, Krause M, Löck S; German Cancer Consortium Radiation Oncology Group. Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. J Mol Diagn 2020;22:801-10. [PMID: 32247864 DOI: 10.1016/j.jmoldx.2020.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
454 |
Shiah SG, Hsiao JR, Chang HJ, Hsu YM, Wu GH, Peng HY, Chou ST, Kuo CC, Chang JY. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer. J Biomed Sci 2020;27:46. [PMID: 32238162 DOI: 10.1186/s12929-020-00644-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
|
455 |
Kim MH, Kim JH, Lee JM, Choi JW, Jung D, Cho H, Kang H, Hong MH, Heo SJ, Kim SH, Choi EC, Kim DH, Park YM, Kim S, Yoon SO, Koh YW, Cho BC, Kim HR. Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response. Br J Cancer 2020;122:1649-60. [PMID: 32235905 DOI: 10.1038/s41416-020-0796-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
456 |
Chen YL, Tsai WH, Ko YC, Lai TY, Cheng AJ, Shiah SG, Hsiao JR, Chang JY, Lin SF. Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer. Cancers (Basel) 2020;12:E841. [PMID: 32244515 DOI: 10.3390/cancers12040841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
457 |
Essers PBM, van der Heijden M, Vossen D, de Roest RH, Leemans CR, Brakenhoff RH, van den Brekel MWM, Bartelink H, Verheij M, Vens C. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma. Int J Cancer 2020;147:1732-9. [PMID: 32167160 DOI: 10.1002/ijc.32962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
458 |
Zhong Z, Hong M, Chen X, Xi Y, Xu Y, Kong D, Deng J, Li Y, Hu R, Sun C, Liang J. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. BMC Med Genomics 2020;13:57. [PMID: 32228580 DOI: 10.1186/s12920-020-0707-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
459 |
Novotný J, Bandúrová V, Strnad H, Chovanec M, Hradilová M, Šáchová J, Šteffl M, Grušanović J, Kodet R, Pačes V, Lacina L, Smetana K Jr., Plzák J, Kolář M, Vomastek T. Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2. Cancers (Basel) 2020;12:E792. [PMID: 32224897 DOI: 10.3390/cancers12040792] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
460 |
Wang H, Xue W, Ouyang W, Jiang X, Jiang X. miR-23a-3p/SIX1 regulates glucose uptake and proliferation through GLUT3 in head and neck squamous cell carcinomas. J Cancer 2020;11:2529-39. [PMID: 32201523 DOI: 10.7150/jca.30995] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
461 |
He Y, Ji P, Li Y, Wang R, Ma H, Yuan H. Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma. Front Oncol 2020;10:372. [PMID: 32266149 DOI: 10.3389/fonc.2020.00372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
462 |
Taberna M, Gil Moncayo F, Jané-Salas E, Antonio M, Arribas L, Vilajosana E, Peralvez Torres E, Mesía R. The Multidisciplinary Team (MDT) Approach and Quality of Care. Front Oncol 2020;10:85. [PMID: 32266126 DOI: 10.3389/fonc.2020.00085] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 13.7] [Reference Citation Analysis]
|
463 |
Jain A. Molecular Pathogenesis of Oral Squamous Cell Carcinoma. Squamous Cell Carcinoma - Hallmark and Treatment Modalities 2020. [DOI: 10.5772/intechopen.85650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
464 |
Witzke K, Seebauer C, Jesse K, Kwiatek E, Berner J, Semmler M, Boeckmann L, Emmert S, Weltmann K, Metelmann H, Bekeschus S. Plasma medical oncology: Immunological interpretation of head and neck squamous cell carcinoma. Plasma Process Polym 2020;17:1900258. [DOI: 10.1002/ppap.201900258] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
465 |
Ishida K, Tomita H, Kanayama T, Noguchi K, Niwa A, Kawaguchi M, Miyai M, Matsuo M, Imaizumi Y, Kato K, Hatano Y, Hirata A, Okada H, Shibata T, Hara A. Specific Deletion of p16INK4a with Retention of p19ARF Enhances the Development of Invasive Oral Squamous Cell Carcinoma. Am J Pathol 2020;190:1332-42. [PMID: 32194051 DOI: 10.1016/j.ajpath.2020.01.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
466 |
Berner J, Seebauer C, Sagwal SK, Boeckmann L, Emmert S, Metelmann H, Bekeschus S. Medical Gas Plasma Treatment in Head and Neck Cancer—Challenges and Opportunities. Applied Sciences 2020;10:1944. [DOI: 10.3390/app10061944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
467 |
Yang J, Chen Y, Luo H, Cai H. The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma. Front Oncol 2020;10:321. [PMID: 32226775 DOI: 10.3389/fonc.2020.00321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
468 |
Billard-Sandu C, Tao YG, Sablin MP, Dumitrescu G, Billard D, Deutsch E. CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2020;277:1273-80. [PMID: 32162057 DOI: 10.1007/s00405-020-05891-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
469 |
Wang H, Ma N, Li W, Wang Z. MicroRNA-96-5p promotes proliferation, invasion and EMT of oral carcinoma cells by directly targeting FOXF2. Biol Open 2020;9:bio049478. [PMID: 32014885 DOI: 10.1242/bio.049478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
470 |
Zheng Y, Song A, Zhou Y, Zhong Y, Zhang W, Wang C, Ding X, Du Y, Zhang W, Li G, Wu H, Wu Y, Song X. Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma. J Cell Commun Signal 2020;14:389-402. [PMID: 32157550 DOI: 10.1007/s12079-020-00546-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
471 |
García-Carracedo D, Cai Y, Qiu W, Saeki K, Friedman RA, Lee A, Li Y, Goldberg EM, Stratikopoulos EE, Parsons R, Lu C, Efstratiadis A, Philipone EM, Yoon AJ, Su GH. PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. Mol Cancer Res 2020;18:822-34. [PMID: 32152233 DOI: 10.1158/1541-7786.MCR-19-0549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
472 |
Kato MG, Baek CH, Chaturvedi P, Gallagher R, Kowalski LP, Leemans CR, Warnakulasuriya S, Nguyen SA, Day TA. Update on oral and oropharyngeal cancer staging - International perspectives. World J Otorhinolaryngol Head Neck Surg 2020;6:66-75. [PMID: 32426706 DOI: 10.1016/j.wjorl.2019.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
473 |
Hernandez AL, Young CD, Bian L, Weigel K, Nolan K, Frederick B, Han G, He G, Devon Trahan G, Rudolph MC, Jones KL, Oweida AJ, Karam SD, Raben D, Wang XJ. PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clin Cancer Res 2020;26:3058-70. [PMID: 32139402 DOI: 10.1158/1078-0432.CCR-19-0514] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
474 |
Hao Y, Zhang D, Guo Y, Fu Z, Yu D, Guan G. miR-488-3p sponged by circ-0000495 and mediated upregulation of TROP2 in head and neck squamous cell carcinoma development. J Cancer 2020;11:3375-86. [PMID: 32231744 DOI: 10.7150/jca.40339] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
475 |
Outh-Gauer S, Morini A, Tartour E, Lépine C, Jung AC, Badoual C. The Microenvironment of Head and Neck Cancers: Papillomavirus Involvement and Potential Impact of Immunomodulatory Treatments. Head Neck Pathol 2020;14:330-40. [PMID: 32124416 DOI: 10.1007/s12105-020-01147-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
476 |
Jiang Y, Wu K, Cao W, Xu Q, Wang X, Qin X, Wang X, Li Y, Zhang J, Chen W. Long noncoding RNA KTN1-AS1 promotes head and neck squamous cell carcinoma cell epithelial-mesenchymal transition by targeting miR-153-3p. Epigenomics 2020;12:487-505. [PMID: 32267161 DOI: 10.2217/epi-2019-0173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
477 |
Liu Z, Shi J, Zhu B, Xu Q. Development of a multifunctional gold nanoplatform for combined chemo-photothermal therapy against oral cancer. Nanomedicine 2020;15:661-76. [DOI: 10.2217/nnm-2019-0415] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
478 |
Brychtova V, Coates PJ, Hrabal V, Boldrup L, Fabian P, Vojtesek B, Sgaramella N, Nylander K. Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue. Mol Clin Oncol 2020;12:421-8. [PMID: 32257198 DOI: 10.3892/mco.2020.2005] [Reference Citation Analysis]
|
479 |
Mittal K, Choi DH, Wei G, Kaur J, Klimov S, Arora K, Griffith CC, Kumar M, Imhansi-Jacob P, Melton BD, Bhimji-Pattni S, Osan RM, Rida P, Golusinski P, Aneja R. Hypoxia-Induced Centrosome Amplification Underlies Aggressive Disease Course in HPV-Negative Oropharyngeal Squamous Cell Carcinomas. Cancers (Basel) 2020;12:E517. [PMID: 32102296 DOI: 10.3390/cancers12020517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
480 |
Lee E, Han AR, Nam B, Kim YR, Jin CH, Kim JB, Eun YG, Jung CH. Moscatilin Induces Apoptosis in Human Head and Neck Squamous Cell Carcinoma Cells via JNK Signaling Pathway. Molecules 2020;25:E901. [PMID: 32085431 DOI: 10.3390/molecules25040901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
481 |
Kulas P, Seidel M, Bozzato A, Schick B, Sessler DI, Kreuer S, Hüppe T. Volatile organic compounds in head and neck squamous cell carcinoma-An in vitro pilot study. Biomed Chromatogr 2020;34:e4811. [PMID: 32059060 DOI: 10.1002/bmc.4811] [Reference Citation Analysis]
|
482 |
Sun Q, Zhang SY, Zhao JF, Han XG, Wang HB, Sun ML. HIF-1α or HOTTIP/CTCF Promotes Head and Neck Squamous Cell Carcinoma Progression and Drug Resistance by Targeting HOXA9. Mol Ther Nucleic Acids 2020;20:164-75. [PMID: 32169804 DOI: 10.1016/j.omtn.2019.12.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
|
483 |
Zhu Q, Fang L, Heuberger J, Kranz A, Schipper J, Scheckenbach K, Vidal RO, Sunaga-Franze DY, Müller M, Wulf-Goldenberg A, Sauer S, Birchmeier W. The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck Cancer. Cell Rep 2019;26:415-428.e5. [PMID: 30625324 DOI: 10.1016/j.celrep.2018.12.059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
|
484 |
Wan Y, Liu H, Zhang M, Huang Z, Zhou H, Zhu Y, Tao Y, Xie N, Liu X, Hou J, Wang C. Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis. Head Neck 2020;42:1067-76. [PMID: 32048783 DOI: 10.1002/hed.26104] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
|
485 |
van Harten AM, de Boer DV, Martens-de Kemp SR, Buijze M, Ganzevles SH, Hunter KD, Leemans CR, van Beusechem VW, Wolthuis RMF, de Menezes RX, Brakenhoff RH. Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition. Sci Rep 2020;10:2330. [PMID: 32047167 DOI: 10.1038/s41598-020-58509-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
486 |
Wang D, Qi H, Zhang H, Zhou W, Li Y, Li A, Liu Q, Wang Y. TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis. Int J Biol Sci 2020;16:1180-93. [PMID: 32174793 DOI: 10.7150/ijbs.41148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
487 |
Liao J, Yang Z, Carter-Cooper B, Chang ET, Choi EY, Kallakury B, Liu X, Lapidus RG, Cullen KJ, Dan H. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition. Clin Exp Metastasis 2020;37:283-92. [PMID: 32020377 DOI: 10.1007/s10585-020-10021-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
488 |
Chen Y, Shao Z, Jiang E, Zhou X, Wang L, Wang H, Luo X, Chen Q, Liu K, Shang Z. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway. J Cell Physiol 2020;235:5995-6009. [PMID: 32017846 DOI: 10.1002/jcp.29525] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
|
489 |
Singh S, Aggarwal A, Bhupathiraju NDK, Jovanovic IR, Landress M, Tuz MP, Gao R, Drain CM. Comparing a thioglycosylated chlorin and phthalocyanine as potential theranostic agents. Bioorganic & Medicinal Chemistry 2020;28:115259. [DOI: 10.1016/j.bmc.2019.115259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
490 |
Clayton SM, Archard JA, Wagner J, Farwell DG, Bewley AF, Beliveau A, Birkeland A, Rao S, Abouyared M, Belafsky PC, Anderson JD. Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells. Stem Cells Dev 2020;29:327-35. [PMID: 31856674 DOI: 10.1089/scd.2019.0197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
491 |
Wu HT, Chen WT, Li GW, Shen JX, Ye QQ, Zhang ML, Chen WJ, Liu J. Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction. Front Genet 2019;10:1328. [PMID: 32038705 DOI: 10.3389/fgene.2019.01328] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
492 |
Misawa K, Mima M, Satoshi Y, Misawa Y, Imai A, Mochizuki D, Nakagawa T, Kurokawa T, Oguro M, Ishikawa R, Yamaguchi Y, Endo S, Kawasaki H, Kanazawa T, Mineta H. Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer. Sci Rep 2020;10:1007. [PMID: 31974445 DOI: 10.1038/s41598-020-57920-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
493 |
Tang C, Lin L, Zhou W, Liu X, Fu Y, Zhang L, Li L, Wang X, Zhao L, Liang J. CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck. Chin J Cancer Res 2019;31:901-9. [PMID: 31949392 DOI: 10.21147/j.issn.1000-9604.2019.06.06] [Reference Citation Analysis]
|
494 |
Broutian TR, Jiang B, Li J, Akagi K, Gui S, Zhou Z, Xiao W, Symer DE, Gillison ML. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma. Cancer Lett 2020;476:23-33. [PMID: 31958486 DOI: 10.1016/j.canlet.2020.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
|
495 |
Chen TC, Wu CT, Ko JY, Yang TL, Lou PJ, Wang CP, Chang YL. Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region. Sci Rep 2020;10:526. [PMID: 31949181 DOI: 10.1038/s41598-019-57177-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
496 |
Zaini ZM, Neat M, Stokes A, Tavassoli M, Odell EW. DNA aneuploidy and tissue architecture in oral potentially malignant disorders with epithelial dysplasia assessed by a 10 locus FISH panel. Oncol Rep 2020;43:877-85. [PMID: 32020221 DOI: 10.3892/or.2020.7461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
497 |
Wang J, Chen X, Tian Y, Zhu G, Qin Y, Chen X, Pi L, Wei M, Liu G, Li Z, Chen C, Lv Y, Cai G. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma. Aging (Albany NY) 2020;12:767-83. [PMID: 31927533 DOI: 10.18632/aging.102655] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
|
498 |
Khan M, Khaznadar SS, Routila J, Ventelä S, Schmid E, Gebhart B, Becker ET, Roider HG, Perala M, Schmitz AA, Krahn T, von Ahsen O. Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients. Head Neck 2020;42:625-35. [PMID: 31919967 DOI: 10.1002/hed.26049] [Reference Citation Analysis]
|
499 |
van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Front Oncol 2019;9:1470. [PMID: 31998639 DOI: 10.3389/fonc.2019.01470] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
500 |
O'Keefe RA, Bhola NE, Lee DS, Johnson DE, Grandis JR. Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance. PLoS One 2020;15:e0227261. [PMID: 31914141 DOI: 10.1371/journal.pone.0227261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
501 |
Kostrzewska-Poczekaj M, Bednarek K, Jarmuz-Szymczak M, Bodnar M, Filas V, Marszalek A, Bartochowska A, Grenman R, Kiwerska K, Szyfter K, Giefing M. Copy number gains of the putative CRKL oncogene in laryngeal squamous cell carcinoma result in strong nuclear expression of the protein and influence cell proliferation and migration. Sci Rep 2020;10:24. [PMID: 31913340 DOI: 10.1038/s41598-019-56870-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
|
502 |
Orosz E, Gombos K, Petrevszky N, Csonka D, Haber I, Kaszas B, Toth A, Molnar K, Kalacs K, Piski Z, Gerlinger I, Burian A, Bellyei S, Szanyi I. Visualization of mucosal field in HPV positive and negative oropharyngeal squamous cell carcinomas: combined genomic and radiology based 3D model. Sci Rep 2020;10:40. [PMID: 31913295 DOI: 10.1038/s41598-019-56429-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
503 |
Usman M, Tanveer F, Ilyas A, Zarina S. Varlitinib Mediates Its Activity Through Down Regulating MAPK/EGFR Pathway in Oral Cancer. CP 2020;17:51-8. [DOI: 10.2174/1570164616666190516114749] [Reference Citation Analysis]
|
504 |
Jayaprakash C, Varghese VK, Jayaram P, Chakrabarty S, Kudva A, Ray S, Satyamoorthy K. Relevance and actionable mutational spectrum in oral squamous cell carcinoma. J Oral Pathol Med 2020;49:427-34. [DOI: 10.1111/jop.12985] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
505 |
Karpathiou G, Dumollard JM, Peoc'h M. Laryngeal Tumor Microenvironment. Adv Exp Med Biol 2020;1296:79-101. [PMID: 34185287 DOI: 10.1007/978-3-030-59038-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
506 |
Jones J, Ahmad FI. Anesthesia for Free Flap Reconstruction After Head and Neck Surgical Resection. Oncologic Critical Care 2020. [DOI: 10.1007/978-3-319-74588-6_158] [Reference Citation Analysis]
|
507 |
Agarwal A, Garg C, Ganesh MS, Reddy S. Molecular mechanisms of tobacco induced oral and oropharyngeal cancer: Results of a tissue microarray and immunohistochemistry-based study from a tertiary cancer center in India. Indian J Pathol Microbiol 2020;63:7-12. [PMID: 32031115 DOI: 10.4103/IJPM.IJPM_783_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
508 |
Dadgar S, Paidi SK, Barman I, Rajaram N. Multimodal Optical Spectroscopy of Functional and Molecular Changes in Tumors after Radiation Therapy. Biophotonics Congress: Biomedical Optics 2020 (Translational, Microscopy, OCT, OTS, BRAIN) 2020. [DOI: 10.1364/translational.2020.ttu4b.7] [Reference Citation Analysis]
|
509 |
Lee Y, Eckers JC, Kimple RJ. Autophagy in head and neck cancer therapy. Improving the Therapeutic Ratio in Head and Neck Cancer 2020. [DOI: 10.1016/b978-0-12-817868-3.00013-5] [Reference Citation Analysis]
|
510 |
Elbers JB, Al-mamgani A, Tesseslaar ME, van den Brekel MW, Lange CA, van der Wal JE, Verheij M, Zuur CL, de Boer JP. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. Radiotherapy and Oncology 2020;142:79-84. [DOI: 10.1016/j.radonc.2019.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
511 |
Porter A, Natsuhara M, Daniels GA, Patel SP, Sacco AG, Bykowski J, Banks KC, Cohen EEW. Next generation sequencing of cell free circulating tumor DNA in blood samples of recurrent and metastatic head and neck cancer patients. Transl Cancer Res 2020;9:203-9. [PMID: 35117174 DOI: 10.21037/tcr.2019.12.70] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
512 |
Del-Río-Ibisate N, Granda-Díaz R, Rodrigo JP, Menéndez ST, García-Pedrero JM. Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application. Rev Physiol Biochem Pharmacol 2021;181:375-427. [PMID: 32789787 DOI: 10.1007/112_2020_38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
513 |
Monteiro L, Warnakulasuriya S. Molecular and Signaling Pathways During Oral Carcinogenesis. Textbook of Oral Cancer 2020. [DOI: 10.1007/978-3-030-32316-5_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
514 |
Qian X, Hoffmann TK, Kaufmann AM, Albers AE. Immunopathology as a Basis for Immunotherapy of Head and Neck Squamous Cell Carcinoma. Cancer Immunology 2020. [DOI: 10.1007/978-3-030-57949-4_13] [Reference Citation Analysis]
|
515 |
Tuomainen K, Al-Samadi A, Potdar S, Turunen L, Turunen M, Karhemo PR, Bergman P, Risteli M, Åström P, Tiikkaja R, Grenman R, Wennerberg K, Monni O, Salo T. Human Tumor-Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing. Cancers (Basel) 2019;12:E92. [PMID: 31905951 DOI: 10.3390/cancers12010092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
516 |
Paver EC, Currie AM, Gupta R, Dahlstrom JE. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV. Pathology. 2020;52:179-191. [PMID: 31889547 DOI: 10.1016/j.pathol.2019.10.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
|
517 |
Riva G, Biolatti M, Pecorari G, Dell'Oste V, Landolfo S. PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma. Microorganisms 2019;8:E14. [PMID: 31861809 DOI: 10.3390/microorganisms8010014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
518 |
Sundaresan S, Rajapriya P. Introductory Chapter: Head and Neck Cancer. Prevention, Detection and Management of Oral Cancer 2019. [DOI: 10.5772/intechopen.86272] [Reference Citation Analysis]
|
519 |
Lv XX, Zheng XY, Yu JJ, Ma HR, Hua C, Gao RT. EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2. Cancer Med 2020;9:1131-40. [PMID: 31823521 DOI: 10.1002/cam4.2772] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
520 |
Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther. 2020;206:107448. [PMID: 31836455 DOI: 10.1016/j.pharmthera.2019.107448] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
521 |
Jain AP, Patel K, Pinto S, Radhakrishnan A, Nanjappa V, Kumar M, Raja R, Patil AH, Kumari A, Manoharan M, Karunakaran C, Murugan S, Keshava Prasad TS, Chang X, Mathur PP, Kumar P, Gupta R, Gupta R, Khanna-Gupta A, Sidransky D, Chatterjee A, Gowda H. MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma. Sci Rep 2019;9:18793. [PMID: 31827134 DOI: 10.1038/s41598-019-55208-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
522 |
Cheng H, Yang X, Si H, Saleh AD, Xiao W, Coupar J, Gollin SM, Ferris RL, Issaeva N, Yarbrough WG, Prince ME, Carey TE, Van Waes C, Chen Z. Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. Cell Rep 2018;25:1332-1345.e5. [PMID: 30380422 DOI: 10.1016/j.celrep.2018.10.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
|
523 |
Schubert AD, Channah Broner E, Agrawal N, London N, Pearson A, Gupta A, Wali N, Seiwert TY, Wheelan S, Lingen M, Macleod K, Allen H, Chatterjee A, Vassiliki S, Gaykalova D, Hoque MO, Sidransky D, Suresh K, Izumchenko E. Somatic mitochondrial mutation discovery using ultra-deep sequencing of the mitochondrial genome reveals spatial tumor heterogeneity in head and neck squamous cell carcinoma. Cancer Lett 2020;471:49-60. [PMID: 31830557 DOI: 10.1016/j.canlet.2019.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
524 |
Cordero E, Latka I, Matthäus C, Schie I, Popp J. In-vivo Raman spectroscopy: from basics to applications. J Biomed Opt 2018;23:1-23. [PMID: 29956506 DOI: 10.1117/1.JBO.23.7.071210] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 20.8] [Reference Citation Analysis]
|
525 |
Li L, Zhang X, Zhang ZT. Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis. Int J Genomics 2019;2019:2789035. [PMID: 31886162 DOI: 10.1155/2019/2789035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
526 |
Wang Z, Wu VH, Allevato MM, Gilardi M, He Y, Luis Callejas-Valera J, Vitale-Cross L, Martin D, Amornphimoltham P, Mcdermott J, Yung BS, Goto Y, Molinolo AA, Sharabi AB, Cohen EEW, Chen Q, Lyons JG, Alexandrov LB, Gutkind JS. Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nat Commun 2019;10:5546. [PMID: 31804466 DOI: 10.1038/s41467-019-13471-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 18.8] [Reference Citation Analysis]
|
527 |
Mei Z, Zhang K, Lam AK, Huang J, Qiu F, Qiao B, Zhang Y. MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma. Cancer Med 2020;9:640-52. [PMID: 31800160 DOI: 10.1002/cam4.2733] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
|
528 |
Roh V, Hiou-Feige A, Misetic V, Rivals JP, Sponarova J, Teh MT, Ferreira Lopes S, Truan Z, Mermod M, Monnier Y, Hess J, Tolstonog GV, Simon C. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma. J Pathol 2020;250:107-19. [PMID: 31465124 DOI: 10.1002/path.5342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
529 |
Powrózek T, Porgador A, Małecka-massalska T. Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients. Expert Review of Molecular Diagnostics 2020;20:31-9. [DOI: 10.1080/14737159.2020.1699062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
530 |
Denninghoff V, Muino A, Diaz M, Harada L, Lence A, Turon P, Labbrozzi M, Aguas S, Peñaloza P, Avagnina A, Adler I. Mutational status of PIK3ca oncogene in oral cancer-In the new age of PI3K inhibitors. Pathol Res Pract 2020;216:152777. [PMID: 31831300 DOI: 10.1016/j.prp.2019.152777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
531 |
Tang H, Zhou X, Ye Y, Zhou Y, Wu C, Xu Y. The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis. Pathol Res Pract 2020;216:152768. [PMID: 31837884 DOI: 10.1016/j.prp.2019.152768] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
532 |
Okada R, Koshizuka K, Yamada Y, Moriya S, Kikkawa N, Kinoshita T, Hanazawa T, Seki N. Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma. Cells 2019;8:E1535. [PMID: 31795200 DOI: 10.3390/cells8121535] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
533 |
Liu C, Yu Z, Huang S, Zhao Q, Sun Z, Fletcher C, Jiang Y, Zhang D. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC. EBioMedicine 2019;50:135-43. [PMID: 31780396 DOI: 10.1016/j.ebiom.2019.11.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
|
534 |
Boscolo-Rizzo P, Rampazzo E, Polesel J, Giunco S, Menegaldo A, Mantovani M, Stellin M, Bandolin L, Spinato G, Del Mistro A, Borsetto D, Fussey J, Tirelli G, Da Mosto MC, De Rossi A. Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma. Sci Rep 2019;9:17572. [PMID: 31772219 DOI: 10.1038/s41598-019-54028-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
535 |
Tran WT, Suraweera H, Quaioit K, Cardenas D, Leong KX, Karam I, Poon I, Jang D, Sannachi L, Gangeh M, Tabbarah S, Lagree A, Sadeghi-Naini A, Czarnota GJ. Predictive quantitative ultrasound radiomic markers associated with treatment response in head and neck cancer. Future Sci OA 2019;6:FSO433. [PMID: 31915534 DOI: 10.2144/fsoa-2019-0048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
536 |
Gurbi B, Brauswetter D, Varga A, Gyulavári P, Pénzes K, Murányi J, Zámbó V, Birtalan E, Krenács T, Becker DL, Csala M, Vályi-Nagy I, Peták I, Dános K. The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers-In Vitro Studies. Cancers (Basel) 2019;11:E1848. [PMID: 31766723 DOI: 10.3390/cancers11121848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
537 |
Zhang WL, Zhu ZL, Huang MC, Tang YJ, Tang YL, Liang XH. Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture? Front Oncol 2019;9:1275. [PMID: 31824853 DOI: 10.3389/fonc.2019.01275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
538 |
Usman M, Ilyas A, Hashim Z, Zarina S. Identification of GIMAP7 and Rabl3 as Putative Biomarkers for Oral Squamous Cell Carcinoma Through Comparative Proteomic Approach. Pathol Oncol Res 2020;26:1817-22. [PMID: 31748878 DOI: 10.1007/s12253-019-00775-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
539 |
Tuna M, Liu W, Amos CI, Mills GB. Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma. Neoplasia 2019;21:1102-9. [PMID: 31734631 DOI: 10.1016/j.neo.2019.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
540 |
Lu S, Sun Z, Tang L, Chen L. LINC00355 Promotes Tumor Progression in HNSCC by Hindering MicroRNA-195-Mediated Suppression of HOXA10 Expression. Mol Ther Nucleic Acids 2020;19:61-71. [PMID: 31837606 DOI: 10.1016/j.omtn.2019.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
|
541 |
Ghias K, Rehmani SS, Razzak SA, Madhani S, Azim MK, Ahmed R, Khan MJ. Mutational landscape of head and neck squamous cell carcinomas in a South Asian population. Genet Mol Biol 2019;4242:526-42. [PMID: 31188922 DOI: 10.1590/1678-4685-GMB-2018-0005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
542 |
Mehrad M, Stelow EB, Bishop JA, Wang X, Haynes W, Oliver D, Chernock RD, Lewis JS. Transcriptionally Active HPV and Targetable EGFR Mutations in Sinonasal Inverted Papilloma: An Association Between Low-risk HPV, Condylomatous Morphology, and Cancer Risk? American Journal of Surgical Pathology 2020;44:340-6. [DOI: 10.1097/pas.0000000000001411] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
543 |
Gaździcka J, Gołąbek K, Strzelczyk JK, Ostrowska Z. Epigenetic Modifications in Head and Neck Cancer. Biochem Genet 2020;58:213-44. [PMID: 31712935 DOI: 10.1007/s10528-019-09941-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
|
544 |
Pérez Sayáns M, Chamorro Petronacci CM, Lorenzo Pouso AI, Padín Iruegas E, Blanco Carrión A, Suárez Peñaranda JM, García García A. Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC). J Clin Med 2019;8:E1896. [PMID: 31703248 DOI: 10.3390/jcm8111896] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
|
545 |
De Felice F, Musio D, Abate G, Moscarelli E, Bulzonetti N, Tombolini V. Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2020;146:477-83. [PMID: 31686249 DOI: 10.1007/s00432-019-03075-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
546 |
Altun E, Yazici H, Arslan E, Tulaci KG, Erken HA. The Impact of Type II Diabetes on Tongue Dysplasia and p16-Related Aging Process: An Experimental Study. Anal Cell Pathol (Amst) 2019;2019:3563215. [PMID: 31687322 DOI: 10.1155/2019/3563215] [Reference Citation Analysis]
|
547 |
Ji Y, Wang Q, Zhao Q, Zhao S, Li L, Sun G, Ye L. Autophagy suppression enhances DNA damage and cell death upon treatment with PARP inhibitor Niraparib in laryngeal squamous cell carcinoma. Appl Microbiol Biotechnol 2019;103:9557-68. [PMID: 31686145 DOI: 10.1007/s00253-019-10148-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
548 |
Bukhari N, Joseph JP, Hussain SS, Khan MA, Wakim MJY, Yahya EB, Arif A, Saleem A, Sharif N. Prevalence of Human Papilloma Virus Sub Genotypes following Head and Neck Squamous Cell Carcinomas in Asian Continent, A Systematic Review Article. Asian Pac J Cancer Prev 2019;20:3269-77. [PMID: 31759348 DOI: 10.31557/APJCP.2019.20.11.3269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
549 |
Cramer JD, Burtness B, Ferris RL. Immunotherapy for head and neck cancer: Recent advances and future directions. Oral Oncol 2019;99:104460. [PMID: 31683169 DOI: 10.1016/j.oraloncology.2019.104460] [Cited by in Crossref: 115] [Cited by in F6Publishing: 125] [Article Influence: 28.8] [Reference Citation Analysis]
|
550 |
Chen X, Cao Y, Sedhom W, Lu L, Liu Y, Wang H, Oka M, Bornstein S, Said S, Song J, Lu SL. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma. Mol Oncol 2020;14:139-58. [PMID: 31600013 DOI: 10.1002/1878-0261.12584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
551 |
Scott GM, Best C, Fung K, Gupta M, Sommer DD, Szeto C, Micomonaco DC. Impact of marginalization on tobacco use in individuals diagnosed with head and neck Cancer. J Otolaryngol Head Neck Surg 2019;48:54. [PMID: 31651374 DOI: 10.1186/s40463-019-0380-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
552 |
Bogowicz M, Tanadini-Lang S, Guckenberger M, Riesterer O. Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer. Sci Rep. 2019;9:15198. [PMID: 31645603 DOI: 10.1038/s41598-019-51599-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
|
553 |
Orhan C, Bakır B, Dalay N, Buyru N. ZNF703 is an important player in head and neck cancer. Clin Otolaryngol 2019;44:1080-6. [DOI: 10.1111/coa.13450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
554 |
Poelman MR, Brand HS, Forouzanfar T, Daley EM, Jager DHJ. Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students. J Cancer Educ 2018;33:1347-54. [PMID: 28741269 DOI: 10.1007/s13187-017-1257-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
|
555 |
Huang GZ, Wu QQ, Zheng ZN, Shao TR, Lv XZ. Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma. Front Oncol 2019;9:1054. [PMID: 31681590 DOI: 10.3389/fonc.2019.01054] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
|
556 |
Gorbacheva AM, Mitkin NA. Interleukin-33: Friend or Enemy in the Fight against Tumors? Mol Biol 2019;53:681-95. [DOI: 10.1134/s0026893319050066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
557 |
Chen DR, Xiao Y, Li H, Wu CC, Yang LL, Yang QC, Yang SC, Zhou JJ, Sun ZJ. Expression and clinicopathologic significance of coxsackie-adenovirus receptor in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;129:141-8. [PMID: 31606425 DOI: 10.1016/j.oooo.2019.08.013] [Reference Citation Analysis]
|
558 |
Li Y, Jin F, Zhou J, Yu F, Duan X, He X, Wang R, Wu W, Long J, Luo X. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis. Chronobiology International 2019;36:1723-32. [DOI: 10.1080/07420528.2019.1648486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
559 |
Qureishi A, Rieunier G, Shah KA, Aleksic T, Winter SC, Møller H, Macaulay VM. Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling. Clin Otolaryngol 2019;44:1026-36. [PMID: 31536667 DOI: 10.1111/coa.13434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
560 |
Chowdhury FN, Reisinger J, Gomez KE, Chimed TS, Thomas CM, Le PN, Miller B, Morton JJ, Nieto CM, Somerset HL, Wang XJ, Keysar SB, Jimeno A. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function. Oral Oncol 2019;98:118-24. [PMID: 31586893 DOI: 10.1016/j.oraloncology.2019.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
561 |
Petruczynik A, Plech T, Tuzimski T, Misiurek J, Kaproń B, Misiurek D, Szultka-Młyńska M, Buszewski B, Waksmundzka-Hajnos M. Determination of Selected Isoquinoline Alkaloids from Mahonia Aquifolia; Meconopsis Cambrica; Corydalis Lutea; Dicentra Spectabilis; Fumaria Officinalis; Macleaya Cordata Extracts by HPLC-DAD and Comparison of Their Cytotoxic Activity. Toxins (Basel) 2019;11:E575. [PMID: 31581717 DOI: 10.3390/toxins11100575] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|
562 |
Li Q, Hong J, Shen Z, Deng H, Shen Y, Wu Z, Zhou C. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma. Medicine (Baltimore) 2019;98:e17651. [PMID: 31651887 DOI: 10.1097/MD.0000000000017651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
563 |
Chen D, Wang CY. Targeting cancer stem cells in squamous cell carcinoma. Precis Clin Med 2019;2:152-65. [PMID: 31598386 DOI: 10.1093/pcmedi/pbz016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
|
564 |
Gomez Hernandez MP, Bates AM, Starman EE, Lanzel EA, Comnick C, Xie XJ, Brogden KA. HBD3 Induces PD-L1 Expression on Head and Neck Squamous Cell Carcinoma Cell Lines. Antibiotics (Basel) 2019;8:E161. [PMID: 31554151 DOI: 10.3390/antibiotics8040161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
565 |
Lee YS. Current Development and Research Trend of Chemotherapeutic Agents for Head and Neck Squamous Cell Carcinoma. Korean J Otorhinolaryngol-Head Neck Surg 2019;62:487-498. [DOI: 10.3342/kjorl-hns.2019.00479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
566 |
Rong L, Wang L, Shuai Y, Guo H, Liu K. CXCL14 regulates cell proliferation, invasion, migration and epithelial-mesenchymal transition of oral squamous cell carcinoma. Biotechnology & Biotechnological Equipment 2019;33:1335-42. [DOI: 10.1080/13102818.2019.1664930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
567 |
Kriegs M, Clauditz TS, Hoffer K, Bartels J, Buhs S, Gerull H, Zech HB, Bußmann L, Struve N, Rieckmann T, Petersen C, Betz CS, Rothkamm K, Nollau P, Münscher A. Analyzing expression and phosphorylation of the EGF receptor in HNSCC. Sci Rep 2019;9:13564. [PMID: 31537844 DOI: 10.1038/s41598-019-49885-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
568 |
van Harten AM, Poell JB, Buijze M, Brink A, Wells SI, René Leemans C, Wolthuis RMF, Brakenhoff RH. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass. Oral Oncol 2019;98:53-61. [PMID: 31541927 DOI: 10.1016/j.oraloncology.2019.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
569 |
Yang B, Shen J, Xu L, Chen Y, Che X, Qu X, Liu Y, Teng Y, Li Z. Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma. Front Oncol 2019;9:898. [PMID: 31620361 DOI: 10.3389/fonc.2019.00898] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
570 |
Li L, Zhang ZT. Genetic Association between NFKBIA and NFKB1 Gene Polymorphisms and the Susceptibility to Head and Neck Cancer: A Meta-Analysis. Dis Markers 2019;2019:6523837. [PMID: 31612070 DOI: 10.1155/2019/6523837] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
571 |
Balázs K, Kis E, Badie C, Bogdándi EN, Candéias S, Garcia LC, Dominczyk I, Frey B, Gaipl U, Jurányi Z, Kocsis ZS, Rutten EA, Sáfrány G, Widlak P, Lumniczky K. Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients. Cancers (Basel) 2019;11:E1324. [PMID: 31500214 DOI: 10.3390/cancers11091324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
572 |
Karpathiou G, Stachowitz ML, Dumollard JM, Gavid M, Froudarakis M, Prades JM, Peoc'h M. Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study. Cancer Genomics Proteomics 2019;16:155-61. [PMID: 31018946 DOI: 10.21873/cgp.20121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
573 |
Jelinek MJ, Vokes EE. Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? J Clin Oncol 2019;37:2807-14. [PMID: 31483688 DOI: 10.1200/JCO.19.01981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
574 |
Esaki S, Goshima F, Ozaki H, Takano G, Hatano Y, Kawakita D, Ijichi K, Watanabe T, Sato Y, Murata T, Iwata H, Shibamoto Y, Murakami S, Nishiyama Y, Kimura H. Oncolytic activity of HF10 in head and neck squamous cell carcinomas. Cancer Gene Ther 2020;27:585-98. [PMID: 31477804 DOI: 10.1038/s41417-019-0129-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
575 |
Tsompana M, Gluck C, Sethi I, Joshi I, Bard J, Nowak NJ, Sinha S, Buck MJ. Reactivation of super-enhancers by KLF4 in human Head and Neck Squamous Cell Carcinoma. Oncogene 2020;39:262-77. [PMID: 31477832 DOI: 10.1038/s41388-019-0990-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
576 |
Moon JH, Rho YS, Lee SH, Koo BS, Lee HJ, Do SI, Cho JH, Eun YG, Park MW, Shin HA, Lim YC. Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma. Oral Oncology 2019;96:34-41. [DOI: 10.1016/j.oraloncology.2019.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
577 |
Benzerdjeb N, Traverse-Glehen A, Philouze P, Bishop J, Devouassoux-Shisheboran M. Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival. Histopathology 2020;76:581-91. [PMID: 31463946 DOI: 10.1111/his.13982] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
578 |
Yoshida T, Terabe T, Nagai H, Uchida F, Hasegawa S, Nagao T, Miyabe S, Ishibashi-Kanno N, Yamagata K, Warabi E, Gosho M, Yanagawa T, Bukawa H. Association between p62 expression and clinicopathological characteristics in oral leukoplakia. Clin Exp Dent Res 2019;5:389-97. [PMID: 31452949 DOI: 10.1002/cre2.193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
579 |
Arenz A, Patze J, Kornmann E, Wilhelm J, Ziemann F, Wagner S, Wittig A, Schoetz U, Engenhart-Cabillic R, Dikomey E, Fritz B. HPV-negative and HPV-positive HNSCC cell lines show similar numerical but different structural chromosomal aberrations. Head Neck 2019;41:3869-79. [PMID: 31441163 DOI: 10.1002/hed.25924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
580 |
Badr M, Jöhrens K, Allgäuer M, Boxberg M, Weichert W, Tinhofer I, Denkert C, Schirmacher P, Stenzinger A, Budczies J. Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer. Cancer Immunol Immunother 2019;68:1443-54. [PMID: 31444607 DOI: 10.1007/s00262-019-02378-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
581 |
Kasahara Y, Endo K, Ueno T, Ueno H, Moriyama-Kita M, Odani A, Yoshizaki T. Bone invasion-targeted chemotherapy with a novel anionic platinum complex (3Pt) for oral squamous cell carcinoma. Cancer Sci 2019;110:3288-95. [PMID: 31348586 DOI: 10.1111/cas.14145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
582 |
Brzozowska A, Gołębiowski P. Acute radiation-induced oral mucositis in patients subjected to radiotherapy due to head and neck cancer. Polish Journal of Public Health 2019;129:27-30. [DOI: 10.2478/pjph-2019-0006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
583 |
Decker AS, Pylaeva E, Brenzel A, Spyra I, Droege F, Hussain T, Lang S, Jablonska J. Prognostic Role of Blood NETosis in the Progression of Head and Neck Cancer.Cells. 2019;8:946. [PMID: 31438586 DOI: 10.3390/cells8090946] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
584 |
Jiang Y, Cao W, Wu K, Qin X, Wang X, Li Y, Yu B, Zhang Z, Wang X, Yan M, Xu Q, Zhang J, Chen W. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. J Exp Clin Cancer Res 2019;38:365. [PMID: 31429766 DOI: 10.1186/s13046-019-1364-z] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 23.0] [Reference Citation Analysis]
|
585 |
Hsieh YT, Chen YF, Lin SC, Chang KW, Li WC. Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis. Int J Mol Sci 2019;20:E3960. [PMID: 31416244 DOI: 10.3390/ijms20163960] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
586 |
Zwick A, Bernhard M, Knoerck A, Linxweiler M, Schick B, Heinzelmann J, Smola S, Lohse S. Monitoring kinetics reveals critical parameters of IgA-dependent granulocyte-mediated anti-tumor cell cytotoxicity. J Immunol Methods 2019;473:112644. [PMID: 31404549 DOI: 10.1016/j.jim.2019.112644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
587 |
Xie Y, Zhong L, Duan D, Li T. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma. J Oral Pathol Med 2019;48:897-905. [PMID: 31318467 DOI: 10.1111/jop.12930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
588 |
Salvatore Benito A, Valero Zanuy MÁ, Alarza Cano M, Ruiz Alonso A, Alda Bravo I, Rogero Blanco E, Maíz Jiménez M, León Sanz M. Adherence to Mediterranean diet: A comparison of patients with head and neck cancer and healthy population. Endocrinología, Diabetes y Nutrición (English ed ) 2019;66:417-424. [DOI: 10.1016/j.endien.2018.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
589 |
Roy S, Kar M, Roy S, Padhi S, Saha A, Banerjee B. KLF4 expression in the surgical cut margin is associated with disease relapse of oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2019;128:154-65. [DOI: 10.1016/j.oooo.2019.02.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
590 |
Jin Y, Yang Y. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma. Biosci Rep 2019;39:BSR20191612. [PMID: 31324732 DOI: 10.1042/BSR20191612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
|
591 |
Zhou S, Zhu Y, He Z, Zhang D, Guo F, Jian X, Zhang C. Long Non-Coding RNA Expression Profile Associated with Malignant Progression of Oral Submucous Fibrosis. J Oncol 2019;2019:6835176. [PMID: 31467541 DOI: 10.1155/2019/6835176] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
592 |
Yang LL, Mao L, Wu H, Chen L, Deng WW, Xiao Y, Li H, Zhang L, Sun ZJ. pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma. Oral Oncol 2019;96:131-9. [PMID: 31422204 DOI: 10.1016/j.oraloncology.2019.07.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
593 |
Furqan M, Huma Z, Ashfaq Z, Nasir A, Ullah R, Bilal A, Iqbal M, Khalid MH, Hussain I, Faisal A. Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells. Cell Cycle 2019;18:2281-92. [PMID: 31318643 DOI: 10.1080/15384101.2019.1643658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
594 |
Yang D, Shi Y, Tang Y, Yin H, Guo Y, Wen S, Wang B, An C, Wu Y, Gao W. Effect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A Review. J Cancer 2019;10:4455-62. [PMID: 31528209 DOI: 10.7150/jca.34016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
|
595 |
Gu X, Boldrup L, Coates PJ, Fahraeus R, Wang L, Wilms T, Norberg-Spaak L, Sgaramella N, Nylander K. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue. J Pathol Clin Res 2019;5:240-7. [PMID: 31237113 DOI: 10.1002/cjp2.138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
596 |
Fan J, Liu W, Zhang M, Xing C. A literature review and systematic meta-analysis on XRCC3 Thr241Met polymorphism associating with susceptibility of oral cancer. Oncol Lett 2019;18:3265-73. [PMID: 31452804 DOI: 10.3892/ol.2019.10609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
597 |
Liu K, Du S, Gao P, Zheng J. Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1. J Cancer 2019;10:4196-207. [PMID: 31413738 DOI: 10.7150/jca.34145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
598 |
Britt EL, Raman S, Leek K, Sheehy CH, Kim SW, Harada H. Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment. PLoS One 2019;14:e0219398. [PMID: 31276572 DOI: 10.1371/journal.pone.0219398] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
599 |
Cui Z, Sun S, Liu Q, Zhou X, Gao S, Peng P, Li Q. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression. Biochem Cell Biol 2020;98:154-63. [PMID: 31265790 DOI: 10.1139/bcb-2019-0017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
600 |
Xiao R, An Y, Ye W, Derakhshan A, Cheng H, Yang X, Allen C, Chen Z, Schmitt NC, Van Waes C. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV- and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. Clin Cancer Res 2019;25:6463-74. [PMID: 31266830 DOI: 10.1158/1078-0432.CCR-18-3802] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
601 |
Jin RU, Mills JC. The cyclical hit model: how paligenosis might establish the mutational landscape in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Gastroenterol 2019;35:363-70. [PMID: 31021922 DOI: 10.1097/MOG.0000000000000540] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
|
602 |
Sun Z, Liu L, Wang C, Qian L, Yang J, Zhao Z, Fan Y, Peng Z. Assessment of the cancerization risk for oral potentially malignant disorders by clinical risk model combined with autofluorescence and brush biopsy with DNA-image cytometry. Eur Arch Otorhinolaryngol 2019;276:2549-57. [PMID: 31263980 DOI: 10.1007/s00405-019-05520-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
603 |
den Toom IJ, Boeve K, van Weert S, Bloemena E, Brouwers AH, Hoekstra OS, de Keizer B, van der Vegt B, Willems SM, Leemans CR, Witjes MJ, de Bree R. High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment. Oral Oncology 2019;94:68-72. [DOI: 10.1016/j.oraloncology.2019.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
|
604 |
Nam B, Ryu SM, Lee D, Jung CH, Jin CH, Kim JB, Lee IS, Han AR. Identification of Two New Phenanthrenes from Dendrobii Herba and Their Cytotoxicity towards Human Hypopharynx Squamous Carcinoma Cell (FaDu). Molecules 2019;24:E2339. [PMID: 31242649 DOI: 10.3390/molecules24122339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
605 |
Seo SB, Baek JY, Lim JH, Jin X, Lee MY, Lee JH. 14-3-3ζ targeting induced senescence in Hep-2 laryngeal cancer cell through deneddylation of Cullin1 in the Skp1-Cullin-F-box protein complex. Cell Prolif 2019;52:e12654. [PMID: 31222857 DOI: 10.1111/cpr.12654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
606 |
Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, Weichenhan D, Ullrich ND, Shang V, Richter D, Stögbauer F, Schroeder L, de Bem Prunes B, Visioli F, Rados PV, Jou A, Plath M, Federspil PA, Thierauf J, Döscher J, Weissinger SE, Hoffmann TK, Wagner S, Wittekindt C, Ishaque N, Eils R, Klussmann JP, Holzinger D, Plass C, Abdollahi A, Freier K, Weichert W, Zaoui K, Hess J. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. Int J Cancer 2019;145:3299-310. [PMID: 31135957 DOI: 10.1002/ijc.32481] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
607 |
van Harten AM, Buijze M, van der Mast R, Rooimans MA, Martens-de Kemp SR, Bachas C, Brink A, Stigter-van Walsum M, Wolthuis RMF, Brakenhoff RH. Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death. Oncogenesis 2019;8:38. [PMID: 31209198 DOI: 10.1038/s41389-019-0147-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
|
608 |
Liang Y, Feng G, Zhong S, Gao X, Tong Y, Cui W, Huang G, Zhang Z, Zhou X. An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma. Med Sci Monit 2019;25:4485-94. [PMID: 31203306 DOI: 10.12659/MSM.915248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
609 |
Wang Z, Wu VH, Allevato MM, Gilardi M, He Y, Callejas-valera JL, Vitale-cross L, Martin D, Amornphimoltham P, Mcdermott J, Goto Y, Molinolo AA, Sharabi AB, Cohen EEW, Chen Q, Lyons JG, Alexandrov LB, Gutkind JS. Novel syngeneic animal model of tobacco-associated oral cancer reveals the activity of in situ anti-CTLA-4.. [DOI: 10.1101/672527] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
610 |
Wichmann G, Gaede C, Melzer S, Bocsi J, Henger S, Engel C, Wirkner K, Wenning JR, Wald T, Freitag J, Willner M, Kolb M, Wiegand S, Löffler M, Dietz A, Tárnok A. Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets. Cancers (Basel) 2019;11:E814. [PMID: 31212819 DOI: 10.3390/cancers11060814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
611 |
Ha S, Zhou H, Gautam M, Song Y, Wang C. Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma. Mol Genet Genomic Med 2019;7:e00783. [PMID: 31169368 DOI: 10.1002/mgg3.783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
612 |
Li J, Li Z, Wu Y, Diao P, Zhang W, Wang Y, Yang J, Cheng J. Overexpression of lncRNA WWTR1‐AS1 associates with tumor aggressiveness and unfavorable survival in head‐neck squamous cell carcinoma. J Cell Biochem 2019;120:18266-77. [DOI: 10.1002/jcb.29132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
613 |
Saravani S, Miri-Moghaddam M, Bazi A, Miri-Moghaddam E. Association of Glutathione-S-Transferases M1 and T1 Deletional Variants with Development of Oral Squamous Cell Carcinoma: A Study in the South-East of Iran. Asian Pac J Cancer Prev 2019;20:1921-6. [PMID: 31244319 DOI: 10.31557/APJCP.2019.20.6.1921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
614 |
Hultin E, Arroyo Mühr LS, Lagheden C, Dillner J. HPV transcription in skin tumors. PLoS One 2019;14:e0217942. [PMID: 31150522 DOI: 10.1371/journal.pone.0217942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
615 |
Rahman S, Kraljević Pavelić S, Markova-Car E. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E2662. [PMID: 31151182 DOI: 10.3390/ijms20112662] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
616 |
Kaczor-Urbanowicz KE, Wei F, Rao SL, Kim J, Shin H, Cheng J, Tu M, Wong DTW, Kim Y. Clinical validity of saliva and novel technology for cancer detection. Biochim Biophys Acta Rev Cancer 2019;1872:49-59. [PMID: 31152821 DOI: 10.1016/j.bbcan.2019.05.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 9.5] [Reference Citation Analysis]
|
617 |
Dogan S, Xu B, Middha S, Vanderbilt CM, Bowman AS, Migliacci J, Morris LGT, Seshan VE, Ganly I. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. Int J Cancer 2019;145:3152-62. [PMID: 31093971 DOI: 10.1002/ijc.32412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
|
618 |
Ludwig S, Hong C, Razzo BM, Fabian KPL, Chelvanambi M, Lang S, Storkus WJ, Whiteside TL. Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma. Cancer Immunol Immunother 2019;68:1133-41. [DOI: 10.1007/s00262-019-02348-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
619 |
Blandino G, Valenti F, Sacconi A, Di Agostino S. Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease. Semin Cell Dev Biol 2020;98:105-17. [PMID: 31112799 DOI: 10.1016/j.semcdb.2019.05.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
|
620 |
Yang Z, Liao J, Carter-Cooper BA, Lapidus RG, Cullen KJ, Dan H. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer 2019;19:485. [PMID: 31118072 DOI: 10.1186/s12885-019-5664-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
621 |
Zhou L, Li Y, Gao W, Huangfu H, Wen S, Zhang C, Zhao Q, Dong Z, Qu C, Li G, Wu L, Wang B. Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2019;145:1761-72. [PMID: 31115672 DOI: 10.1007/s00432-019-02936-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
622 |
Ebrahim S, Weigert R. Intravital microscopy in mammalian multicellular organisms. Curr Opin Cell Biol 2019;59:97-103. [PMID: 31125832 DOI: 10.1016/j.ceb.2019.03.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
623 |
Zhou K, Chen J, Wu J, Xu Y, Wu Q, Yue J, Song Y, Li S, Zhou P, Tu W, Yang G, Jiang S. Profilin 2 Promotes Proliferation and Metastasis of Head and Neck Cancer Cells by Regulating PI3K/AKT/β-Catenin Signaling Pathway. Oncol Res 2019;27:1079-88. [PMID: 31122311 DOI: 10.3727/096504019X15579146061957] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
624 |
Kleszcz R, Szymańska A, Krajka-Kuźniak V, Baer-Dubowska W, Paluszczak J. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Cell Oncol (Dordr) 2019;42:505-20. [PMID: 31089983 DOI: 10.1007/s13402-019-00440-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
625 |
Chen TY, Hsieh YT, Huang JM, Liu CJ, Chuang LT, Huang PC, Kuo TY, Chia HY, Chou CY, Chang CW, Chen YF, Chen HM, Lo JF, Li WC. Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis. Neoplasia 2019;21:641-52. [PMID: 31100640 DOI: 10.1016/j.neo.2019.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
626 |
Rong C, Muller M, Flechtenmacher C, Holzinger D, Dyckhoff G, Bulut OC, Horn D, Plinkert P, Hess J, Affolter A. Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E584. [PMID: 31027243 DOI: 10.3390/cancers11040584] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
627 |
Soni S, Saroch MK, Chander B, Tirpude NV, Padwad YS. MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability. J Exp Clin Cancer Res 2019;38:175. [PMID: 31023373 DOI: 10.1186/s13046-019-1167-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
628 |
van de Goor RMGE, Hardy JCA, van Hooren MRA, Kremer B, Kross KW. Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study. Head Neck 2019;41:2983-90. [PMID: 31012533 DOI: 10.1002/hed.25787] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
629 |
Yang L, Kumar B, Shen C, Zhao S, Blakaj D, Li T, Romito M, Teknos TN, Williams TM. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma. Mol Cancer Ther 2019;18:1025-35. [PMID: 31015310 DOI: 10.1158/1535-7163.MCT-18-1157] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
630 |
Ambele MA, Pepper MS, van Heerden MB, van Heerden WFP. Molecular profile of tongue cancer in an 18-year-old female patient with no recognizable risk factor. Laryngoscope Investig Otolaryngol 2019;4:310-3. [PMID: 31236464 DOI: 10.1002/lio2.266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
631 |
Kytö E, Haapio E, Minn H, Irjala H. Critical review of the follow-up protocol for head and neck cancer patients. J Laryngol Otol 2019;133:424-9. [PMID: 31006389 DOI: 10.1017/S0022215119000811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
632 |
Hasan F, Katiyar T, Maurya SS, Yadav V, Yadav S, Pandey R, Mehrotra D, Hadi R, Singh S, Bhatt ML, Parmar D. Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients. Biomarkers 2019;24:574-83. [PMID: 31002268 DOI: 10.1080/1354750X.2019.1609090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
633 |
Chen WC, Li QL, Pan Q, Zhang HY, Fu XY, Yao F, Wang JN, Yang AK. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling. J Exp Clin Cancer Res 2019;38:167. [PMID: 30995931 DOI: 10.1186/s13046-019-1155-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
634 |
Sur S, Nakanishi H, Steele R, Ray RB. Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways. BMC Cancer 2019;19:354. [PMID: 30987615 DOI: 10.1186/s12885-019-5562-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
|
635 |
Zhang C, Qiao H, Guo W, Liu Y, Yang L, Liu Y, Jin B, Fu M, Wang G, Li W. CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis. Cancer Lett 2019;455:1-13. [PMID: 30981760 DOI: 10.1016/j.canlet.2019.04.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
636 |
Aoki R, Clanner‐engelshofen B, Charnowski S, Ruzicka T, Reinholz M. Distribution of high‐risk α‐genus human papillomavirus genotypes impacts cutaneous neoplasms. J Eur Acad Dermatol Venereol 2019;33:1304-11. [DOI: 10.1111/jdv.15547] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
637 |
Fernández-Mateos J, Seijas-Tamayo R, Adansa Klain JC, Pastor Borgoñón M, Pérez-Ruiz E, Mesía R, Del Barco E, Salvador Coloma C, Rueda Dominguez A, Caballero Daroqui J, Fernández Ruiz E, Ocana A, González-Sarmiento R, Cruz-Hernández JJ. Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population. Cancers (Basel) 2019;11:E493. [PMID: 30959967 DOI: 10.3390/cancers11040493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
638 |
Guo Y, Qiao X, Zhu L, Song R. MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene. Pathol Oncol Res 2020;26:1007-13. [PMID: 30949866 DOI: 10.1007/s12253-019-00647-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
639 |
Ouchida AT, Uyemura VT, Queiroz AL, Brauer VS, Cavalcanti-neto MP, Sousa LO, Uyemura SA, Curti C, Leopoldino AM. SET protein accumulation prevents cell death in head and neck squamous cell carcinoma through regulation of redox state and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2019;1866:623-37. [DOI: 10.1016/j.bbamcr.2019.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
640 |
Vahabi M, Pulito C, Sacconi A, Donzelli S, D'Andrea M, Manciocco V, Pellini R, Paci P, Sanguineti G, Strigari L, Spriano G, Muti P, Pandolfi PP, Strano S, Safarian S, Ganci F, Blandino G. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells. J Exp Clin Cancer Res 2019;38:141. [PMID: 30925916 DOI: 10.1186/s13046-019-1119-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
|
641 |
Plzák J, Bouček J, Bandúrová V, Kolář M, Hradilová M, Szabo P, Lacina L, Chovanec M, Smetana K Jr. The Head and Neck Squamous Cell Carcinoma Microenvironment as a Potential Target for Cancer Therapy. Cancers (Basel) 2019;11:E440. [PMID: 30925774 DOI: 10.3390/cancers11040440] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
|
642 |
Yang CX, Sedhom W, Song J, Lu SL. The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E395. [PMID: 30901831 DOI: 10.3390/cancers11030395] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
643 |
Hsing EW, Shiah SG, Peng HY, Chen YW, Chuu CP, Hsiao JR, Lyu PC, Chang JY. TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility. PLoS One 2019;14:e0213463. [PMID: 30893332 DOI: 10.1371/journal.pone.0213463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
644 |
Wang Z, Feng X, Molinolo AA, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen DJ, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman SM, Gutkind JS. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res 2019;79:1438-50. [PMID: 30894372 DOI: 10.1158/0008-5472.CAN-18-1220] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
|
645 |
Linge A, Schmidt S, Lohaus F, Krenn C, Bandurska-Luque A, Platzek I, von Neubeck C, Appold S, Nowak A, Gudziol V, Buchholz F, Baretton GB, Baumann M, Löck S, Krause M. Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy. Clin Transl Radiat Oncol 2019;16:40-7. [PMID: 30993218 DOI: 10.1016/j.ctro.2019.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
|
646 |
Hänel L, Kwiatkowski M, Heikaus L, Schlüter H. Mass spectrometry-based intraoperative tumor diagnostics. Future Sci OA 2019;5:FSO373. [PMID: 30906569 DOI: 10.4155/fsoa-2018-0087] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
|
647 |
Reid P, Marcu LG, Olver I, Moghaddasi L, Staudacher AH, Bezak E. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiother Oncol 2019;135:1-12. [PMID: 31015153 DOI: 10.1016/j.radonc.2019.02.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
648 |
Yang JG, Wang WM, Xia HF, Yu ZL, Li HM, Ren JG, Chen G, Wang BK, Jia J, Zhang W, Zhao YF. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner. Int J Cancer 2019;145:1358-70. [PMID: 30785217 DOI: 10.1002/ijc.32221] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
649 |
Islam T, Rahman R, Gov E, Turanli B, Gulfidan G, Haque A, Arga KY, Haque Mollah N. Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses. OMICS 2018;22:422-36. [PMID: 29927717 DOI: 10.1089/omi.2018.0048] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
|
650 |
Bu L, Rao L, Yu G, Chen L, Deng W, Liu J, Wu H, Meng Q, Guo S, Zhao X, Zhang W, Chen G, Gu Z, Liu W, Sun Z. Cancer Stem Cell‐Platelet Hybrid Membrane‐Coated Magnetic Nanoparticles for Enhanced Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. Adv Funct Mater 2019;29:1807733. [DOI: 10.1002/adfm.201807733] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 23.0] [Reference Citation Analysis]
|
651 |
Liu L, Jung S, Oh C, Lee K, Won H, Chang JW, Kim JM, Koo BS. LAMB3 is associated with disease progression and cisplatin cytotoxic sensitivity in head and neck squamous cell carcinoma. European Journal of Surgical Oncology 2019;45:359-65. [DOI: 10.1016/j.ejso.2018.10.543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
652 |
Ramos-garcía P, González-moles MÁ, González-ruiz L, Ayén Á, Ruiz-ávila I, Bravo M, Gil-montoya JA. Clinicopathological significance of tumor cyclin D1 expression in oral cancer. Archives of Oral Biology 2019;99:177-82. [DOI: 10.1016/j.archoralbio.2019.01.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
|
653 |
Hsu C, Chen Y, Hsieh Y, Chang K, Hsueh P, Chen T, Yu J, Chang Y, Li L, Wu C. Integrated analyses utilizing metabolomics and transcriptomics reveal perturbation of the polyamine pathway in oral cavity squamous cell carcinoma. Analytica Chimica Acta 2019;1050:113-22. [DOI: 10.1016/j.aca.2018.10.070] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
|
654 |
Božinović K, Sabol I, Dediol E, Milutin Gašperov N, Manojlović S, Vojtechova Z, Tachezy R, Grce M. Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer. Sci Rep 2019;9:2306. [PMID: 30783190 DOI: 10.1038/s41598-019-38797-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
|
655 |
Zheng T, Feng H, Liu L, Peng J, Xiao H, Yu T, Zhou Z, Li Y, Zhang Y, Bai X, Zhao S, Shi Y, Chen Y. Enhanced antiproliferative effect of resveratrol in head and neck squamous cell carcinoma using GE11 peptide conjugated liposome. Int J Mol Med 2019;43:1635-42. [PMID: 30816515 DOI: 10.3892/ijmm.2019.4096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
656 |
Novoplansky O, Fury M, Prasad M, Yegodayev K, Zorea J, Cohen L, Pelossof R, Cohen L, Katabi N, Cecchi F, Joshua BZ, Popovtzer A, Baselga J, Scaltriti M, Elkabets M. MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer. Int J Cancer 2019;145:748-62. [PMID: 30694565 DOI: 10.1002/ijc.32170] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
657 |
Cohen PA, Anderson L, Eva L, Scurry J. Clinical and molecular classification of vulvar squamous pre-cancers. Int J Gynecol Cancer 2019;29:821-8. [PMID: 30737358 DOI: 10.1136/ijgc-2018-000135] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
|
658 |
Huebbers CU, Verhees F, Poluschkin L, Olthof NC, Kolligs J, Siefer OG, Henfling M, Ramaekers FCS, Preuss SF, Beutner D, Seehawer J, Drebber U, Korkmaz Y, Lam WL, Vucic EA, Kremer B, Klussmann JP, Speel EM. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis. Int J Cancer 2019;144:2465-77. [PMID: 30367463 DOI: 10.1002/ijc.31954] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
659 |
Deng P, Wang J, Zhang X, Wu X, Ji N, Li J, Zhou M, Jiang L, Zeng X, Chen Q. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2. Carcinogenesis 2018;39:937-47. [PMID: 29741610 DOI: 10.1093/carcin/bgy046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
|
660 |
Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma. Theranostics 2019;9:920-31. [PMID: 30867806 DOI: 10.7150/thno.30339] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
|
661 |
Salvatore Benito A, Valero Zanuy MÁ, Alarza Cano M, Ruiz Alonso A, Alda Bravo I, Rogero Blanco E, Maíz Jiménez M, León Sanz M. Adherence to Mediterranean diet: A comparison of patients with head and neck cancer and healthy population. Endocrinol Diabetes Nutr (Engl Ed) 2019;66:417-24. [PMID: 30683496 DOI: 10.1016/j.endinu.2018.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
662 |
Guo YZ, Sun HH, Wang XT, Wang MT. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. J Zhejiang Univ Sci B 2018;19:674-88. [PMID: 30178634 DOI: 10.1631/jzus.B1700319] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
663 |
Pavón MA, Arroyo-Solera I, León X, Téllez-Gabriel M, Virós D, Gallardo A, Céspedes MV, Casanova I, Lopez-Pousa A, Barnadas A, Quer M, Mangues R. The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes. Head Neck 2019;41:1830-45. [PMID: 30652380 DOI: 10.1002/hed.25623] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
664 |
Byeon HK, Ku M, Yang J. Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer. Exp Mol Med 2019;51:1-14. [PMID: 30700700 DOI: 10.1038/s12276-018-0202-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
|
665 |
Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I, Roccuzzo G, Colella G, Caraglia M, Franco R. Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther 2019;19:105-19. [PMID: 30582397 DOI: 10.1080/14737140.2019.1561288] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
|
666 |
Qin X, Guo H, Wang X, Zhu X, Yan M, Wang X, Xu Q, Shi J, Lu E, Chen W, Zhang J. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol 2019;20:12. [PMID: 30642385 DOI: 10.1186/s13059-018-1604-0] [Cited by in Crossref: 189] [Cited by in F6Publishing: 213] [Article Influence: 47.3] [Reference Citation Analysis]
|
667 |
Yadav P, Malik R, Balani S, Nigam RK, Jain P, Tandon P. Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx. J Oral Maxillofac Pathol 2019;23:224-30. [PMID: 31516228 DOI: 10.4103/jomfp.JOMFP_299_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
668 |
Li W, Tao C, Wang J, Le Y, Zhang J. MMP-responsive in situ forming hydrogel loaded with doxorubicin-encapsulated biodegradable micelles for local chemotherapy of oral squamous cell carcinoma. RSC Adv 2019;9:31264-73. [DOI: 10.1039/c9ra04343h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
669 |
Jones J, Ahmad FI. Anesthesia for Free Flap Reconstruction after Head and Neck Surgical Resection. Oncologic Critical Care 2019. [DOI: 10.1007/978-3-319-74698-2_158-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
670 |
Giordano F. HNO-Tumoren. Strahlentherapie kompakt 2019. [DOI: 10.1016/b978-3-437-23292-3.00003-9] [Reference Citation Analysis]
|
671 |
Andreadis DA, Pavlou A, Panta P. Biopsy and Oral Squamous Cell Carcinoma Histopathology. Oral Cancer Detection 2019. [DOI: 10.1007/978-3-319-61255-3_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
672 |
Yang QC, Wu CC, Cao LY, Xiao Y, Li H, Liu B, Sun ZJ. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma. Int J Med Sci 2019;16:783-92. [PMID: 31337951 DOI: 10.7150/ijms.33415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
673 |
Ramos‐garcía P, González‐moles MÁ, Ayén Á, González‐ruiz L, Ruiz‐ávila I, Gil‐montoya JA. Prognostic and clinicopathological significance of CTTN /cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta‐analysis. Head & Neck 2019;41:1963-78. [DOI: 10.1002/hed.25632] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
674 |
Li Z, Liao J, Yang Z, Choi EY, Lapidus RG, Liu X, Cullen KJ, Dan H. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. Br J Cancer 2019;120:306-16. [PMID: 30585254 DOI: 10.1038/s41416-018-0351-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
675 |
Hollows R, Wei W, Cazier JB, Mehanna H, Parry G, Halford G, Murray P. Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma. Head Neck 2019;41:993-1006. [PMID: 30582241 DOI: 10.1002/hed.25537] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
676 |
Cordes N, Ney M, Beleites T, Aust D, Baretton G, Thames H, Baumann M, Krause M, Löck S, Appold S. Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy. PLoS One 2018;13:e0209479. [PMID: 30571736 DOI: 10.1371/journal.pone.0209479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
677 |
Teknos TN, Grecula J, Agrawal A, Old MO, Ozer E, Carrau R, Kang S, Rocco J, Blakaj D, Diavolitsis V, Kumar B, Kumar P, Pan Q, Palettas M, Wei L, Baiocchi R, Savvides P. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma. Invest New Drugs 2019;37:702-10. [PMID: 30569244 DOI: 10.1007/s10637-018-0696-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
|
678 |
Wu H, Yu DH, Wu MH, Huang T. Long non-coding RNA LOC541471: A novel prognostic biomarker for head and neck squamous cell carcinoma. Oncol Lett 2019;17:2457-64. [PMID: 30675311 DOI: 10.3892/ol.2018.9831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
679 |
Ambele MA, Pepper MS, van Heerden MB, van Heerden WFP. Heterozygosity of p16 expression in an oral squamous cell carcinoma with associated loss of heterozygosity and copy number alterations. Head Neck 2019;41:E62-5. [PMID: 30552721 DOI: 10.1002/hed.25566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
680 |
Yang LL, Zhang MJ, Wu L, Mao L, Chen L, Yu GT, Deng WW, Zhang WF, Liu B, Sun WK, Sun ZJ. LAIR-1 overexpression and correlation with advanced pathological grade and immune suppressive status in oral squamous cell carcinoma. Head Neck 2019;41:1080-6. [PMID: 30549148 DOI: 10.1002/hed.25539] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
681 |
Corpman DW, Masroor F, Carpenter DM, Nayak S, Gurushanthaiah D, Wang KH. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer. Head Neck 2019;41:456-62. [PMID: 30549345 DOI: 10.1002/hed.25425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
682 |
Arroyo-Solera I, Pavón MÁ, León X, López M, Gallardo A, Céspedes MV, Casanova I, Pallarès V, López-Pousa A, Mangues MA, Barnadas A, Quer M, Mangues R. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma. Head Neck 2019;41:429-39. [PMID: 30548470 DOI: 10.1002/hed.25437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
683 |
Firigato I, de Toledo Gonçalves F, De Antonio J, Alberto Curioni O, Rocha Silva M, Jorge Fígaro Gattás G. How many copies of GSTM1 and GSTT1 are associated with head and neck cancer risk? Biomarkers 2019;24:262-7. [PMID: 30526121 DOI: 10.1080/1354750X.2018.1556337] [Reference Citation Analysis]
|
684 |
Diao P, Song Y, Ge H, Wu Y, Li J, Zhang W, Wang Y, Cheng J. Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma. J Cell Biochem 2019;120:10010-20. [PMID: 30548328 DOI: 10.1002/jcb.28284] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
|
685 |
Strzelczyk JK, Krakowczyk Ł, Owczarek AJ. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma. Arch Oral Biol 2019;98:265-72. [PMID: 30576962 DOI: 10.1016/j.archoralbio.2018.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
|
686 |
Lee YS, Johnson DE, Grandis JR. An update: emerging drugs to treat squamous cell carcinomas of the head and neck. Expert Opin Emerg Drugs 2018;23:283-99. [PMID: 30376740 DOI: 10.1080/14728214.2018.1543400] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
|
687 |
Shah S, Mishra G, Kalia K. Single nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with oral cancer. Oral Cancer 2018;2:83-89. [DOI: 10.1007/s41548-018-0012-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
688 |
Das R, Coupar J, Clavijo PE, Saleh A, Cheng TF, Yang X, Chen J, Van Waes C, Chen Z. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. Mol Carcinog 2019;58:411-25. [PMID: 30488488 DOI: 10.1002/mc.22938] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
689 |
Sapna G, Gokul S. Next generation sequencing in oral disease diagnostics. World J Stomatol 2018; 6(2): 6-10 [DOI: 10.5321/wjs.v6.i2.6] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
690 |
Sharma A, Cao EY, Kumar V, Zhang X, Leong HS, Wong AML, Ramakrishnan N, Hakimullah M, Teo HMV, Chong FT, Chia S, Thangavelu MT, Kwang XL, Gupta R, Clark JR, Periyasamy G, Iyer NG, DasGupta R. Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy. Nat Commun 2018;9:4931. [PMID: 30467425 DOI: 10.1038/s41467-018-07261-3] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 17.2] [Reference Citation Analysis]
|
691 |
Wang R, Ma Z, Feng L, Yang Y, Tan C, Shi Q, Lian M, He S, Ma H, Fang J. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression. Mol Cancer 2018;17:162. [PMID: 30458787 DOI: 10.1186/s12943-018-0916-8] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 14.6] [Reference Citation Analysis]
|
692 |
Wang P, Jin M, Sun CH, Yang L, Li YS, Wang X, Sun YN, Tian LL, Liu M. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC). Biosci Rep 2018;38:BSR20181528. [PMID: 30355656 DOI: 10.1042/BSR20181528] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
|
693 |
Gao P, Fan R, Ge T. SNHG20 serves as a predictor for prognosis and promotes cell growth in oral squamous cell carcinoma. Oncol Lett 2019;17:951-7. [PMID: 30655853 DOI: 10.3892/ol.2018.9709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
694 |
Zhang L, Li Z, Liu Y, Xu S, Tandon M, Appelboom B, LaValle CR, Chiosea SI, Wang L, Sen M, Lui VWY, Grandis JR, Wang QJ. Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma. BMC Cancer 2018;18:1107. [PMID: 30419840 DOI: 10.1186/s12885-018-4965-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
695 |
Vossen DM, Verhagen CVM, Grénman R, Kluin RJC, Verheij M, van den Brekel MWM, Wessels LFA, Vens C. Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association. PLoS One 2018;13:e0206632. [PMID: 30408064 DOI: 10.1371/journal.pone.0206632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
696 |
Liu Z, Li H, Fan S, Lin H, Lian W. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Cancer Biol Ther 2019;20:444-53. [PMID: 30404566 DOI: 10.1080/15384047.2018.1529119] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
|
697 |
Kareemaghay S, Tavassoli M. Clinical immunotherapeutic approaches for the treatment of head and neck cancer. Int J Oral Maxillofac Surg 2019;48:419-36. [PMID: 30401512 DOI: 10.1016/j.ijom.2018.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
698 |
Du S, Liu K, Gao P, Li Z, Zheng J. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Life Sci 2018;212:182-93. [PMID: 30243648 DOI: 10.1016/j.lfs.2018.09.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
699 |
Wintergerst L, Selmansberger M, Maihoefer C, Schüttrumpf L, Walch A, Wilke C, Pitea A, Woischke C, Baumeister P, Kirchner T, Belka C, Ganswindt U, Zitzelsberger H, Unger K, Hess J. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Mol Oncol 2018;12:2085-101. [PMID: 30259648 DOI: 10.1002/1878-0261.12388] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
700 |
Tanaka N, Osman AA, Takahashi Y, Lindemann A, Patel AA, Zhao M, Takahashi H, Myers JN. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncol 2018;87:49-57. [PMID: 30527243 DOI: 10.1016/j.oraloncology.2018.10.018] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
|
701 |
Khan AQ, Siveen KS, Prabhu KS, Kuttikrishnan S, Akhtar S, Shaar A, Raza A, Mraiche F, Dermime S, Uddin S. Curcumin-Mediated Degradation of S-Phase Kinase Protein 2 Induces Cytotoxic Effects in Human Papillomavirus-Positive and Negative Squamous Carcinoma Cells. Front Oncol 2018;8:399. [PMID: 30333956 DOI: 10.3389/fonc.2018.00399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
702 |
Baumeister P, Hollmann A, Kitz J, Afthonidou A, Simon F, Shakhtour J, Mack B, Kranz G, Libl D, Leu M, Schirmer MA, Canis M, Belka C, Zitzelsberger H, Ganswindt U, Hess J, Jakob M, Unger K, Gires O. High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma. Sci Rep 2018;8:14582. [PMID: 30275505 DOI: 10.1038/s41598-018-32178-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
703 |
Araldi RP, Sant’ana TA, Módolo DG, de Melo TC, Spadacci-morena DD, de Cassia Stocco R, Cerutti JM, de Souza EB. The human papillomavirus (HPV)-related cancer biology: An overview. Biomedicine & Pharmacotherapy 2018;106:1537-56. [DOI: 10.1016/j.biopha.2018.06.149] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
|
704 |
Pan M, Schinke H, Luxenburger E, Kranz G, Shakhtour J, Libl D, Huang Y, Gaber A, Pavšič M, Lenarčič B, Kitz J, Jakob M, Schwenk-Zieger S, Canis M, Hess J, Unger K, Baumeister P, Gires O. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers. PLoS Biol 2018;16:e2006624. [PMID: 30261040 DOI: 10.1371/journal.pbio.2006624] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
|
705 |
Hong J, Kim S, Lin PC. Interleukin-33 and ST2 Signaling in Tumor Microenvironment. J Interferon Cytokine Res 2019;39:61-71. [PMID: 30256696 DOI: 10.1089/jir.2018.0044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
706 |
Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJG, Harrington KJ, Smith G, Kramer-Marek G. Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models. J Nucl Med 2019;60:353-61. [PMID: 30213849 DOI: 10.2967/jnumed.118.216069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
707 |
Tong Q, Wang XL, Li SB, Yang GL, Jin S, Gao ZY, Liu XB. Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips. Onco Targets Ther. 2018;11:5777-5787. [PMID: 30254470 DOI: 10.2147/ott.s171242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
|
708 |
Segrelles C, Paramio JM, Lorz C. The transcriptional co-activator YAP: A new player in head and neck cancer. Oral Oncol 2018;86:25-32. [PMID: 30409308 DOI: 10.1016/j.oraloncology.2018.08.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
|
709 |
Li C, Torres VC, Tichauer KM. Noninvasive detection of cancer spread to lymph nodes: A review of molecular imaging principles and protocols. J Surg Oncol 2018;118:301-14. [PMID: 30196532 DOI: 10.1002/jso.25124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
710 |
Liu XX, Liu WD, Wang L, Zhu B, Shi X, Peng ZX, Zhu HC, Liu XD, Zhong MZ, Xie D, Zeng MS, Ren CP. Roles of flotillins in tumors. J Zhejiang Univ Sci B 2018;19:171-82. [PMID: 29504311 DOI: 10.1631/jzus.B1700102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
711 |
Ambatipudi S, Langdon R, Richmond RC, Suderman M, Koestler DC, Kelsey KT, Kazmi N, Penfold C, Ho KM, McArdle W, Ring SM, Pring M, Waterboer T, Pawlita M, Gaunt TR, Davey Smith G, Thomas S, Ness AR, Relton CL. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival. Oral Oncol 2018;85:87-94. [PMID: 30220325 DOI: 10.1016/j.oraloncology.2018.08.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
712 |
Wu JS, Zheng M, Zhang M, Pang X, Li L, Wang SS, Yang X, Wu JB, Tang YJ, Tang YL, Liang XH. Porphyromonas gingivalis Promotes 4-Nitroquinoline-1-Oxide-Induced Oral Carcinogenesis With an Alteration of Fatty Acid Metabolism. Front Microbiol 2018;9:2081. [PMID: 30233549 DOI: 10.3389/fmicb.2018.02081] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
|
713 |
Madrigal E, Bishop JA, Faquin WC. Head and Neck Cytopathology. Surgical Pathology Clinics 2018;11:501-14. [DOI: 10.1016/j.path.2018.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
714 |
Sánchez-Danés A, Blanpain C. Deciphering the cells of origin of squamous cell carcinomas. Nat Rev Cancer 2018;18:549-61. [PMID: 29849070 DOI: 10.1038/s41568-018-0024-5] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 24.2] [Reference Citation Analysis]
|
715 |
Yang SH, Lee TY, Ho CA, Yang CY, Huang WY, Lin YC, Nieh S, Lin YS, Chen SF, Lin FH. Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma. PLoS One 2018;13:e0201267. [PMID: 30148841 DOI: 10.1371/journal.pone.0201267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
716 |
Sequeira I, Neves JF, Carrero D, Peng Q, Palasz N, Liakath-Ali K, Lord GM, Morgan PR, Lombardi G, Watt FM. Immunomodulatory role of Keratin 76 in oral and gastric cancer. Nat Commun 2018;9:3437. [PMID: 30143634 DOI: 10.1038/s41467-018-05872-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
717 |
Zhong Q, Fang J, Huang Z, Yang Y, Lian M, Liu H, Zhang Y, Ye J, Hui X, Wang Y, Ying Y, Zhang Q, Cheng Y. A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma. Sci Rep 2018;8:12675. [PMID: 30139993 DOI: 10.1038/s41598-018-31027-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
718 |
Vukovic V, Stojanovic J, Vecchioni A, Pastorino R, Boccia S. Systematic Review and Meta-analysis of SNPs from Genome-Wide Association Studies of Head and Neck Cancer. Otolaryngol Head Neck Surg 2018;159:615-24. [PMID: 30126334 DOI: 10.1177/0194599818792262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
719 |
Lee BS, Kim YS, Kim HJ, Kim DH, Won HR, Kim YS, Kim CH. HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells. Sci Rep 2018;8:12520. [PMID: 30131570 DOI: 10.1038/s41598-018-31039-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
720 |
Vishwakarma V, New J, Kumar D, Snyder V, Arnold L, Nissen E, Hu Q, Cheng N, Miller D, Thomas AR, Shnayder Y, Kakarala K, Tsue TT, Girod DA, Thomas SM. Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds. Sci Rep 2018;8:12163. [PMID: 30111862 DOI: 10.1038/s41598-018-29683-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
721 |
de Carvalho AC, Melendez ME, da Silva Sabato C, Palmero EI, Arantes LMRB, Neto CS, Carvalho AL. Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples. Pathol Oncol Res 2019;25:1047-58. [PMID: 30099696 DOI: 10.1007/s12253-018-0462-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
722 |
Kiessling SY, Broglie MA, Soltermann A, Huber GF, Stoeckli SJ. Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure. Laryngoscope Investig Otolaryngol 2018;3:283-9. [PMID: 30186959 DOI: 10.1002/lio2.175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
723 |
Sobecka A, Blaszczak W, Barczak W, Golusinski P, Rubis B, Masternak MM, Suchorska WM, Golusinski W. hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression. J Appl Genet 2018;59:453-61. [PMID: 30088231 DOI: 10.1007/s13353-018-0458-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
724 |
Puttipanyalears C, Arayataweegool A, Chalertpet K, Rattanachayoto P, Mahattanasakul P, Tangjaturonsasme N, Kerekhanjanarong V, Mutirangura A, Kitkumthorn N. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma. BMC Cancer 2018;18:786. [PMID: 30081853 DOI: 10.1186/s12885-018-4706-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
725 |
Li CC, Shen Z, Bavarian R, Yang F, Bhattacharya A. Oral Cancer: Genetics and the Role of Precision Medicine. Dent Clin North Am 2018;62:29-46. [PMID: 29126492 DOI: 10.1016/j.cden.2017.08.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
726 |
Jin RU, Mills JC. Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM. Dig Dis Sci 2018;63:2028-41. [PMID: 29948563 DOI: 10.1007/s10620-018-5150-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
727 |
Xiao R, Allen CT, Tran L, Patel P, Park SJ, Chen Z, Van Waes C, Schmitt NC. Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. Oncoimmunology 2018;7:e1471440. [PMID: 30393585 DOI: 10.1080/2162402X.2018.1471440] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
|
728 |
Gupta A, Ajith A, Singh S, Panday RK, Samaiya A, Shukla S. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect. Cell Death Dis 2018;9:825. [PMID: 30068946 DOI: 10.1038/s41419-018-0887-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
|
729 |
Ong HS, Gokavarapu S, Tian Z, Li J, Xu Q, Zhang CP, Cao W. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma. J Oral Pathol Med 2018;47:652-9. [PMID: 29660835 DOI: 10.1111/jop.12713] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
730 |
Russo D, Merolla F, Varricchio S, Salzano G, Zarrilli G, Mascolo M, Strazzullo V, Di Crescenzo RM, Celetti A, Ilardi G. Epigenetics of oral and oropharyngeal cancers. Biomed Rep 2018;9:275-83. [PMID: 30233779 DOI: 10.3892/br.2018.1136] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
731 |
Baker LCJ, Sikka A, Price JM, Boult JKR, Lepicard EY, Box G, Jamin Y, Spinks TJ, Kramer-Marek G, Leach MO, Eccles SA, Box C, Robinson SP. Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma. Front Oncol 2018;8:271. [PMID: 30083516 DOI: 10.3389/fonc.2018.00271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
732 |
Gao L, Zhao X, Lang L, Shay C, Andrew Yeudall W, Teng Y. Autophagy blockade sensitizes human head and neck squamous cell carcinoma towards CYT997 through enhancing excessively high reactive oxygen species-induced apoptosis. J Mol Med (Berl) 2018;96:929-38. [PMID: 30022281 DOI: 10.1007/s00109-018-1670-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
733 |
Sarkar S, Panda CK. Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection. Cancer Biol Ther 2018;19:631-5. [PMID: 29624473 DOI: 10.1080/15384047.2018.1449615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
734 |
Villa A, Hanna GJ. Human papillomavirus and oropharyngeal cancer. Curr Probl Cancer 2018;42:466-75. [PMID: 30049422 DOI: 10.1016/j.currproblcancer.2018.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
735 |
Brown JA, Yonekubo Y, Hanson N, Sastre-Perona A, Basin A, Rytlewski JA, Dolgalev I, Meehan S, Tsirigos A, Beronja S, Schober M. TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. Cell Stem Cell 2017;21:650-664.e8. [PMID: 29100014 DOI: 10.1016/j.stem.2017.10.001] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 17.2] [Reference Citation Analysis]
|
736 |
Khaznadar SS, Khan M, Schmid E, Gebhart S, Becker ET, Krahn T, von Ahsen O. EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication. Oncotarget 2018;9:28965-75. [PMID: 29989001 DOI: 10.18632/oncotarget.25656] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
737 |
Segrelles C, Contreras D, Navarro EM, Gutiérrez-Muñoz C, García-Escudero R, Paramio JM, Lorz C. Bosutinib Inhibits EGFR Activation in Head and Neck Cancer. Int J Mol Sci 2018;19:E1824. [PMID: 29933569 DOI: 10.3390/ijms19071824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
738 |
Lin MC, Chien PH, Wu HY, Chen ST, Juan HF, Lou PJ, Huang MC. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer. Oncogene 2018;37:5780-93. [PMID: 29930379 DOI: 10.1038/s41388-018-0375-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
|
739 |
Qian X, Nie X, Yao W, Klinghammer K, Sudhoff H, Kaufmann AM, Albers AE. Reactive oxygen species in cancer stem cells of head and neck squamous cancer. Semin Cancer Biol 2018;53:248-57. [PMID: 29935313 DOI: 10.1016/j.semcancer.2018.06.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
|
740 |
Zhang J, Chen T, Yang X, Cheng H, Späth SS, Clavijo PE, Chen J, Silvin C, Issaeva N, Su X, Yarbrough WG, Annunziata CM, Chen Z, Van Waes C. Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. Cancer Res 2018;78:4613-26. [PMID: 29921694 DOI: 10.1158/0008-5472.CAN-17-0642] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
|
741 |
Ramos-García P, González-Moles MÁ, González-Ruiz L, Ruiz-Ávila I, Ayén Á, Gil-Montoya JA. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol 2018;83:96-106. [PMID: 30098785 DOI: 10.1016/j.oraloncology.2018.06.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
|
742 |
Yap LF, Lai SL, Rhodes A, Sathasivam HP, Abdullah MA, Pua KC, Rajadurai P, Cheah PL, Thavaraj S, Robinson M, Paterson IC. Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infection. Infect Agent Cancer 2018;13:21. [PMID: 29942347 DOI: 10.1186/s13027-018-0193-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
743 |
Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2018;125:650-69. [DOI: 10.1016/j.oooo.2018.03.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
|
744 |
Bates AM, Gomez Hernandez MP, Lanzel EA, Qian F, Brogden KA. Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines. Transl Cancer Res 2018;7:533-42. [PMID: 30221145 DOI: 10.21037/tcr.2018.05.09] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
745 |
Tang PL, Chen HC, Huang WC, Li SF, Kuo HC. Factors pertaining to long-term mortality following emergency visits for head and neck cancer. J Dent Sci 2018;13:234-41. [PMID: 30895126 DOI: 10.1016/j.jds.2018.03.003] [Reference Citation Analysis]
|
746 |
Wu H, Deng WW, Yang LL, Zhang WF, Sun ZJ. Expression and phosphorylation of Stathmin 1 indicate poor survival in head and neck squamous cell carcinoma and associate with immune suppression. Biomark Med. 2018;12:759-769. [PMID: 29847156 DOI: 10.2217/bmm-2017-0443] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
747 |
Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. Human papillomavirus-related oropharyngeal cancer. Ann Oncol 2017;28:2386-98. [PMID: 28633362 DOI: 10.1093/annonc/mdx304] [Cited by in Crossref: 183] [Cited by in F6Publishing: 194] [Article Influence: 36.6] [Reference Citation Analysis]
|
748 |
Chernesky M, Jang D, Schweizer J, Arias M, Doerwald-Munoz L, Gupta M, Jackson B, Archibald S, Young J, Lytwyn A, Smieja M, Severini A, Ecobichon-Morris A, Hyrcza M. HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma. Papillomavirus Res 2018;6:1-5. [PMID: 29842928 DOI: 10.1016/j.pvr.2018.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
749 |
Abolhalaj M, Askmyr D, Sakellariou CA, Lundberg K, Greiff L, Lindstedt M. Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils. Sci Rep 2018;8:8030. [PMID: 29795118 DOI: 10.1038/s41598-018-26193-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
750 |
Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf GT, Taylor JMG, D'Silva NJ. Redefining Perineural Invasion: Integration of Biology With Clinical Outcome. Neoplasia 2018;20:657-67. [PMID: 29800815 DOI: 10.101 |